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ABSTRACT 
Designer Exons Inform a Biophysical Model for Exon Definition 
Mauricio Arias 
Pre-mRNA molecules in humans contain mostly short internal exons flanked by long introns. To 
explain the removal of such introns, recognition of the exons instead of recognition of the introns 
has been proposed. This thesis studies this exon definition mechanism using a bottom-up 
approach. To reduce the complexity of the system under study, this exon definition mechanism 
was addressed using designer exons made up of prototype sequence modules of our own design 
(including an exonic splicing enhancer or silencer). Studies were performed in vitro with a set of 
DEs obtained from random combinations of the exonic splicing enhancer and the exonic splicing 
silencer modules. The results showed considerable variability both in terms of the composition 
and size of the DEs and in terms of their inclusion level. To understand how different DEs 
generated different inclusion levels, the problem was divided into understanding separately 
parameters varied between DEs. Subsequent studies focused on each of three parameters: size, 
ESE composition and ESS composition. The final objective was to be able to combine their 
effects to predict the inclusion levels obtained for the “random” DEs mentioned previously. To 
complement this experimental approach an equation was generated in two stages. First a general 
“framework” equation was obtained modeling a necessary exon definition complex that enabled 
commitment to inclusion. This equation used rates for the formation and dissociation of this 
complex without elaborating on the details for how those rates came about. In the second stage, 
however, formation and dissociation were modeled using novel but intuitive ideas and these 
models were combined into a final equation. This equation using the single-parameter 
perturbation data obtained previously performed well in predicting the inclusion levels of the 
“random” DEs. Additionally, both the final equation and the mechanisms proposed align well 
with results published by other groups. In order to make these results more accessible and to 
open more opportunities to extend them, an initial attempt is presented to identify the proteins 
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Since the discovery of split genes in the 1970s (Berget et al. 1977), there have been 
significant advances in our understanding of how these genes function in the cell. Transcription 
of these genes produces pre-mRNA molecules. These molecules are processed to generate 
shorter mRNA molecules, in which the intervening sequences have been removed. One crucial 
aspect in this process is how the cell accurately identifies which regions are to be removed, 
introns, and which are to be kept and spliced together, exons (Fox-Walsh and Hertel 2009). The 
importance of this recognition is highlighted by many diseases that occur when proper operation 
is hindered by mutations (Ward and Cooper 2010). 
 
In the study of this recognition, two models have shaped how splicing is studied (Berget 
1995; De Conti et al. 2013). The first model is known as the intron definition model. This model 
postulates that introns are the units of recognition and that splicing together the sequences that 
flank them generates mRNA and as a byproduct delineates the exons. The second model is 
known as the exon definition model. It postulates that exons are the units of recognition and that 
once two adjacent ones have been recognized they can be joined. Determining adjacency implies 
that the intron has to be defined and, therefore, exon definition should be followed by intron 
definition. It has been suggested that both models are valid but are active under different 
circumstances: intron definition is predominant when introns are small, while exon definition 






Intron/exon boundaries play an important role independent of which part is recognized 
first and their sequence became established functional elements from early on (Mount 1982; 
Mount and Steitz 1983). However, the information encoded in such sequences seems insufficient 
to recognize proper exons from a plethora of pseudoexons (Sun and Chasin 2000). Another 
source of information was postulated to exist in the exons themselves (Reed and Maniatis 1986; 
Mardon et al. 1987; Cooper and Ordahl 1989; Tsai et al. 1989) in the form of exonic splicing 
enhancers (ESEs) and exonic splicing silencers (ESSs), which provide positive and negative 
effects on exon inclusion, respectively. Indeed the number of ESEs and ESSs proposed has made 
the exons rich and dense in information. So much so that changes to disrupt a target sequence for 
study are likely to create new functional sequences (Zhang et al. 2009). 
 
Several tools have helped in the study splicing. One that has had great impact is in vitro 
splicing (Krainer et al. 1984). Shortly after its development, use of this tool led to the discovery 
of a family of proteins that play a fundamental role in splicing: the SR proteins (Ge and Manley 
1990; Krainer et al. 1990). Many of the ESEs have been shown to exert their effects through SR 
proteins (Long and Caceres 2009). Moreover, in vitro splicing has allowed the characterization 
of the effects of another family of proteins, hnRNPs, which in many cases bind ESSs and curtail 
exon inclusion (Martinez-Contreras et al. 2007). However, in vitro splicing has limitations and 
attempts are being made to address them. One of them is the reliance on shortened versions of 
the genes due to the slower rate of the in vitro splicing reaction compared to in vivo experiments 
(Hicks et al. 2005). This limitation has negatively affected the study of exon definition because 
the abridged introns usually preclude this mechanism. Another limitation is the uncoupling of 






la Mata et al. 2003; de la Mata et al. 2011) but this phenomenon of co-transcriptional splicing is 
not easily studied in traditional in vitro experiments (Lazarev and Manley 2007). 
 
The present work builds on several results in the literature, namely the existence of an 
early irreversible step that determines the inclusion of an exon and the observation of splicing 
occurring while the transcript is being synthesized, i.e., co-transcriptional splicing. Even though 
many of the steps in the splicing reactions seem reversible, the existence of early irreversible 
steps in the splicing process was demonstrated by Lim and Hertel (Lim and Hertel 2004). These 
researchers characterized an early irreversible step that pairs the splice sites across the intron, 
implies the inclusion of the exon, occurs after complex E formation and might precede or 
coincide with the ATP-dependent formation of complex A (Lim and Hertel 2004). This result 
implies that the splicing outcome can be determined early in the splicing process. As a matter of 
fact, it is often thought that the splicing outcome is regulated by altering the binding of the initial 
factors (Black 2003; House and Lynch 2006; Chen and Manley 2009). Subsequent studies have 
confirmed this but some have shown that other downstream steps in the splicing process can be 
affected (House and Lynch 2006; Sharma et al. 2008; Chen and Manley 2009). However, even in 
some of these cases changes in the early steps result in a modificiation in the splicing process 
that would not enable commitment, effectively poisoning the downstream reactions (House and 
Lynch 2006). This makes the early steps in splicing a particularly interesting topic to study the 
decisions involved in exon inclusion. 
 
Another important aspect to consider is the observation that splicing in at least some 






2009; Dujardin et al. 2013). Since splicing is not an event but rather a process involving the 
formation of several intermediate complexes, co-transcriptional splicing can occur even if the 
final product is generated after transcription has finalized. In this case, occurrence of the 
irreversible step before transcription is finalized implies that transcription kinetics could affect 
the splicing decision (Dujardin et al. 2013). 
 
From studies of natural phenomena particularly in physics we have learned that even 
complex systems can be understood in terms of simple mechanisms. This simplicity can be 
hidden by the complex nature of the systems studied, in fact making the underlying mechanisms 
practically indiscernible. At least two approaches are available for the study of complex systems. 
A currently favored one attempts to understand the relationships between the parts of a system 
by studying it as a whole: top-down approach. This approach has been particularly used for the 
study of emergent properties which are postulated to be unforeseeable from even complete 
understanding of each individual constituent part (Cohen and Harel 2007).  A more traditional 
approach attempts to understand each part separately, then understand the relationships as the 
parts are gradually put together and then focus on the system as a whole: a bottom-up approach. 
Both strategies have different strengths and weaknesses which allow them to be good 
complements. The studies presented here use a bottom-up approach because of its intrinsic 
power to make simple relationships apparent, which aligns with our focus on the underlying 
molecular mechanisms governing splicing. 
 
To reduce the complexity of the system to study, designer exons (DEs) are introduced in 






small number of naturally occurring modules that include three types of sequences: a 
prototypical ESE, a prototypical ESS and a “neutral” sequence (also known as the reference 
sequence). A description of the complete system for the in vivo study of DE splicing is included, 
which satisfies the requirements for exon definition. A report is then given of how a set of DEs 
composed of random combinations of ESEs and ESSs was made and analyses of exon inclusion 
are presented. This initial approach sets the stage for more focused experiments but gave little 
insight into the role of the different parameters varied. 
 
Chapter 3 describes a reductionist approach to the study of exon recognition focusing on 
three parameters: size, ESE composition and ESS composition. Studying these parameters 
separately allows an uncomplicated view of their effects on splicing. Experimental assessments 
of the effects of varying size on inclusion levels are presented, using DEs composed exclusively 
of reference sequences. The effect in DE inclusion level of a sole ESE is analyzed in vivo by 
placing the ESE in different positions along the exon. After this the effect of adding more copies 
of ESE to the DE is studied. A similar set of experiments is described for ESS. 
 
Chapter 4 presents the mathematical derivation of a biophysical model to connect 
inclusion levels to the parameters varied in Chapter 3. This derivation is presented in two parts: a 
framework model that addresses how commitment progresses based on the states in which the 
molecules can be, while keeping the details of the molecular mechanisms for the transitions 
between states general, and a refinement of the model where hypothetical mechanisms to model 
these transitions are devised and implemented. Clearly delineated assumptions are introduced, 






framework model is shown. A general solution is derived for modeling splicing in terms of the 
rates of formation and dissociation of the exon definition complex and the rate at which exons 
containing it commit to inclusion. In order to gain an intuitive grasp of the roles of the different 
components in the resulting complex equation, a simplification is presented based on 
assumptions regarding the magnitude of the rates involved. A simpler equation is obtained and a 
biological interpretation of its terms included. This basic equation is then used to explore the 
effect of different biophysical mechanisms on the inclusion level of DEs. A model is derived for 
two crucial parameters: size and ESE content. ESSs and reference sequences are modeled as 
having effects opposed to or similar to ESEs. To account for the effect of size, the collision of 
exon ends is modeled using results from statistical mechanics of polyelectrolytes. To account for 
the effect of ESEs, the stability of the exon definition complex is modeled analyzing the 
frequency of complex disruption by collisions with random molecules. 
 
Chapter 5 expands the reductionist approach to the study of exon recognition introduced 
in Chapter 3. To explore mechanistic explanations for the observations previously discussed 
about size, ESE composition and ESS composition, the development of a biophysical model for 
exon definition of internal exons undergoing co-transcriptional splicing is presented. The 
mechanisms analyzed are restricted to those that are deemed to affect DEs and natural exons 
alike. This model features commitment to inclusion before the downstream exon is synthesized 
and competition between skipping and inclusion fates afterwards. Collision of both exon ends to 
form an exon definition complex is incorporated to account for the effect of size. Stabilization of 






evaluated in terms of its ability to reproduce the single-parameter results as well as its ability to 
predict the inclusion level of the more complex designer exons presented in Chapter 2. 
 
Chapter 6 presents initial attempts at identifying the proteins involved in splicing of DEs. 
We first introduce a sequence, ESS2, that represents an extension for future DEs and that is used 
in the process of identifying candidates for the other sequences. The silencer effects of this 
sequence are studied at different positions along the exon to provide background for the 
following experiments. For these four sequences, namely ESE, ESS, ESS2 and the reference 
sequence, a pull down experiment is described. Proteins that bind to each of the molecules are 
identified through label-free shotgun mass spectrometry. From these experiments, a list of 26 
candidates is presented. The candidates are then briefly analyzed in terms of their putative roles 
in the cell as well as general characteristics and a short list of favored candidates is compiled. 
 
Chapter 7 summarizes the main points presented in the previous chapters. The 
significance of designer exons is discussed in the context of identifying mechanisms that affect 
splicing of natural exons. Some conclusions are also presented regarding the significance of 
unexpected results observed in Chapter 3. Additionally, the usefulness of the equations 
developed in Chapter 4 is evaluated placing special emphasis on the mechanisms proposed to 
explain size and ESE effect. The value of identifying the proteins associated with the 
functionality of each of the sequences studied is discussed briefly. Finally, an exploration is 
conducted on directions for future research. 
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Pre-mRNA splicing requires the accurate recognition of splice sites by the cellular RNA 
processing machinery. In addition to sequences that comprise the branchpoint and the 3’ and 5’ 
splice sites, the cellular splicing machinery relies on additional information in the form of exonic 
and intronic splicing enhancer and silencer sequences. The high abundance of these motifs 
makes it difficult to investigate their effects using standard genetic perturbations, since their 
disruption often leads to the formation of yet new elements. To lessen this problem, we have 
designed synthetic exons comprised of multiple copies of a single prototypical exonic enhancer 
and a single prototypical exonic silencer sequence separated by neutral spacer sequences. The 
spacer sequences buffer the exon against the formation of new elements as the number and order 
of the original elements is varied. Over 100 such central designer exons were constructed by 
random ligation of enhancer, silencer and neutral elements. Each exon was positioned as the 
central exon in a 3-exon minigene and tested for exon inclusion after transient transfection. The 






could be decreased by the provision of silencers. In general, there was a good quantitative 
correlation between the proportion of enhancers and splicing. However, widely varying inclusion 
levels could be produced by different permutations of the enhancer and silencer elements, 
indicating that even in this simplified system splicing decisions rest on complex interplays of yet 




 In higher organisms, pre-mRNA splicing represents an essential step in the transfer of 
information from DNA to protein, i.e., the central dogma. Much is known about the chemistry of 
intron removal catalyzed by the spliceosome, a multi-subunit ribonucleoprotein comparable in 
size and complexity to the ribosome. Less is known about the recognition of the splice sites, 
which is the key step in deciphering the information resident in the primary transcript. The splice 
site sequences themselves – a 9 nt stretch straddling the 5’ splice site, a ~ 15 nt region at the 3’ 
splice site (including the polypyrimidine tract) and a 7 nt branch point sequence – do not seem to 
contain sufficient information for this purpose, since such combinations of sequences occur 
within large introns at frequencies greater than the actual splice sites (Senapathy et al. 1990; Sun 
and Chasin 2000; Chasin 2007). Additional information can be provided in the form of splicing 
enhancer elements located at various positions within the exons (ESEs) or their intronic flanks 
(ISEs) and in similarly placed splicing silencers (ESSs and ISSs). In general ESE elements are 
bound by SR-proteins and ESSs and ISSs by hnRNP proteins but proteins outside these exact 
categories are also often involved (for reviews see (Ladd and Cooper 2002; Black 2003; 







 Complete catalogues of these regulatory sequence motifs have been sought by protein 
binding determinations, functional selections, and validated computational predictions. The 
results have in a sense been too successful, in that by now at least 75% of the nucleotides in a 
typical human exon reside in motifs that have been found to influence splicing in one study or 
another (Chasin 2007). This high density of regulatory information often makes it difficult to 
make genetic perturbations that cleanly test the role of a particular motif. Three examples of this 
emergent ambiguity are presented in Fig. 2.1. Example 1 shows 2 typical cases of a SELEX 
winner from a functional selection for splicing activity (Liu et al. 1998). The fact that many 
motifs are likely to be found in any random sequence leads to the presence of a high noise level 
in such experiments. (A complete analysis of all sequences underlying the ESEfinder program is 
presented in Supplementary Fig. S2.1.) Example 2 shows the sequence resulting from the 
insertion of a putative exonic splicing silencer (PESS) that we examined for silencing activity in 
a test exon (Zhang and Chasin 2004). Besides the addition of the ESS, several enhancer motifs 
were created and a pre-existing silencer of another class was disrupted. Example 3 shows the 
substitution in a test exon of a predicted exonic splicing regulator (ESR) motif that reduced 
splicing efficiency (Goren et al. 2006). Concomitant with the substitution, an ESE was disrupted 
and an additional ESR was created. These examples are typical rather than exceptional. Thus the 
very act of placing a motif at an exactly specified location often changes the nature of the exon in 
unintended ways, reminiscent of the Heisenberg uncertainty principle (Heisenberg 1927).   
 
 The context of a splicing regulatory motif (Kanopka et al. 1996; Mayeda et al. 1999; 









Figure 2.1.  Examples of ambiguity in the identification or testing of splicing regulatory motifs. 
1) Top: A functional SELEX selected sequence (Liu et al. 1998) that conferred responsiveness to 
SRp55. The match to the derived ESEfinder (Cartegni et al. 2003) SRp55 consensus sequence is 
underlined. The sequence also contains overlapping predicted PESE motifs (bold). Bottom: A 
functional SELEX selected sequence that conferred responsiveness to SRp40, with the SRp40 
ESEfinder motif underlined. The sequence also contains a RESCUE-ESE (Fairbrother et al. 2002) 
motif (bold).  These sequences are taken from those underlying ESEfinder (v.2; 
http://rulai.cshl.edu/tools/ESE2/) and were provided by Adrian Krainer. A similar analysis of all the 
sequences used by ESEfinder is presented in Supplementary Fig. S2.1.  2) Testing of a predicted PESS 
by its insertion into a test exon (thbs4 exon 13) by Zhang and Chasin (Zhang and Chasin 2004). The 
bold sequence at the bottom was inserted into a BamHI site (arrowhead) in a test exon. Beyond the 
addition of the PESS, a fashex3 ESS (f-ESS) was disrupted (underlined in top sequence), a PESE was 
created (underlined in the bottom sequence), and 2 overlapping RESCUE-ESEs were created (R-ESEs, 
underlined in the bottom sequence).  3)  Testing a predicted exonic splicing regulator (ESR, bold 6-
mer  at bottom) by substituting it for a 10-mer (bold at top) in a test exon (Goren et al. 2006). Besides 
the addition of the ESR, a PESE (underlined at top) was disrupted and an additional ESR (underlined 







1997) can exert a strong influence on splicing efficiency. This context can be viewed in 
molecular terms by the quality and proximity of splicing regulatory motifs relative to each other 
and relative to the splice sites. A straightforward molecular genetic approach to test such a model 
would involve varying these parameters, but due to the density of regulatory motifs such 
variations would almost always change several parameters at once, and so confound the 
interpretation. One way to get around this problem might be to search for rare exons containing 
just a few well defined regulatory motifs that are each separated by sequences predicted to have 
no effect on splicing, i.e., neutral sequences.  Another way would be to construct such exons in 
silico and then in vitro, using as building blocks known motifs that have enhancing, silencing or 
neutral effects.  Here we have used the latter approach, using a prototype ESE, ESS and a 
putatively neutral 8-mer motif. We have assembled exons with random combinations of these 
elements placed between a constant pair of natural 3’ and 5’ splice sites. These “designer exons” 
have a general requirement for the ESE modules to achieve efficient splicing and are inhibited by 
the inclusion of the ESS modules. Despite their apparently simplified modular organization, 
splicing of these designer exons exhibits a complex dependence on the exact pattern of the ESEs 




Design of the exons 
 
We used 3 modules to build designer exons: an exonic splicing enhancer (ESE), an 






8-nt sequence chosen from among putative ESEs and ESSs and neutral sequences we previously 
identified on the basis of their overrepresentation in exons vs. human transcript regions that do 
not undergo splicing (Zhang and Chasin 2004). Libraries of exons consisting of multiple 
instances of one ESE and one ESS motif were created by using linkers with complementary 
overhangs (Fig. 2.2A) for the random ligation of the synthetic sequences. The linkers were 
designed to create a neutral motif upon ligation (Fig. 2.2B); thus the same neutral spacer is in 
place between each and every enhancer or silencer motif. The ligation products were inserted 
between 3’ and 5’ splice sites taken from intron 1 and intron 3, respectively, of the Chinese 
hamster dihydrofolate reductase (dhfr) gene.  The exons so formed constituted the middle exon 
of a 3-exon minigene (Fig. 2.2C) with the 5’ exon being dhfr exon 1 (with its promoter) and the 
3’ exon consisting of the fused dhfr exons 4 through 6 (with the first dhfr polyA site). Each 
designer exon also contains a neutral sequence at each end of the stretch of modules, generated 
as part of the insertion process (Fig. 2.2C). 
 
 The first and key step in the experimental design was to select an appropriate 
combination of ESE, ESS and neutral sequence modules. We required the combination of 
ESE/ESS/neutral sequences to meet several criteria. The first, and only essential, criterion was 
that the concatenation of these modules in any order should not yield any sequence that falls 
outside a neutral range (see below). Second, their concatenation should not produce any in-frame 
stop codons, to rule out nonsense codon mediated decay (NMD) as a factor. Third, the ESE and 
ESS should contain distinct restriction sites, to facilitate the determination of their order by 









Figure 2.2. Construction of designer exons.  A. Cartoons of E, N, and S modules showing single-
stranded ends used for ligation, along with the actual sequences. B. Color-coded examples of possible 
designer exons (green, ESE; red, ESS, gray, neutral) along with the abbreviated notation used (E,S,N).  
Note that the abbreviated notation does not indicate the neutral 8-mer that lies between each E and S 
module and at each end. C. Diagram of a designer exon within the test minigene used. Exon 1 is exon 
1 of the Chinese hamster dhfr gene, exon 3 comprises the fused exons 4 to 6 of the dhfr gene. The 3’ 
and 5’ splice sites (SS) are from dhfr introns 1 and 3, respectively. D. Z-score profile of all 8-mers in a 









We previously devised a scoring scheme and identified lists of octamers as putative 
splicing enhancers and silencers (PESE and PESSs, (Zhang and Chasin 2004)). In that work, 
each octamer was assigned two z-scores based on its over/under-representation in internal non-
coding exons versus: 1) pseudo exons and 2) 5’-UTRs of intronless genes.  The two z-scores 
were called the P-score and I-score, respectively. Underrepresented octamers were assigned 
negative z-scores. An octamer was called a PESE if both scores were greater than 2.62 or a PESS 
if both scores were lower than -2.62. Based on these criteria, we collected a list of ~2000 PESEs 
and ~1000 PESSs. We searched this list for PESE, neutral and PESS sequence combinations that 
fulfilled the criteria discussed in the above paragraph, requiring the neutral spacer sequence to 
have a z-score with an absolute value of less than 1.8. From among millions of 8-mer 
combinations, only about 3 dozen met all the criteria.  We chose the following 3 sequences to 
build designer exons: TCCTCGAA (an ESE, P-score +3.99, I-score +3.44), CCAAACAA (a 
neutral sequence: P-score -0.28, I-score -0.98) and CACATGGT (an ESS, P-score -4.50, I-score 
-3.38), which we term “E”, “N”, and “S” for brevity. An example of the distribution of these 
scores across all of the 8-mers of a typical designer exon is shown in Fig. 2.2D.   
 
Enhancers are required for the efficient splicing of designer exons 
 
We first tested these sequences for their effect on splicing by inserting each singly into a 
BamHI site in the central exon (chuk exon 8) of a 3-exon minigene, and measuring the 
proportion exon inclusion (included/(included + skipped)) after transfection into human 293 cells 






expected, the E sequence promoted splicing of a poorly spliced version of the chuk8 exon, the S 
sequence inhibited splicing of a well spliced chuk8 exon, and the N sequence had little effect on 
either type of exon (data not shown). We next constructed homogeneous designer exons made up 
of multiple copies of just a single type of motif (E, S, or N), constructed as described above and 
in Fig. 2.2.  Designer exons made up of E modules spliced very well, whereas those made up of 
S modules showed little or no splicing. Designer exons made up exclusively of concatenated N 
modules were also very poorly spliced: an exon with 3 modules (seven N 8-mers counting the 
spacers) was included 13% of the time and an exon with 5 modules (eleven N 8-mers counting 
the spacers) showed almost no inclusion. Thus these designer exons in this context require an 
enhancer for efficient splicing. We then went on to assemble a large number of additional 
designer exons carrying both E and S modules and test their splicing efficiency after transfection 
into 293 cells. 
 
Splicing of designer exons carrying randomly combined E and S motifs 
 
We ligated E and S motifs at various ratios, inserted the ligation products into the 3-exon 
minigene vector and isolated 139 clones. The number and order of the modules was quickly 
determined by PCR amplification of the plasmid region spanning the designer exon using a 
fluorescently labeled primer followed by partial digestion with TaqI (TCGA) and with CviAII 
(CATG), as these sites are present in the E and S modules, respectively. From the ladder of 
fluorescent bands seen after electrophoresis, the arrangement of modules could be deduced (Fig. 
2.3A). Splicing was then measured after transfection of 293 cells with plasmid DNA and using 







Figure 2.3.  Determination of designer exon genotypes and phenotypes. A. Module order 
screening. Plasmid DNA from designer exon clones was PCR amplified using one fluorescently 
tagged primer and then cleaved with the diagnostic restriction enzymes (RE) TaqI, which cuts in the E 
module or CViAII, which cuts in the S module. Lane 1 represents a clone with 7 E modules and no S 
modules cut with TaqI and lane 4 represents a clone with 6 S modules and no E modules, cut with 
CviAII; these lanes serve here as standards. Lanes 2 and 3 represent the same 10-module clone 
(SEESSESESE) cut with either TaqI (lane 2) or CviAII (lane 3).  The relative positions of the bands 
(labeled E or S) allow the order of E and S modules to be read directly from the gel. All constructs 
used for analysis were subsequently DNA sequenced.  B. Splicing phenotype measurement. Plasmids 
harboring designer exons were transfected into HEK 293 cells and the mRNA products were amplified 
by radioactive RT-PCR. The relative amounts of molecules that included (I) or skipped (S) the 
designer exon were determined by Phosphorimaging. The analysis of 8 representative clones is shown, 
with two independent transfections for each clone. The sequence of modules present in each exon is 







included or skipped the designer exon. An example of these results is shown in Fig. 2.3B. The 
splicing efficiencies of 139 exons are presented in Fig. 2.4, where they are ranked according to 
the proportion of designer exon inclusion along and with a graphical depiction of their structure. 
Reading from left to right it can be seen by eye that in general splicing efficiency decreases as 
the number of Es (green boxes) per exon decreases and as the number of Ss (red boxes) 
increases. It should be kept in mind that in between each E and/or S there exists an N module 
that is not depicted. Less easily seen but also discernible is a tendency for splicing efficiency to 
decrease with exon length. 
 
A more quantitative assessment of correlations between splicing efficiency and designer 
exon structure was made by calculating Pearson’s correlation of determination, R2, from scatter 
plots of the data (Fig. 2.5).  Each of the 6 charts in Fig. 2.5 tests a hypothesis about the 
dependence of splicing on these regulatory sequences. The first is that splicing is proportional to 
the absolute number of enhancer modules in an exon. We found a significant, if weak, 
 
Figure 2. 4.  Splicing of designer exons. Bottom: Splicing of 139 designer exons ranked by percent 
exon inclusion. Exon inclusion is defined as: 100 x included/(included+ skipped), and the value is the 
average of at least 2 independent transfections (average SE= 16%).  Top: Structure of the 
corresponding designer exons. Each colored rectangle represents an E (green) or S (red) module. The 
5’ end of the exon is at the bottom.  Exon inclusion levels for these designer exon are presented in 






correlation between and splicing and the number of Es (R
2
 = 0.06, p=0.004, t-test, Fig. 2.5B). 
The correlation was much stronger when we considered the proportion of Es in an exon (R
2
 = 
0.53, p < 3e-24, Fig. 2.5A). A converse hypothesis is that it is the silencers that play the most 
important role in determining splicing efficiency. Indeed, the number of Ss per exon produced a 
 
Figure 2.5. Correlations between exon inclusion and splicing regulatory elements.  Straight lines 
were fitted by a linear regression (Excel). A) Percent enhancers (100 x E/(E+S)); ; B) Number of 
enhancers; C) Number of silencers; D) Ratio of enhancers to silencers; E) Number of enhancers minus 






much stronger (negative) correlation with inclusion rate (R
2
 = 0.78, p < 5e-47, Fig. 2.5C) than 
the number of Es. The correlation for the proportion of Ss is the same as for the proportion of Es 
by definition here, although of opposite sign. 
 
The factors governing splicing decisions, or the splicing code, have often been ascribed 
to a balance between positive and negative factors, so we tested the effect of combining the E 
and S content of each exon by calculating the E/S ratio and the E-S difference. To our surprise, 
these variables were less correlated with splicing (R
2
 = 0.40 and 0.42 respectively, Fig. 2.5D and 
2.5E) than the proportion of Es or Ss considered independently, suggesting that combining Es 
and Ss in these ways added more noise than information. We also examined exon length, a 
variable related to E or S content, and found a weaker but highly significant negative correlation 
with splicing (R
2
 = 0.16, p < 1e-6, Fig. 2.5F). The strongest correlation seen was with the 
number of Ss (Fig. 2.5C), indicating that silencing was the most important factor at play in these 
exons. However, the negative effect of the number of Ss is actually a measurement of two 
variables: percentage of Ss and length, since longer exons will tend to have more Ss. The effect 
of Ss normalized for exon length can be seen in the plot of %E (Fig. 2.5A), which is equivalent 
to 1-%S, and which shows a lesser but still strong correlation (0.53 for %E vs. 0.78 for number 
of Ss).  
 
Splicing of designer exons carrying no silencers 
 
Although the correlation coefficients for %E and number of Ss indicate that most of the 






remains that there is considerable scatter among these points.  For example, in the plot with the 
best correlation (Fig. 2.5C), exons all having 3 Ss yielded inclusion levels ranging from 3% to 
55%.  We considered the possibility that complexities inherent in antagonism between E’s and 
S’s tend to produce a metastable state, and that a better correlation between splicing and Es 
would be seen in the absence of added silencers. Designer exons were therefore constructed by 
randomly ligating E and N modules. Here again we point out that there were always additional N 
modules as spacers between each pair of named modules, plus one at each end: i.e., the 
designation ENE represents the sequence nEnNnEn, where the lower case n is formed in the 
course of construction and is the same sequence as N. Twenty-two EN exons were analyzed for 
splicing. The results are shown in Fig. 2.6A, which displays the inclusion levels that correspond 
to the specific exon structures. The correlation between inclusion and %E was somewhat better 
for these E+N exons (R
2
 = 0.75, p < 6e-13, Fig. 2.6B) compared to E+S exons (R
2
 = 0.53, p < 
3e-6, Fig. 2.5A), but there was still considerable scatter: at E = 50% the inclusion levels ranged 
from 38% to 94%.   
 
Consideration of predicted secondary structure 
 
It is possible that many of the E and S sequences included in these exons are not available 
for enhancing or silencing splicing because they are sequestered in the double-stranded stems of 
secondary structures. Anecdotal examples of secondary structure affecting splicing are many 
(reviewed in (Buratti and Baralle 2004)) and a survey of functional ESEs showed that these tend 
to remain single stranded (Hiller et al. 2007). If only the single stranded Es in our designer exons 








Figure 2.6. Splicing of exons designed without silencers. A. Bottom: Splicing of 22 designer exons 
ranked by percent exon inclusion.  Top: Structure of the corresponding designer exons. Each colored 
rectangle represents an E (dark gray) or N (light gray) module. An additional N module is present 
between each E and N module but these are not depicted. The 5’ end of the exon is at the bottom.  B. 
Correlation between exon inclusion and the proportion of E elements in an exon. Exon inclusion levels 






We used RNAstructure (Mathews, 2006) to fold each of the E+S designer exons and then 
assigned each base in the E, N, and S modules a probability of being in a double stranded stem 
(s), a single stranded loop (l), or a single stranded interstem region (i). The designer exons as a 
whole did not form exceptionally stable secondary structures; for the most stable structures the 
average free energy value per nucleotide was -0.22 kcal/mole compared to -0.21 for scrambled 
versions. Correlation coefficients were calculated between exon inclusion level and each of these 
9 variables (Es, El, Ei; Ns, Nl; Ss, Sl, Si). As can be seen in Table 2.1, none of the R
2
 values for the 
proportion of E or S nucleotides that are confined to stems, loops or interstem regions was 
appreciably greater than the value for the E or S nucleotides as a whole. These results do not 
support the idea that variable secondary structures underlie the wide ranges of inclusion levels 





Table 2.1.  Correlation coefficients between inclusion level and the proportion of 
module bases found in different types of predicted secondary structures  
Region % in Es % in Ns % in Ss 




 -0.339 -0.482 -0.132 
loops 0.390 0.034 -0.562 -0.202 
interstems 0.347 0.381 -0.152 0.238 
All 3 0.529 0.148 -0.529  
a
 Numbers throughout represent Pearson’s R2 values, with a negative sign denoting a 









Responses to enhancers and silencers 
 
The concatenation of single specific enhancer and silencer modules has been used here to 
construct exons that are much less complex than their natural counterparts. The plainness of 
these exons has allowed us to test some simple hypotheses regarding internal exon recognition in 
pre-mRNA splicing.  
 
The first hypothesis is that enhancers are necessary for efficient splicing, and it is 
supported by our results. Designer exons consisting solely of neutral sequences spliced poorly if 
at all; incorporation of enhancers was required to achieve inclusion levels near 100%.  As yet, 
this conclusion is limited to the context we provided, the natural splice sites and intronic flanks 
found in the dhfr gene. These 3’ and 5’ splice sites are of average or above average strength (i.e., 
agreement with the consensuses), with consensus values (Senapathy et al. 1990; Zhang et al. 
2005b) of 81 and 88 respectively. It is likely that provision of stronger splice site sequences 
could obviate the need for an enhancer (see for example (Ram et al. 2008)).  Nonetheless, most 
natural exons do not have splice sites stronger than those used here.  
 
The second hypothesis is that splicing efficiency increases in proportion to the number of 
enhancer elements, and it is less directly supported by our data. Hertel and Maniatis showed that 
in vitro splicing of a 2-exon transcript responded linearly to the addition of multiple enhancer 






exon agree with this finding in that a highly significant correlation (R
2
 = 0.53) to a linear model 
was found for exon inclusion vs. the number of enhancers per exon if the data were normalized 
for exon length differences (%E, Fig. 2.5A). However, the great splicing variability seen among 
exons having the same proportion of enhancers belies the simple model in which the mere 
presence of an enhancer sequence adds linearly to the probability of binding an activator protein 
which in turn leads to a proportional increase in splicing.  
 
We tried to take into account the possibility that some of the included motifs were being 
sequestered in secondary structures, but our test did not provide support for this idea. In 
particular, the simple notion that E’s are much more effective when present as single-stranded 
targets was not substantiated. This negative result cannot be considered conclusive, as our ability 
to predict the in vivo secondary and tertiary structures of RNA molecules is limited.  RNA 
folding in vivo may be influenced by RNA binding proteins that unwind, compete with or 
enhance RNA-RNA interactions. Some of this secondary structure analysis was rather surprising, 
suggesting that S modules were more effective in inhibiting splicing when present in stems and 
loops compared to interstem regions (Table 2.1). It is possible that the particular S motif we used 
is a better target when presented in double-strand form. The N modules also showed an 
inhibitory effect when present in stems but a stimulatory effect when present in interstem regions 
(Table 2.1). These effects could be indirect, for instance by N sequences forming a stem that 
places an S module in a loop. These ideas are amenable to experimental testing.  
 
The third hypothesis is that splicing is the result of a balance between positive and 






reasonableness, but has rarely been tested using multiple elements. Our data has supported this 
idea in a general sense: whether the balance is considered the difference between enhancer and 
silencer content or their ratio, R
2
 values of 0.4 were obtained. These ways of defining balance 
proved no better than that given by the proportion of enhancer motifs (%E), which intrinsically 
also compares enhancer to silencer content (%E =100x E/(E+S)) in this system. However, the 
scatter in the data suggests that splicing is highly dependent on the relative positions of the E and 
S motifs, beyond their relative proportions.  As yet we cannot posit a straightforward 
mathematical model capable of predicting splicing patterns based on the positions of the E and S 
modules. Table 2.2 illustrates this difficulty by showing 3 examples of pairs of compositional 
isoforms exhibiting 2- to 10-fold differences in splicing efficiency despite having identical E/S 
ratios and E-S differences. 
 
 
Table 2.2. Designer exon pairs with the same composition but different splicing behavior. 
 Modules Exon length (nts) Percent inclusion 
    
1 
ESESESE 126 55 
SEEEESS 126 14 
    
2 
EESE 78 93 
ESEE 78 41 
    
3 
EESESSSE 142 21 







Designer exons as a model system 
 
The synthetic biology used to create designer exons results in molecules that are unlike 
any found in living cells. One might argue that we run the danger of being misled by the analysis 
of such artificial molecules; their behavior will tell us little about the rules governing the splicing 
of their more complex natural counterparts. We contend the opposite, that a prerequisite to 
understanding how individual elements combine to yield an emergent property requires an 
understanding of how the individual elements act, first alone, and then in simple combinations.  
The way in which transcriptional regulatory signals combine to produce what is often a binary 
decision is in many ways analogous to the splicing decision problem, and can also be explored 
using synthetic promoters (Alper et al. 2005; Ligr et al. 2006). Additional examples of this 
approach lie in the de novo design of proteins (Kuhlman et al. 2003) and cell membranes 
(Tanaka and Sackmann 2005). 
 
 We have not implemented an orchestrated combinatorial approach in these first 
experiments, but rather relied on seeing simple patterns emerge from randomly assembled 
molecules. Such was not the case, pointing to our ignorance of important parameters yet to be 
defined. We can speculate on several ways in which parameters may have been hidden in these 
designer exons. First, the assumption that the N modules are truly neutral may be wrong. The N 
module was chosen from among 10000 sequences predicted to be neutral and was evaluated in 
an arbitrarily chosen test exon; in a different context it may not act neutrally. Second, we may 
have been overzealous in isolating the E motifs from each other and from the S motifs. The 






that require close apposition. In this regard, we see no reason to assume that fundamentally 
neutral spacers are not occupied by RNA-binding proteins and so act passively to prevent 
positive interactions. Third, the multiplicity of exon lengths that were produced by random 
ligation added a confounding factor in the interpretation of the results.  
 
 Many of these problems will be solved by synthesizing designer exons in a more 
deliberate fashion. To this end we are developing methods to readily synthesize exons of defined 
size, and adding specific modules one or two at a time to produce a stable of exactly designed 
molecules. For instance, the placement of an E at 10 evenly spaced positions within a 160 nt 
exon will answer the question of whether proximity to a splice site is required for ESE action and 
whether there is specificity of a given E for a 3’ or 5’ splice site. This information can then be 
extended to real exons to weigh the potential of embedded ESEs and so improve exon prediction 
and the prediction of alternative splicing efficiency.  The interplay between splice site strength 
and ESE and ESS effectiveness can also be weighed first in designer exons and then applied to 
natural exons. Finally, an all N vector a with a unique restriction site will provide a convenient 
and perhaps more reliable vector for testing candidate ESEs gathered from real genes. Thus 
despite the complexities revealed by this first generation analysis, we think that the properties of 











Materials and Methods 
 
Construction of designer exons 
A starting plasmid was pDCH1P12D, which contains a Chinese hamster dhfr minigene 
consisting of exon 1, a hybrid intron1+3, exons 4 through 6 of the cDNA and the first natural 
dhfr polyA site in exon 6; a NotI site was added near the center of the intron, which also contains 
a unique NheI site. The chuk8 minigene used for the initial test of candidate motifs was 
constructed by inserting exon 8 of the human chuk gene into the NotI site, either with about 50 nt 
of intronic flanks or with just its splice sites. The construction of these chuk8 minigenes has been 
described previously (Zhang et al. 2005a; Zhang et al. 2005c).  To construct designer exons, the 
two strands of E, S or N modules were first mixed in an annealing buffer (30mM pH7.4 HEPES, 
2mM MgOAc, 100mM K2OAc) at equal concentration (~5ug/ul). The mixtures were heated to 
95
o
C and then gradually cooled at room temperature. The annealed E, S or N modules were 
mixed at different ratios (1:3, 1:1 or 3:1) with T4 ligase (10 U in a 20 ul reaction mixture, 0.5 ug 
of each module). The ligation mix was subsequently electrophoresed in a 2% agarose gel and the 
products corresponding in length to 3 to 16 modules were extracted from the gel. These 
fragments were then ligated as a pool to the constant 5’ and 3’ modules containing an upstream 
EagI or downstream NheI restriction site, respectively. The product of this second ligation was 
then subjected to PCR with primers targeting the constant 5’ and 3’ modules. The PCR products 
were cut with EagI and NheI and inserted into pDCH1P12D that had been cut with NotI and 
NheI, the latter located 300 nt downstream the Not I site of pDCH1P12D. The resulting 
minigenes have the designer exon located between a 300 bp upstream intron and a 600 bp downs 






by PCR amplification of the region spanning the designer exon using one primer 5’ end labeled 
with Cy5 followed by partial separate digestions with TaqI and CviAII, for which there are 
restriction sites in the E and S sequences respectively. After electrophoresis, the fluorescent 
bands were visualized using a Phosphorimager Storm (Fig. 2.3A). The sequence of the E and S 
modules could be read from the partial digest patterns. All unique designer exons chosen for 
analysis were subsequently sequenced (GeneWiz).  
 
Measurement of splicing 
Human HEK293 cells were transfected with plasmid DNA using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s protocol. After 24 hours, total RNA was isolated 
using RNAwiz (Ambion), reverse transcribed with Omniscript and random hexamers from 
QIAGEN and subjected to radioactive semiquantitative PCR as described previously (Chen and 
Chasin 1993). Percent inclusion was calculated as 100 x included/(included + skipped), using 
Phosphoimager counts of the indicated electrophoretic bands taking into account the number of 
labeled bases in each molecule. Each transfection was performed at least twice; the average 
standard error for biological replicates was 16%.  
 
Secondary structure analysis 
The 139 E+S designer exon sequences were folded from -100 to +100 relative to the exon ends 
using RNAstructure 4.5 (Mathews 2006) for DOS with default settings. The output of this 
program included the 20 most stable structures in .ct table format. The .ct values from all 20 
structures were converted to Vienna dot-bracket depiction. The average designation of each base 






identity as part of an E, N or S motif. Pearson’s correlation coefficient (r) and coefficient of 
determination (R
2
) were calculated for % inclusion vs. % of motif bases in each of the various 
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Table S2.1. Inclusion level for the set of designer exons used in this chapter. 
Clone # Sequence Modules Mean SEM 
S-E combinations 
7-14-16 EEEEEEE 7 0.978 0.006 
5-2-82 EEESE 5 0.989 0.007 
7-13-34 EEEEEEEEES 10 0.623 0.183 
7-11-22 ESEEEEEEE 9 0.890 0.033 
7-53 EESEEEE 7 0.916 0.004 
7-85 ESEEEE 6 0.947 0.013 
5-2-90 SEEEEE 6 0.946 0.023 
6-9-19 EEEESE 6 0.941 0.011 
5-46 EEESEE 6 0.906 0.011 
31-30 ESEEE 5 0.960 0.006 
6-16-89 EEEES 5 0.890 0.036 
30-21 EESE 4 0.926 0.015 
31-40 EEES 4 0.879 0.024 
27-24 ESEE 4 0.411 0.003 
3-27-8 SEE 3 0.804 0.082 
3-23-10 ESE 3 0.509 0.020 
7-11-3 SEEEEEEEES 10 0.553 0.105 
7-14-35 EEEEEESEES 10 0.491 0.109 
7-14-26 EESEEEESE 9 0.631 0.099 
6-13-31 ESSEEEEE 8 0.667 0.016 
7-14-8 ESEEEEES 8 0.309 0.059 
7-11-19 SSEEEEE 7 0.933 0.022 






7-13-64 ESEEEES 7 0.776 0.025 
31-14 EEEESES 7 0.727 0.008 
5-2-6 SEEEESE 7 0.589 0.004 
29-60 SEESEE 6 0.927 0.006 
7-11-26 EEESSE 6 0.838 
 5-39 ESESEE 6 0.835 0.032 
30-31 EESSEE 6 0.833 0.023 
7-11-72 EEEESS 6 0.705 0.044 
25-3 ESSEE 5 0.927 0.001 
6-9-87 ESESE 5 0.862 0.041 
27-35 ESEES 5 0.835 0.039 
7-72 EEESS 5 0.815 0.040 
7-69 SEESE 5 0.792 0.033 
6-16-65 SSEEE 5 0.783 0.077 
6-9-42 SEEES 5 0.718 0.029 
22-4 EESSE 5 0.673 0.039 
30-27 SESEE 5 0.619 0.019 
7-74 EESES 5 0.560 0.038 
25-10 SSEE 4 0.932 0.017 
30-8 SESE 4 0.748 0.007 
31-16 ESES 4 0.737 0.013 
31-34 ESSE 4 0.648 0.017 
31-24 EESS 4 0.626 0.016 
3-23-7 SEES 4 0.588 0.090 
31-36 SES 3 0.413 0.013 
31-42 ESS 3 0.373 0.005 
6-14-72 SEEESESEEE 10 0.338 0.084 






29-86 SESEESEEE 9 0.317 0.003 
6-13-71 EEESESEES 9 0.248 0.039 
6-16-6 SSEESEEE 8 0.452 0.061 
6-14-39 ESESEEES 8 0.357 0.065 
22-19 EEESEESS 8 0.286 0.030 
6-14-25 EESSEEES 8 0.244 0.055 
5-2-35 EEEEESSS 8 0.143 0.031 
5-2-7 SEESSEEE 8 0.025 0.002 
6-14-38 ESESESE 7 0.549 0.036 
29-30 SEESESE 7 0.427 0.046 
5-2-80 SSSEEEE 7 0.412 0.005 
6-13-42 EESSSEE 7 0.350 0.033 
8-7 SEEEESS 7 0.139 0.004 
6-9-55 SESESE 6 0.495 0.029 
5-2-33 SESEES 6 0.458 0.016 
6-13-46 SSEESE 6 0.451 0.030 
5-2-16 SSESEE 6 0.390 0.011 
5-31 ESSEES 6 0.359 0.036 
6-13-9 ESESES 6 0.355 0.035 
6-16-70 EESSES 6 0.331 0.066 
3-23-2 ESSSEE 6 0.296 0.073 
30-25 SEESS 5 0.469 0.009 
6-9-60 SESSE 5 0.413 0.023 
7-60 SSESE 5 0.370 0.014 
8-16 ESSES 5 0.304 0.039 
27-58 ESSSE 5 0.262 0.056 
6-16-76 EESSS 5 0.258 0.053 






7-27 SSSE 4 0.269 0.034 
7-8 SESS 4 0.172 0.008 
30-16 ESSS 4 0.112 0.014 
7-14-20 EEEESSEEEEEEEESS 16 0.049 0.031 
30-15 ESEEESSEESE 11 0.062 0.025 
29-17 EESSSESEEEE 11 0.050 0.004 
6-9-89 SSEESESE 8 0.226 0.018 
5-2-59 EESESSSE 8 0.211 0.019 
31-10 SESSSEEE 8 0.144 0.008 
6-9-6 EESSSESE 8 0.140 0.015 
6-9-17 ESSESSEE 8 0.123 0.008 
7-12 ESEESSSE 8 0.085 0.007 
6-14-64 ESESEESS 8 0.076 0.013 
6-9-64 ESSSEEES 8 0.019 0.011 
6-13-88 SSESESE 7 0.484 0.019 
29-96 SSSESEE 7 0.217 0.005 
6-14-76 ESEESSS 7 0.161 0.033 
6-9-12 ESSSEES 7 0.113 0.001 
5-2-62 EESSESS 7 0.042 0.006 
7-76 SESSSE 6 0.244 0.030 
6-14-30 ESSSES 6 0.239 0.057 
25-13 ESSESS 6 0.151 0.013 
8-23 SESESS 6 0.124 0.010 
27-31 SSSSEE 6 0.091 0.022 
7-57 ESESSS 6 0.045 0.004 
22-12 SSESS 5 0.107 0.020 
3-23-4 SSSSE 5 0.065 0.011 






5-2-12 SEEESEESEESS 12 0.000 0.000 
25-5 SEESSESESE 10 0.063 0.005 
6-9-9 SSESESSEEE 10 0.000 0.000 
6-13-32 EESESSSSE 9 0.030 0.003 
5-2-11 SSSESEESE 9 0.017 0.000 
6-9-28 SESSSEES 8 0.049 0.011 
6-16-68 SSSESSEE 8 0.039 0.018 
6-20-30 SSSSSEEE 8 0.038 0.025 
6-16-22 ESSSESES 8 0.028 0.007 
6-9-77 ESEESSSS 8 0.027 0.018 
6-14-73 SSSESES 7 0.050 0.012 
7-84 SSSESSE 7 0.048 0.007 
6-9-32 ESSSSES 7 0.046 0.010 
27-39 SSESESS 7 0.042 0.002 
6-14-23 SESESSS 7 0.036 0.008 
5-21 SSSEESS 7 0.035 0.005 
7-75 SSSSSEE 7 0.026 0.007 
27-23 ESSSESS 7 0.007 0.003 
6-14-47 SSSSSE 6 0.048 0.004 
7-11-46 SSSESS 6 0.042 0.001 
7-6 SSSSES 6 0.020 0.002 
6-13-65 SSESSS 6 0.012 0.012 
3-23-3 SSSSS 5 0.000 0.000 
6-16-92 SESESESSES 10 0.015 0.007 
6-9-83 ESSSSSEESE 10 0.009 0.009 
29-47 SSESEESSS 9 0.002 0.002 
6-14-88 SSSSSEES 8 0.002 0.002 






5-37 SSESSSS 7 0.022 0.009 
6-20-38 SESSSSS 7 0.012 0.008 
6-16-96 SSSSESS 7 0.006 0.006 
6-13-72 SSSESEESSESE 12 0.000 0.000 
N-E Combinations 
7-20-10 ENEEE 5 0.996 0.004 
7-20-46 EEEEEE 6 0.989 0.011 
7-20-33 NEE 3 0.986 0.014 
7-19-28 NEEEE 5 0.971 0.001 
7-19-23 EEENEEE 7 0.965 0.002 
7-19-47 EEEEEN 6 0.964 0.003 
7-20-32 EENEE 5 0.962 0.009 
7-19-21 EENEEEE 7 0.947 0.004 
7-19-8 ENNNEE 6 0.941 0.014 
7-20-47 NEEE 4 0.901 0.016 
7-20-20 EENEEEEEEE 10 0.879 0.015 
7-20-11 ENE 3 0.846 0.094 
7-20-31 NEENEEEN 8 0.749 0.040 
7-19-17 EENNEN 6 0.715 0.015 
7-20-26 EEENNN 6 0.700 0.053 
7-19-36 ENNENE 6 0.679 0.072 
7-20-37 NNNEEEEN 8 0.569 0.034 
7-19-6 NENE 4 0.379 0.010 
7-19-43 NEENNNENE 9 0.362 0.104 
7-19-40 EEEENENNN 9 0.269 0.079 
7-20-9 NNN 3 0.137 0.029 











Figure. S2.1. RESCUE-ESEs and PESEs in sequences found by SR protein responsive 
functional SELEX (Liu et al. 2000; Liu et al. 1998). The ~34-mers shown include a central 20 
nt derived from a random insert, plus constant flanks of 7 nt each; the 20-mers represent the 
sequences underlying ESEfinder (Cartegni et al. 2003), kindly provided by Adrian Krainer. 
RESCUE-ESEs are in bold blue, PESEs are in bold red, overlaps between the two are in violet 
italics and the top ESEfinder sequences (largest increment over the default threshold) are 







This chapter is part of a manuscript submitted for publication (Arias et al. 2013) 




For many genes, transcription produces pre-mRNA molecules that include exons and 
introns; the introns are removed and the exons are spliced together. Machinery in the cell is able 
to identify the boundaries between exons and introns with extreme accuracy. Early studies 
showed that the sequences at these boundaries are fundamental contributors and consensus 
sequences were published (Mount 1982). However, it was later realized that these sequences by 
themselves are not enough since many sequences that resemble the consensus are ignored in the 
process of splicing while others that show less similarity are used (Sun and Chasin 2000). 
 
Two alternative models have been implicit in thinking about the early recognition of sites 
(De Conti et al. 2013). In the first model, intron definition, each intron is recognized as a unit and 
removed; the exons are joined as a byproduct. In the second model, exon definition, each exon is 
recognized as a unit and joined to another similarly recognized exon. Hence, the ends of the 
intervening intron must be paired, requiring intron definition. The first model leads to studies of 
the recognition of the boundaries across the intron while the second leads to studies of the 
recognition of the boundaries across the exon. These considerations are particularly informative 
for internal exons for it has been suggested that exons flanked on both sides by introns longer 






solely by intron definition. More than 75% of human exons belong to the former category, 
stressing the importance of studying exon definition (Fox-Walsh et al. 2005). 
 
A protocol to obtain nuclear extracts and the subsequent development of in vitro splicing 
have facilitated research into many aspects of splicing (Dignam et al. 1983; Krainer et al. 1984). 
However, this tool works well only with short introns and systems with only a single such intron 
are routinely used. Accordingly, systems with internal exons that are surrounded by long introns 
have usually been abbreviated by removing large chunks of the introns and frequently further 
abridged to comprise only two exons. Even with these restrictions, the rate of intron removal is 
lower in vitro than in vivo (Hicks et al. 2005) and is lower yet for long introns in vitro (Lazarev 
and Manley 2007). These limitations in splicing long introns are present even in current 
transcription-splicing coupled systems (Lazarev and Manley 2007). Therefore, modifications to 
the in vitro assay or the development of new tools to complement it are needed for the study of 
exon definition. 
 
Several factors affect inclusion of an exon in the final mRNA molecule, including the 
strengths of the 5' and 3' splice sites and the presence of regulatory sequences both in the exon 
(exonic splicing enhancers, ESEs; and exonic splicing silencers, ESSs) and in the intron (intronic 
splicing enhancers, ISEs; and intronic splicing silencers, ISSs). More recently, the importance of 
transcription kinetics (Dujardin et al. 2013) and the influence of chromatin structure (Luco et al. 
2011) have been recognized. Many of these factors have been targeted by systematic studies 
(Graveley et al. 1998; Luco et al. 2010; Shepard et al. 2011). Genomic studies have given us an 






conditions; understanding how that picture is realized represents a fundamental goal and remains 
a challenge for which new approaches may be required (Roca et al. 2013). 
 
We have chosen to explore these issues using a reductionist approach, attempting to 
segregate individual parameters governing splicing so as to identify fundamental biophysical 
principles and parameters involved. Toward this end we have created simplified exon sequences 
of our own design (“designer exons” or DEs). A key feature in the design of these exons was the 
ability to vary the parameters of exon length, ESE/ESS number and ESE/ESS position without 
otherwise changing the sequence characteristics of the exon. We found that the relationships 




 DEs: effect of size 
 
 The exon definition model for splice site recognition (Berget 1995) maintains that 
internal exons will be chosen for inclusion only if they have acceptable splice sites at both ends, 
suggesting a physical interaction between the two ends of the exon. Thus the distance between 
the two ends of the exon could be an important parameter for the realization of this interaction. 
Consistent with this idea internal exon size in humans is limited, with less than 4% being greater 
than 300 nt (Berget 1995). In most previous experiments on the effect of exon size in splicing the 
experimental expansion of exons changed the quality as well as the length of the test exons, 






(Chen and Chasin 1994; Sterner et al. 1996). Since DEs can be expanded by adding identical 
sequence modules, chosen to avoid exonic regulatory elements, the contribution of parameters 
other than length should be diminished. 
 To assess the effect of size on exon inclusion we constructed a series of 3-exon 
minigenes containing a DE as the central exon (Fig. 3.1 and Supplemental Fig. S3.1). The DE is 
composed of 6 nucleotides that are parts of the splice sites or necessary “linker” sequences with 
the remainder of the DE being comprised exclusively of repeats of the reference sequence 
CCAAACAA. This sequence, previously termed “neutral,” is predicted to be neither an exonic 
splicing enhancer (ESE) nor an exonic splicing silencer (ESS) and had relatively little effect on 
the splicing of a test exon (Zhang et al. 2009). More importantly this sequence has the property 
 
Figure 3.1. Construction of designer exons (example). From the bottom: The RNA sequence with 
two 8 nt ESE motifs in green. Above that is a plot of the computationally predicted enhancer/silencer 
strengths of each overlapping 8-mer using two different criteria: red or blue (Zhang and Chasin 2004). 
The dashed lines indicate cutoffs used for classifying a sequence as an ESE (green) or ESS (red). The 
exon is indicated by a blue bar, where E refers to the ESE motif and N or n refers to the reference 
motif, with the lower case indicating its use as a spacer. At the top of the panel is an abbreviated 
version of the motif composition in which the spacer n motifs have been omitted. Finally, at the top is 
a cartoon showing the overall structure of a minigene containing a DE, with the splice sites in blue and 






of creating neither a predicted ESE nor a predicted ESS when all overlapping 8-mers created by 
self-concatenation are considered (Zhang et al. 2009). The exon sizes used here ranged from 14 
nt to 302 nt. In preliminary experiments, we found that the level of exon inclusion was too low to 
be informative using our original DE framework. Changing the sequence at the 3’SS from the 
original wild type UCUCUAACUUUCAG/G to UCUCUUUUUUUCAG/G or the sequence at 
the 5’SS from the original wild type CAA/GUAAGU to CAG/GUAAGU resulted in useful 
levels of splicing. Splicing was assessed in HEK293 cells after transient transfection or site-
specific permanent transfection followed by RT-QPCR; the same location was used in all 
permanent transfection experiments (see Methods). 
 
 As shown in Fig.3.2, the curves describing the inclusion of DEs display an optimum size 
range for exon inclusion (percent spliced in, or psi), with inclusion levels dropping off 
dramatically both above and below this range. The optimum range depends on the nature of the 
splice site sequences, being about 45 to 80 nt for exons with a strong 3’SS and 80 to 110 nt for 
those with a strong 5’SS. Interestingly, not just the optimum but the entire curve was shifted 
according to the splice site sequences used. Although exon inclusion efficiencies differ at many 
points depending on splice site sequences, the shapes of the curves are remarkably similar. A 
stronger 3’SS favors the inclusion of shorter exons whereas a stronger 5’SS favors the inclusion 
of longer exons. For example, compare the effects of the different splice site sequences on DEs 
of 46 nt and 142 nt in Fig. 3.2. To assess the extensibility of these results to a chromosomal 
context, we engineered a cell line where DEs could be placed by stable transfections exclusively 






chromosomal DEs. A series of exons bearing the strong 3’SS yielded a curve closely resembling 
that for transient transfections (Supplemental Fig. S3.2). The interdependence between the 
quality and position of a splice site sequence and size-dependent efficiency of exon inclusion is 
surprising and will be revisited in the Discussion. 
 
 DEs: effect of ESE position 
 
 Interactions that take place in exon definition have been shown to be facilitated by exonic 
splicing enhancers (Blencowe 2000; Chasin 2007). To assess the effect of enhancers on DE 
 
Figure 3.2. Exon inclusion has an optimum size range. Inclusion levels (psi) of DEs in transient 
transfections. DEs consist of reference sequences and have either a strong 3’SS (filled symbols) or a 
strong 5’SS (open symbols). See Supplemental Fig. S3.2 for inclusion levels of DEs in a chromosomal 

















inclusion, we chose as the baseline a DE of 110 nt made up exclusively of reference sequence 
repeats and carrying wild type splice sites, SS Set 7 (see Table 3.1). This exon yielded a psi of 
about 7%, a suitably low value for observing the effect of enhancers. As a prototype ESE we 
used the sequence UCCUCGAA. Like the reference sequence this sequence has the property of 
creating neither a predicted ESS nor a predicted ESE within the overlaps created by its insertion 
into the baseline DE. Importantly, this ESE is the same prototype we used in our initial study of 
designer exons (Zhang et al. 2009). This ESE was always inserted into the baseline DE such that 
 








































1 UCUCUUUUUUUCAG/G CAG/GUAAGU 93.1 99.9 -6.8 95 ND
3
 – – 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 81 99.9 -18.9 94 ND – – 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 93.1 88.4 4.7 77 ND – – 
4 UCUCUUUUUUUCAG/G CAA/GUGAGU 93.1 83.4 9.7 26 59 – 72 0.004*4 0.10 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 87.4 88.4 -1 49 86 – 90 0.0001* 0.27 
6 UCUCUAAUUUUCAG/G CAA/GUAAGU 82.6 88.4 -5.8 11 25 – 37 0.05 0.41 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 81 88.4 -7.4 7 18 – 34 0.001* 0.16 
1
 Based on a modification of the method presented by Shapiro and Senapathy (Shapiro and Senapathy 1987; Zhang 
et al. 2005) 
2
 Defined as the difference between the 3’SS and 5’SS consensus values. 
3
 Not done. 
4







it was flanked by two reference sequences, so as to satisfy the conditions for which it was 
designed and to keep constant the local context defined by the flanking 8 nucleotides. Thus we 
can consider the resulting DEs as being comprised of 16 nt modules each consisting of the 
reference 8-mer followed by either the ESE or another reference 8-mer. The baseline DE 
provides 6 evenly spaced non-overlapping positions at which a 16 nt ESE module can be 
substituted. Later we will describe similar constructs bearing ESS sequences. To define the 
composition of a DE we will use the notation E for ESE, S for ESS and N for the reference 
sequence. So, for instance, we refer to the placement of an ESE at the second of the 6 available 
positions as NENNNN. 
 
 We substituted a sole ESE at each of the 6 evenly spaced positions in the baseline DE and 
measured splicing after transient transfection. At each position the presence of the ESE caused a 
3- to 4-fold increase (p<0.01) with respect to the baseline DE (Fig. 3.3A). Similar increases were 
seen for these exons in the chromosomal context (Supplemental Fig. S3.3A). The ESE was 
effective at each of the 6 positions and there was no statistically significant difference between 
positions, except for 3 modest differences in permanent transfections (maximum psi difference 
of 5%). 
 
Enhancers are often thought of as acting by enhancing the recruitment of components of 
the splicing machinery to a nearby splice site, and as such would be expected to show a position 
effect, being more important close to a weak splice site. The lack of a position effect here could 
be due to the incorrectness of this argument or to the possibility that the ESE is equally effective 






To distinguish between these two ideas, we manipulated one or the other of the DE splice sites so 
as to create a range of differences between the two in terms of strength. This last is taken to be 




Figure 3.3. Addition of a single ESE enhances inclusion level and is position independent. The 
cartoons show the consensus values for splice site strengths used. A. Position variation in DEs with SS 
Set 7. B. Position variation in DEs with SS Set 5. C. Position variation in DEs with SS Set 6. D. 
Position variation in DEs with SS Set 4. Error bars: SEM, n≥3 except panel C, where n=2. In all cases 
the psi of DEs with an ESE are significantly different from that without ESEs (t-test, p<0.01), except 
for the last position in panel C (p=0.05). None of the 90 pairwise comparisons between ESEs at 
different positions showed significant differences (t-test, p>0.05). See also Table 3.1. See 






 We tested 7 combinations of three 5’ and four 3’ SS sequences using transient 
transfection. We started with a DE with two relatively strong splice sites, having consensus 
values of 93.1 and 88.4 for the 3’SS and 5’SS respectively. This exon was efficiently included 
even without an ESE (psi of ~80%) and so was not useful for evaluating enhancement (Table 
3.1, SS Set 3). We then weakened one or the other of the splice sites so as to produce a range of 
disparities between the 3’SS and the 5’SS strengths; the differences in strength (3’SS minus 
5’SS) for the 4 tested pairs were +10, -1, -6 and -7. Weakening either the 3’SS or 5’SS reduced 
the psi to values from 7% to 49% so that the effect of adding an ESE could be evaluated (Table 
3.1, SS Sets 4 through 7). Once again no statistically significant difference was found for the 
effect of the ESE at the various positions: p-values were greater than 0.05 for all pairwise 
comparisons (Fig. 3.3B, 3.3C and 3.3D; and Table 3.1, last column). SS Set 5 was also tested in 
a chromosomal context; addition of a single ESE produced statistically significant increases of 
similar magnitude to those found using transient transfections and was once again position 
independent (Supplemental Fig. S3.3B). These observations provide no support for the existence 
of a position effect for the enhancement by the ESE in these DEs and so likewise provide no 
support for the recruitment model for ESE action. 
 
 DEs with single ESEs have inclusion levels that are much higher than those of their 
corresponding baseline DEs. Moreover, the absolute increments in psi produced by adding a 
single ESE were much higher in the series shown in Fig. 3.3B and 3.3D (~40% ) than that 
observed when the original splice sites were used (~20%, Fig. 3.3A). That is, the magnitude of 







 DEs: effect of multiple ESEs 
 
 The sequence of our DEs allowed us to add an ESE while diminishing the chance of 
creating other regulatory sequences within overlapping sequences. It also allowed us to add 
multiple copies of an ESE while not adding any sequences that were not already present in a 
single ESE DE. It has been shown that the ESE strength or number inversely correlates with 
splice site strength in mammalian exons, i.e., ESEs can compensate for weak splice sites (Xiao et 
al. 2007; Ke et al. 2008). In addition, Hertel and Maniatis (1998) showed that the use of multiple 
downstream enhancer elements increased the use of a 3’SS in an additive manner when tested in 
vitro (Hertel and Maniatis 1998). We asked whether such additivity also holds true for the 
definition of an internal exon in vivo. 
 
 To assess the effect of multiple enhancers in a single exon, splicing of DEs with 0, 1, 2, 3 
or 6 ESEs was measured using transient transfections. For these experiments we used SS Set 7 in 
Table 3.1, which was the same set used in our previous study of randomly constructed DEs 
(Zhang et al. 2009). The data for no ESEs and 1 ESE at all possible positions was shown in Fig. 
3.3A. The analogous data for all 36 combinations of positions for 2, 3 and 6 ESEs are shown in 
Fig. 3.4 and Supplemental Table S3.1. As was the case for 1 ESE, there was no strong or 
consistent position effect when 2 or 3 ESEs were present. Psi values increased with the number 
of ESEs in a linear manner up to 3 ESEs (R
2
 = 0.82) and leveled off when 6 ESEs were included. 
Ascribing the last point to saturation, these results are consistent with the additive model. The 
slope in the linear range was a moderate 20% per ESE added; this kind of limited enhancement 







 DEs: effect of ESS position 
 
 A similar analysis for the effect of an exon silencer sequence (ESS) was performed. In 
this case SS Set 5 (Table 3.1) was used in order to provide a psi of about 50% as a baseline value 
from which decreases could be measured. The ESS sequence, CACAUGGU, was carefully 
chosen so as to not create any other predicted splicing regulatory sequence when placed in the 
DE; this same ESS was used in our previous study (Zhang et al. 2009). Placement of a single 
ESS at positions 2, 3, 5, or 6 reduced the psi significantly (p values from 0.003 to 0.031, Fig. 
3.5). There was no effect at position 1; variability at position 4 did not allow a conclusion. 
 
Figure 3.4. Inclusion levels of DEs increase with the number of ESEs present. The psi for all possible 

















Repeating this experiment in a chromosomal context yielded similar results (Supplemental Fig. 
S3.4). These results indicate some differences between positions, a conclusion that is supported 
by considering the effects of multiple ESSs (see below). 
 
DEs: effect of multiple ESSs 
 
 We next measured the effect of multiple ESSs, once again with the question of additivity 
in mind. The results of including 2, 3 or 6 ESSs in all 36 possible combinations of positions are 
 
 
Figure 3.5. Addition of a single ESS decreases inclusion level and shows some position 
dependence. The psi for DEs with a single ESS are shown for transient transfections. Error bars: 






summarized in Fig. 3.6A and shown in detail in Supplemental Table S3.1, which includes psi 
values for each positional combination. Psi decreased with ESS number in a reasonably linear 
manner up to 3 ESSs (R
2
=0.68); 6 ESSs resulted in 10-fold silencing, but this single point shows 
signs of saturation (Fig. 3.6A). These results are consistent with an additive model in which each 
ESS contributes about a 12% drop in psi. 
 
 The simple relationship between ESS number and psi described above does not take into 
account the lack of an effect for an ESS at position 1 (seen in Fig. 3.5). To address this issue we 
performed a different test of additivity, one that allows each ESS to exert a characteristic position 
effect. The psi of a multi-ESS DE was predicted by summing the effects of the individually 
positioned ESSs as measured in the single-ESS DE experiment:  
3.1. Predicted    =baseline +                           
where baseline is the psi of the baseline DE with no ESSs, i is an index number for positions 1 
through 6, Pi is 1 if an ESS is present at position i and 0 otherwise, and psi(i) is the measured psi 
for a DE bearing a single ESS at position i. The observed psi measurements for all thirty-five 2- 
and 3-ESS DEs show a good agreement to these linear combination predictions (R
2
= 0.80, Fig. 
3.6B). In contrast, when we assumed that all positions were equivalent and used the average 
value for all the single-ESS DEs to predict psi then the R
2
 value dropped to 0.56, supporting the 
position dependence observed in Fig. 3.5. To explore this further, we examined the contributions 
of individual positions to this position effect by averaging all positions but one while retaining 
the position-specific contribution of the latter. Retaining the position-specific contribution of the 
first or last positions increased the R
2
 value from 0.56 to 0.68 or 0.72, respectively, while such 
retention at the internal positions 2 to 5 produced no increase in R
2






positional information is important only for the 2 terminal positions. Indeed, retention of the 
position effect of 1 and 6 alone returned the R
2
 value to 0.80, the same as the value reached using 
all positional information. Taking all this data into account, it appears that an ESS at the first 
 
Figure 3.6. Inclusion levels of DEs decrease with the number of ESSs present. A. The psi for all 
possible permutations with 0, 1, 2, 3, or 6 ESSs were measured (n≥3). The columns depict the average. 
B. The psi for all possible permutations with 2 and 3 ESSs were plotted against predictions based on 







position has no effect, an ESS at the last position is the most effective and ESSs in the middle 




We have described the splicing phenotypes of exons of our own design, each principally 
comprised of just 1 or 2 prototype 8-base sequence modules that represent an ESE, an ESS or a 
reference sequence that resembles neither. The splicing effects of exon size, ESE content and 
ESS content were independently and systematically evaluated in the context of a three-exon 
minigene. We found that there is a major effect of size on splicing. Both small and large exons 
are spliced less efficiently than exons of intermediate size. Surprisingly, when we used different 
splice site sequences, we found a striking difference in exon size dependence. One set showed a 
better efficiency for long exons while the other was better for short exons; that is, one 
dependency was shifted relative to the other. Using a DE of a fixed size, the ESE sequence used 
increased psi in all positions tested. Interestingly, the magnitude of this effect was not position 
dependent, even when the 3’SS or 5’SS was purposely weakened. Moreover, when multiple 
ESEs were used the effect increased proportionately before showing saturation as psi approached 
100%. The ESS sequence, on the other hand, displayed some position dependence. Its effect was 
maximal when placed close to the 5’SS but showed almost no effect near the 3’SS. Intermediate 
positions showed a uniform intermediate effect. When multiple ESSs were present their 
combined effects increased proportionately with signs of saturation as the psi approached 0%. 







Irrespective of the model used, the shift between these two curves implies that comparing 
the strengths of 5’SS sequences might be more complex than previously thought. Finally, 
compared to these simplified exons, natural exons may be influenced by other factors. For 
instance, the collision rate between the exon ends (see Chapter 5) could be increased (or 
decreased) by additional protein-protein interactions, by the formation of secondary structures or 
by a scaffolding platform. In this respect, DEs can provide a framework for investigating such 
possible influences. 
 
Effect of ESEs 
 
The idea that ESEs act by recruitment of the splicing machinery (Kohtz et al. 1994; 
Staknis and Reed 1994) is supported by evidence of interactions between activator proteins that 
bind ESEs and some of the proteins involved in the early steps of splicing (Hoffman and 
Grabowski 1992; Wu and Maniatis 1993; Kohtz et al. 1994; Staknis and Reed 1994). It has often 
been assumed therefore that this interaction should display a position effect: the closer the 
binding site for the activator to the splice site, the more efficient it should be in recruiting the 
splicing machinery to that site. Since we saw no evidence for such a position effect we propose 
that the action of the ESE is stabilization of an otherwise volatile interaction between U2AF and 
U1 snRNP (see Chapter 5). Position independence is also suggested by the finding that SRSF1 









ESS number and position effect 
 
We showed that the effect of multiple ESSs could be predicted by their linear 
combination as long as the particular characteristics of positions 1 and 6 were taken into account 
(Fig. 3.6B). The position effect seen for ESSs suggests that ESSs may act by destabilizing bound 
U1 snRNP or even blocking its binding rather than by affecting an exon definition complex. 
However, other possibilities remain. One of such possibilities includes a destabilizing effect of 
the proteins binding ESS on proteins binding the reference sequence (see Chapter 6). If the 
displaced proteins have a positive effect on splicing, the effect of ESS sequences would appear to 
be negative. Further studies using different ESS/SS combinations and exploring mechanisms 
such as competition for binding RNA could be tried using the present system as a starting point. 
 
Materials and Methods 
 
Plasmids 
A “drafting” plasmid, pAL-SB, containing type IIS restriction sites flanking CCAAACA allowed 
BsmBI and BsaI (NEB) to generate the appropriate overhangs for seamless building-block 
additions on either the upstream or downstream side, respectively, of the DE under construction. 
Building blocks composed of combinations of two synthetic modules: NN, NE, EN, EE, NS, SN 
and SS were added by sequential ligations. The finished DEs were amplified by PCR and 
digested with BbvI (NEB) to generate overhangs compatible with appropriate receiving 
plasmids. Each receiving plasmid contained a modified dhfr minigene controlled by a tet-






sequence placed in exon 3. Each receiving plasmid had a specific SS set and, in place of a DE, a 
specifically designed removable sequence/adapter: RA. Using BveI (Fermentas), this RA was 
removed generating appropriate overhangs for seamless incorporation of the DEs constructed in 
the pAL-SB plasmid. This scheme and some variations were used to generate the DE-containing 
minigenes (see Supplemental Material). 
 
The plasmid employed in the generation of the cell line used for chromosomal incorporations, 
pMA-FW, contains a kanamycin resistance gene for initial selection, a promoterless puromycin 
resistance gene for subsequent selection of site-specific recombinations with DE-containing 
plasmids, a phiC31 attP site and only the downstream half of the modified dhfr minigene. 
pMA-IC contains a CMV promoter to drive the puromycin resistance gene after site-specific 
recombination, the upstream half of the modified dhfr minigene with a replaceable exon 2 for 
reconstitution of the full minigene, and an attB site (Supplemental Fig. S3.5; see Supplemental 
Material). DEs were transferred to this plasmid by replacing the initial exon 2. 
 
An actin-skipped coupled-standard was generated by incorporating cDNA for both gamma actin 
and DE-skipped mRNA in the same plasmid. Purified plasmid was digested with EcoO109I 
(NEB) to generate a solution with equimolar amounts of each type of molecule. This solution 
provided a standard for relative quantification through QPCR. Included-skipped equimolar 
coupled-standards were analogously constructed and used to calibrate the psi measurements 









RNA was extracted from transfected cells and reverse transcribed. Serial dilutions of the 
equimolar coupled-standard were used for QPCR quantification and the ratio of DE-skipped to 
DE-included was obtained (S/I, or SOI). This ratio was used to obtain psi by the formula 
psi=100/(1+SOI). A similar protocol was followed for stable transfections including gamma 
actin quantification (see Supplemental Material). 
 
Transfections 
Transient transfections were performed in modified HEK293 cells carrying a tTA gene (cMA-
HEK293-tTA). RNA was extracted after 25 hours. Stable transfections were performed in cMA-
FW cells using a DE-containing pMA-IC plasmid and the plasmid coding for the site-specific 
recombinase pPGKPhiC31obpA (Addgene). After puromycin selection, the resulting site-
specific recombinants were pooled and grown for RNA extraction (see Supplemental Material). 
 
Cell lines 
HEK293 cells were stably transfected with a plasmid coding for the tet-Off trans-activator 
(Gossen and Bujard 1992). A clone, cMA-HEK293-tTA, was chosen and used for all transient 
transfections. cMA-HEK293-tTA cells were electroporated using linearized pMA-FW plasmid. 
Clone cMA-FW was selected as one that had incorporated a single genomic copy of pMA-FW, 
had a high level of expression and had an adequate level of recombination. This clone was used 
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Materials and methods 
 
Double stranded oligomers 
Sense and antisense oligomers were purchased from either Invitrogen or Fisher Scientific and 
annealed by mixing them together at a concentration of 40 uM in 300 mM sodium acetate. These 
mixtures were placed in a bath of boiling water for 5 min and allowed to slowly cool down to 
room temperature. The annealed oligomers were phosphorylated at a final concentration of 100 
nM with T4 polynucleotide kinase from New England Biolabs (NEB) by following the 




Removable adapters or RAs are sequences that contain recognition sites for type IIS restriction 
enzymes (REs) that cut at both ends of the adapter. Due to the nature of type IIS enzymes, the 
sequence of the overhangs generated can be chosen essentially without restrictions. Two kinds of 
removable adapters were designed. RAs of the first kind (RA-I) are removed by a single type IIS 
RE that cuts on both sides of the adapter. RAs of the second kind (RA-II) allow independently 
controlled cuts on either end: one type IIS RE cuts on one side while a different type IIS RE cuts 









Fig. S3.1 shows the features of the modified dhfr minigene used to harbor the DEs. 
 
All modifications performed on plasmids were verified by sequencing the appropriate regions 
(Genewiz).  
 
A “drafting” plasmid, pAL-SB, was derived from pEGFP-C3 (Addgene) to facilitate the 
construction of DEs. This plasmid contains an adapter that allows the use of type IIS enzymes 
BsmBI and BsaI to add building blocks at either flank of the DE in progress, but it does not 
contain a dhfr minigene. The finished DEs can be copied and pasted into any of the receiving 
plasmids (see below). In order to provide flexibility for future extensions, BfuAI sites were 
removed from pEGFP-C3. For this purpose, nested PCR was performed using two primer pairs: 
oligo36 and oligo37, and oligo38 and oligo39; the oligo36 and oligo39 primers were used for the 
final amplification, which appended temporary BsaI sites at both ends to generate the appropriate 
overhangs. The products were cut with BsaI and ligated into pEGFP-C3 which was previously 
digested with BfuAI. This was followed by transformation of DH5-alpha competent cells and 
selection in kanamycin (Sigma-Aldrich). Successful clones were selected by evaluating digestion 
patterns with BfuAI. The intended use of BsaI for DE construction required removal of the BsaI 
site from pEGFP-C3. To remove it, a PCR fragment was obtained using primers oligo40 and 
oligo41; this PCR fragment and the previously modified pEGFP-C3 plasmid were digested with 






appropriate adapter, the oligo42 primer was designed. Along with oligo43, it was used to amplify 
a fragment from pEGFP-C3. Both the adapter-containing PCR fragment and the plasmid were 
digested with PstI (NEB) and HindIII (NEB), mixed and ligated together to obtain pAL-SB.  
 
As a starting point for all the dhfr minigene containing plasmids, pMA-Universal was made from 
plasmid pUHD10-3 (Gossen and Bujard 1992). The whole dhfr minigene was copied from the 
pD12 plasmid (Zhang et al. 2009) and integrated into pUHD10-3 by placing it under the control 
of the tet-responsive promoter with a SV40 polyA signal for cleavage and polyadenylation. 
During the transfer, all the ATGs in exon 1 were eliminated, the first out-of-frame ATG in exon 
3 was eliminated, and the following in-frame ATG was modified to conform to the Kozak 
sequence. These modifications were performed to reduce possible translation effects of 
modifying the middle exon. Additionally, the DE was substituted with an RA-II. The RA-II 
employed relies on BfuAI and BtgZI for its function. Therefore, the BtgZI site present in 
pUHD10-3 was removed. We call the dhfr minigene in pMA-Universal the modified dhfr 
minigene; its sequence is included below. The details for its generation follow. For the removal 
of the BtgZI site, the plasmid was cut with BtgZI (NEB) and NgoMIV (NEB) and 
dephosphorylated; P-ds-oligo oligo1/oligo2 was ligated to this plasmid using T4 ligase (NEB) by 
following the manufacturer’s protocol. The dhfr minigene was transferred from the pD12 
plasmid (Zhang et al. 2009) and simultaneously modified in five stages using PCR and P-ds-
oligo ligations as described below. An intermediate plasmid, piMA-F5, was obtained by PCR 
amplification of fragment F5 (oligo3 and oligo4), digestion with XbaI and MluI and ligation into 
the modified pUHD10-3 after its digestion with XbaI and BtgI and dephosphorylation. This was 






Aldrich). A clone with piMA-F5 was chosen by verification of the expected sizes of appropriate 
PCR products. Similarly, fragment 4 (oligo5 and oligo6) and fragment 3 (oligo7 and oligo8) 
were sequentially added using BfuAI (NEB) and SphI (NEB) for the digestions of the PCR 
products and BtgZI (NEB) followed by SphI for the plasmids. Fragment 2 was added as 
P-ds-oligo oligo9/oligo10 to the previous plasmid digested with BtgZI followed by SphI. 
Fragment 1 was added as P-ds-oligo oligo11/oligo12 to the resulting plasmid after digestion with 
BtgZI and BsiWI. This new plasmid was digested with NotI (NEB) and NheI (NEB) and 
ligations with P-ds-oligo oligo13/oligo14 generated pMA-Universal.  
 
A series of plasmids containing an RA-II were generated: the construction plasmids. These 
plasmids contain the modified dhfr minigene and an RA-II surrounded by an appropriate SS set 
to allow “on-site” construction of DEs (see below). These plasmids are derived from pMA-
Universal. For SS Set 7, the 5’-SS, the polypyrimidine tract, and the 3’-SS were added by three 
sequential rounds of ligation, transformation and selection using the restriction sites for NheI, for 
NotI and SphI, and for BtgZI and SphI, respectively, and three pairs of P-ds-oligos: 
oligo15/oligo16 for the 5’-SS, oligo17/oligo18 for the polypyrimidine tract, and oligo19/oligo20 
for the 3’-SS. A similar procedure was used for SS Set 3, but oligo21/oligo22 was used for the 
second ligation. For SS Set 5, the 5’-SS, and the polypyrimidine tract together with the 3’-SS 
were added sequentially using the restriction sites for NheI, and for NotI and SphI respectively 
and two pairs of P-ds-oligos: oligo23/oligo24 for the 5’-SS, and oligo25/oligo26 for the rest. For 







The receiving pMA plasmids contain an RA-I and were used for incorporating the DEs made in 
the pAL-SB plasmid into an modified dhfr minigene. Each receiving plasmid contains a SS set. 
For SS Set 5, P-ds-oligo oligo32/oligo33 was ligated into the pMA-Universal plasmid after 
digesting the latter with NheI and NotI. The intermediate plasmid containing the 5’SS of SS Set 
7 described in the previous paragraph was digested with SphI and NotI and ligated to P-ds-oligo 
oligo34/oligo35 to generate the receiving pMA plasmid for SS Set 3. The RA-I used in the 
receiving pMA plasmids is different from the RA-II in the plasmids that allow stepwise 
construction of the DE and it leaves different overhangs upon its removal.  
 
The pMA-FW plasmid provided the basis for incorporation of the modified dhfr minigenes into 
the genome. It contains a kanamycin resistance gene for initial selection of the cell line, a 
promoterless puromycin gene for subsequent selection of site-specific recombinations with DE-
containing plasmids, an attP site for site-specific recombination and only the downstream half of 
the modified dhfr minigene. This plasmid was derived from pEGFP-C3. The CMV promoter and 
the EGFP gene were cut out with AseI and BamHI and in its stead a promoterless puromycin 
resistance gene was ligated by amplification from ptTA (a kind gift from Jim Manley) using 
primers oligo44 and oligo45 and digestion with AseI and BamHI. This new plasmid was 
digested with XhoI (NEB), dephosphorylated and ligated to P-ds-oligo oligo46/oligo47, which 
provides an attP site for PhiC31 recombinase (Groth et al. 2000). Several clones were sequenced 
and, of the two orientations possible for the attP site, the one in which oligo46 was on the sense 
strand of the puromycin gene was chosen. This intermediate plasmid was digested with AseI and 
XhoI. The downstream half of the minigene starting in the middle of intron 2 (1 bp downstream 






pMA-Universal using the primers oligo48 and oligo49, digested with AseI and XhoI, mixed with 
the digested intermediate plasmid and ligated to obtain pMA-FW.  
 
Plasmid pMA-IC allows reconstitution of a fully functional puromycin resistance gene and a DE-
containing modified dhfr minigene upon site-specific recombination with the sequence from 
pMA-FW (Fig. S3.5). The DE-containing plasmids for site-specific recombinations contained a 
CMV promoter to drive the puromycin resistance gene after site-specific recombination, the 
upstream half of the modified dhfr minigene including the DE for reconstitution of the modified 
dhfr minigene, and an attB site for site-specific recombination. An “empty” pMA-IC plasmid 
was constructed from a pMA-Universal derived plasmid which contained an irrelevant sequence 
between the NotI and the NheI sites. The CMV promoter was amplified from pEGFP-C3 using 
oligo50 and oligo51; both the pMA-Universal derived plasmid and the PCR product were cut 
with XbaI (NEB) and EcoRI (NEB) and ligated together. This step removed the downstream half 
of the minigene. An attB site for PhiC31 recombinase (Groth et al. 2000) was ligated into the 
XhoI site of the modified plasmid as P-ds-oligo oligo52/oligo53. Of the two orientations 
possible, the one in which oligo52 was on the sense strand of the partial dhfr minigene was 
chosen. The BtgZI site was removed to enable future extensions by digesting the previous 
plasmid with NcoI (NEB) and BsaAI (NEB) and ligating P-ds-oligo oligo54/oligo55.  
 
To serve as the basis for the coupled-standards, the plasmid piS-Std was generated, which 
contained the skipped cDNA for the modified dhfr minigene. The cDNA of a transient 
transfection with a DE of 110nt (SS Set 7) composed exclusively of reference sequences was 






digested with BfuAI and BsiWI and ligated into the plasmid piMA-F5 previously digested 
sequentially with BsiWI and BtgZI. Plasmid piS-Std was selected by the size of the products in 
appropriately chosen PCR amplifications. An adapter to facilitate subsequent ligations was added 
to generate piS-StdwAd by digestion with NcoI and XbaI, dephosphorylation and ligation of P-
ds-oligo oligo57/oligo58. For generating the Gamma Actin coupled-standard, piSActin-Std, 
cDNA generated from MA-tTA cells by reverse transcription with primer oligo61 was amplified 
using primers oligo62 and oligo63. The PCR product and plasmid piS-StdwAd were digested 
with EcoRI and NotI and ligated together. For generating the coupled-standard for SS Sets 1, 2 
and 4, piSI-CAG-Std, cDNA from a transient transfection using a DE of 110nt composed 
exclusively of reference sequences and SS Set 1 was amplified using primers oligo59 and 
oligo60. This PCR product and plasmid piS-StdwAd were digested with EcoRI and NotI and 
ligated together. The coupled-standard for SS Sets 3, 5, 6 and 7, piSI-CAA-Std, was made 
analogously from a transient transfection using a DE with SS Set 3: a mutation of A to G at 
position 64 of the DE was deemed innocuous and accepted.  
 
DE construction 
Most DEs were constructed in a stepwise fashion by ligating P-ds-oligos oligo64/oligo65 (NN), 
oligo66/oligo67 (EE), oligo68/oligo69 (EN), oligo70/oligo71 (NE), oligo72/oligo73 (SS), 
oligo74/oligo75 (SN), and oligo76/oligo77 (NS) into pAL-SB or the RA-II-containing 
construction plasmids (previous section). For the pAL-SB plasmids, the appropriate plasmids 
were digested with either BsmBI (to add a building block upstream of the DE in progress) or 
BsaI (to add a building block downstream). The final DEs were amplified with primers oligo78 






removing its RA-I by digestion with BfuAI or its isoschizomer BveI (Fermentas). For the RA-II-
containing construction plasmids, appropriate plasmids were digested with BfuAI (to add a 
building block downstream of the RA), BtgZI (to add a building block upstream) or both (to 
remove the RA or replace it with a building block). RA-II-containing construction plasmids with 
SS Sets 3 and 7 were digested with NheI and BtgZI to incorporate 22 bp DEs by ligating a 
P-ds-oligo oligo79/oligo80 or oligo81/oligo82 as appropriate. Constructs using SS Set 1 and SS 
Set 2 were made by amplifying the corresponding DEs from plasmids with SS Sets 3 and 7, 
respectively, using primers oligo29 and oligo30, digesting both the PCR products and pMA-
Universal with NheI and NotI and ligating them together. By following this protocol, DEs using 
SS Set 4 were made by amplifying the corresponding DEs from plasmids with SS Set 3 using 
primers oligo29 and oligo31.  
 
For generating the DE-containing pMA-IC plasmids, DEs were amplified by PCR from the 
appropriate modified dhfr minigenes using oligo29 and oligo83, digested with NotI and EcoRI 




RNA was extracted from transiently transfected cells using the RNA Spin Mini kit (GE 
Healthcare) and quantified using a Nanodrop 1000 (Thermo Scientific). Lack of degradation was 
assessed by gel electrophoresis. Reverse transcription (RT) was performed using an Omniscript 
kit (QIAGEN) in 10 µl reactions with 400 ng of RNA for each sample using the primer oligo84 






contain it for SS Sets 3, 5, 6 and 7, the appropriate coupled-standard was prepared from plasmid 
piSI-CAA-Std by digestion with EcoO109I (NEB) followed by inactivation. The concentration 
of this digested plasmid was approximately 10
10
 plasmid molecules per µl based on absorbance 
measurements. This solution was diluted to approximately 10
8
 molecules per µl and a dilution 
series was prepared: 10-fold dilution per step. The starting solution was labeled as having exactly 
10
8
 arbitrary units. Given that the coupled-standard plasmid concatenates a molecule that skips 
the DE and a molecule that includes it (see Supplemental Fig. S3.6), each diluted solution 
contains equimolar amounts of each, which enables accurate calibration by QPCR of one type of 
molecule relative to the other. (Furthermore, all coupled-standards were calibrated to each other 
by means of the common “skipped mRNA” region to further allow comparisons among 
standards.) QPCR was performed in 20 µl reactions that included 400 nM of forward and reverse 
primers, 2 µl of a 1:5 dilution of the RT product for each sample and 10 µl of 2X Power Green 
QPCR Master Mix (Applied Biosystems) using a 7300 PCR System (Applied Biosystems) 
according to the manufacturer’s protocol. The data was analyzed using the software provided by 
the manufacturer. The primer sets used in QPCR reactions share the reverse primer oligo83 and 
include either oligo85 as the forward primer to detect the molecules that contain the DE or 
oligo86 to detect molecules that skip it. Since there is at least a 100-fold reduction in cross-
detection of the molecules that skip the DE with the primers that detect its inclusion and vice 
versa (data not shown), this scheme provides the ratio (termed the SOI) of molecules that skip to 
those that include the DE for each sample; SOI should not be affected by differences in 
efficiency between the sets of primers used. The psi was obtained by the formula 
psi=100/(1+SOI). For SS Sets 1, 2 and 4, the coupled-standard derived from the plasmid 






Importantly, because of the placement of the QPCR primers all amplified products consist of 
identical sequences for each SS set and in particular are independent of the E, S and N 
combinations used, thus ensuring equal PCR efficiencies.  
 
To assess the expression levels of the minigenes in stable transfections, the Gamma Actin primer 
oligo61 was added to the RT reaction. To quantify the mRNA levels for Gamma Actin, the 
coupled-standard derived from piSActin-Std was used in QPCR reactions. Comparisons between 
Gamma Actin mRNA and mRNA for the minigene are affected by the relative efficiency of the 
two reverse transcription primers, disallowing a direct comparison. However, normalization to 
Gamma Actin mRNA enables direct comparisons for the transcription levels of the minigene 
between samples.  
 
Transfections 
For transient transfections, cMA-HEK293-tTA cells were grown in 10 cm dishes to ~80% 
confluence. Cells from each dish were plated in 6 wells of a 6-well plate and incubated at 37°C 
for 24 hours. Transient transfections were performed using 600 ng of plasmid and 4 µl of 
Lipofectamine 2000 (Invitrogen) using Opti-MEM I (Invitrogen) according to the manufacturer’s 
protocol. Cells were incubated at 37°C for 25 hours before RNA extraction.  
 
For stable transfections, cMA-FW cells were grown in 10 cm dishes to ~80% confluence. 
Transfections were performed using 2.4 µg of the DE-containing pMA-IC plasmid, 15 µg of 
pPGKPhiC31obpA plasmid (Addgene) and 30 µl of Lipofectamine 2000 using Opti-MEM I 






Supplemental Fig. S3.5) were selected after 72 hours of incubation at 37°C by adding puromycin 
(Sigma-Aldrich) to a final concentration of 4.2 µg/ml. In effect, only site-specific recombination 
allows reconstitution of the minigene (Supplemental Fig. S3.5). The puromycin containing 
medium was changed every 5 days. After ~3 weeks of puromycin exposure, the surviving clones 
were pooled and allowed to grow in 6-well dishes before RNA extraction.  
 
Cell lines 
HEK 293 cells were modified to express the tet-Off trans-activator (Gossen and Bujard 1992) by 
co-transfecting 1 µg of pUHD15-1 plasmid and 0.1 µg of pLi082 plasmid, which provides 
hygromycin resistance. Clones were grown in 100 µg/ml hygromycin and recloned. Individual 
clones were chosen and expression of a tetracycline-response-element controlled minigene was 
evaluated. A clone, cMA-HEK293-tTA, that displayed adequate expression levels and a good 
response to doxycycline was chosen (data not shown). This clone was used for all transient 
transfections.  
 
This cell line was used to generate the cMA-FW by incorporation of pMA-FW digested with 
MluI and transfected by electroporation using Nucleofector II (Lonza) according to the 
manufacturer’s protocol. Cells were incubated for 48 hours at 37°C and successful genomic 
incorporations of the transfected DNA were selected by adding G418 (Invitrogen) at a final 
concentration of 500 µg/ml. Site-specific recombination into these cells was evaluated with a 
pMA-IC plasmid containing the DE NNNENE. One clone cMA-FW was selected that provided 
adequate levels of expression for the reconstituted minigene and generated an acceptable number 






of pMA-FW was evaluated by verifying the full disruption of attP sites in puromycin surviving 
colonies by PCR using primers oligo83 and oligo88 (data not shown): full disruption in multiple 
independent site-specific recombinations, evidenced by the absence of PCR products, is expected 
only if a single attP site is present since reconstitution of a single puromycin resistance gene 
suffices for survival. This result was confirmed by using a Southern blot (data not shown). Also 
genomic DNA was digested with NspI, diluted and ligated to obtain DNA circles; inverse PCR 
was then performed using nested primer pairs: oligo83 and oligo44 in the first PCR reaction and 
oligo89 and oligo90 in the second. These products were cloned into the Not I site of pMA-
Universal and sequenced. This information allowed mapping of the genomic integration point to 
PLEKHG1 in chromosome 6, specifically 141 bp before its 23 nt exon (i.e., intron 14 in 
NM_001029884.1). The location was verified by detection of PCR products that crossed the 2 
ends of the integration site in the genomic DNA using primer pairs oligo91 with oligo89 and 
oligo92 with oligo93.  Additionally, the size profile observed in the Southern Blot coincided with 
that predicted from integration at this genomic location. 
 
Since the minigene was integrated into the sense strand of the PLEKHG1gene, we were 
concerned about the possibility that fusion transcripts would be synthesized in which a 
PLEKHG1 exon was spliced to a DE, leading to a counterfeit measurement of inclusion.  
However, no such fused mRNAs were detected by PCR using oligo94 (in the PLEKHG1 
sequence) and oligo83 (in dhfr exon 3) probably due to the presence of a SV40 polyA site in 









Sequence of pMA-Universal 
 
Shown below is the sequence inserted into pUHD10-3. Regions of exons 1 and 3 are shown in 
blue. The regions of introns 1 and 2 that were used are shown in gray. The restriction sites used 
for incorporation of DEs are indicated: the NotI site is shown in magenta and the NheI site is 
highlighted in yellow. The removable adapter is highlighted in green. The first and last four 
nucleotides of the entire sequence correspond to the overhangs added for cloning. The 3 















































3 UCUCUUUUUUUCAG/G CAA/GUAAGU 14 i6un 0N 42 4 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 46 i6uNN 2N 97 1 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 78 i6u(N)x4 4N 96 2 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 110 i6u(N)x6 6N 76 5 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 142 i6u(N)x8 8N 33 11 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 174 i6u(N)x10 10N 13 5 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 206 i6u(N)x12 12N 12 6 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 238 i6u(N)x14 14N 4 1 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 270 i6u(N)x16 16N 7 4 
3 UCUCUUUUUUUCAG/G CAA/GUAAGU 302 i6u(N)x18 18N 5 2 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 22 innm1I3 ½N 4 2 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 46 iNNm1I3 2N 58 14 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 78 i(N)x4m1I3 4N 94 3 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 110 i(N)x6m1I3 6N 94 3 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 142 i(N)x8m1I3 8N 78 2 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 174 i(N)x10m1I3 10N 31 1 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 206 i(N)x12m1I3 12N 10 4 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 238 i(N)x14m1I3 14N 8 3 
2 UCUCUAACUUUCAG/G CAG/GUAAGU 270 i(N)x16m1I3 16N 4 0 
ESE Perturbation 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i555 NNNNNN 7 0 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i255 ENNNNN 30 6 






7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i525 NNENNN 34 11 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i545 NNNENN 27 5 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i552 NNNNEN 30 7 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i554 NNNNNE 18 3 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i155 EENNNN 34 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i225 ENENNN 38 8 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i245 ENNENN 57 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i252 ENNNEN 59 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i254 ENNNNE 35 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i425 NEENNN 47 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i445 NENENN 50 4 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i452 NENNEN 41 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i454 NENNNE 46 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i515 NNEENN 46 5 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i522 NNENEN 39 3 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i524 NNENNE 34 4 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i542 NNNEEN 32 4 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i544 NNNENE 31 4 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i551 NNNNEE 29 5 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i125 EEENNN 74 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i145 EENENN 80 7 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i152 EENNEN 75 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i154 EENNNE 56 8 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i215 ENEENN 81 8 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i222 ENENEN 79 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i224 ENENNE 57 3 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i242 ENNEEN 79 5 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i244 ENNENE 65 3 






7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i415 NEEENN 73 4 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i422 NEENEN 74 5 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i424 NEENNE 71 5 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i442 NENEEN 76 6 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i444 NENENE 67 5 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i451 NENNEE 78 4 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i512 NNEEEN 74 7 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i514 NNEENE 72 11 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i521 NNENEE 70 11 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i541 NNNEEE 63 13 
7 UCUCUAACUUUCAG/G CAA/GUAAGU 110 i4u555 EEEEEE 96 0 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u255 ENNNNN 90 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u455 NENNNN 90 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u525 NNENNN 90 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u545 NNNENN 89 3 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u552 NNNNEN 89 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u554 NNNNNE 86 4 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u111 EEEEEE 98 0 
ESS Perturbation 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u555 NNNNNN 49 3 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u855 SNNNNN 47 1 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u655 NSNNNN 38 4 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u585 NNSNNN 38 4 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u565 NNNSNN 38 9 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u558 NNNNSN 34 4 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u556 NNNNNS 30 5 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u955 SSNNNN 37 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u885 SNSNNN 35 2 






5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u858 SNNNSN 38 4 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u856 SNNNNS 30 3 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u685 NSSNNN 35 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u665 NSNSNN 33 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u658 NSNNSN 34 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u656 NSNNNS 24 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u595 NNSSNN 32 3 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u588 NNSNSN 20 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u586 NNSNNS 22 4 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u568 NNNSSN 27 4 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u566 NNNSNS 19 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u559 NNNNSS 15 3 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u985 SSSNNN 27 5 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u965 SSNSNN 19 1 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u958 SSNNSN 18 1 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u956 SSNNNS 16 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u895 SNSSNN 18 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u888 SNSNSN 22 1 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u886 SNSNNS 13 1 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u868 SNNSSN 18 1 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u866 SNNSNS 17 6 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u859 SNNNSS 16 6 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u695 NSSSNN 16 5 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u688 NSSNSN 15 5 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u686 NSSNNS 8 1 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u668 NSNSSN 16 5 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u666 NSNSNS 5 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u659 NSNNSS 8 1 






5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u596 NNSSNS 11 3 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u589 NNSNSS 11 2 
5 UCUCUAUUUUUCAG/G CAA/GUAAGU 110 i4u569 NNNSSS 14 3 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S3.2. Exon inclusion has an optimum size range in a chromosomal context. Inclusion 
levels (psi) of DEs of various sizes in a chromosomal context. DEs consist of reference sequences and 
have a strong 3’SS. Error bars: SEM, n≥3. 
 








Figure S3.3. Addition of a single ESE enhances inclusion level and is position independent in a 
chromosomal context. The cartoons show the consensus values for splice site strengths used. A. 
Position variation in DEs with SS Set 7. B. Position variation in DEs with SS Set 5. Error bars: SEM, 
n≥3.  In all panels the psi of DEs with an ESE are significantly different from that without an ESE (t-








Figure S3.4. Addition of a single ESS decreases inclusion level and shows some position 
dependence in a chromosomal context. The psi for DEs with a single ESS are shown for stable 









Figure S3.5. Site-specific recombination reconstitutes the minigene in a specific location of the 
genome. Using the kanamycin resistance gene (Kana) through selection with G418, an attP site has 
been incorporated in the genome of HEK 293 cells along with the downstream half of the modified 
dhfr minigene and a promoterless copy of a gene conferring puromycin resistance (Puro). After 
transient transfection with a plasmid incorporating the upstream half of the minigene as well as a 
promoter for the puromycin resistance gene, along with a gene for PhiC31 recombinase, puromycin-
resistant site-specific recombinants can be isolated that have reconstituted the minigene as well as the 
puromycin resistance gene. Exons are indicated with boxes while introns and intergenic regions are 
indicated by thin lines. The promoters are indicated with thick horizontal lines: gray for the minigene 
and black for the puromycin and G418 resistance genes. The direction of transcription is indicated by 
bent arrows; the dashed arrow indicates the nominal direction of transcription for the promoterless 
puromycin resistance gene. For exon 3 of the minigene, the nominal direction of transcription is 











Figure S3.6. Coupled-standards incorporate two cDNAs into a single molecule. A reverse 
transcribed copy of the mRNA with the DE spliced in (included) as well as a copy without it (skipped) 
have been incorporated into the same plasmid molecule by sequential ligations. Digestions of this 
plasmid are therefore guaranteed to have equimolar amounts of both species. A dilution series of these 
molecules was used as a standard in QPCR reactions. The primers used for QPCR of the standards and 
the experimental samples are indicated with arrows: black, shared primer; blue, joint primer for 
detection of included molecules; and red, joint primer for detection of skipped molecules. See Detailed 







Parts of this chapter were submitted as part of a manuscript (Arias et al. 2013) 




Transcripts of many genes in higher eukaryotes are interrupted by sequences that are 
removed to generate mRNA molecules. These sequences are called introns and those sequences 
that are spliced together to form the mRNA molecule are called exons. This splicing process 
occurs with very high accuracy regarding the identification of the ends of the exons (Fox-Walsh 
and Hertel 2009). Many decades of research have seen continuous progress in understanding this 
phenomenon. Early on the exon/intron junctions were identified as functional sequences (Mount 
1982). This was followed by the identification of functional sequences inside of the exons that 
could have either a facilitator effect on the proper inclusion of the exon in which they reside, 
Exonic Splicing Enhancers or ESEs, or a silencing effect that negatively affected exon inclusion, 
Exonic Splicing Silencers or ESSs. 
 
 There are two models that have been proposed regarding how the exons are paired up 
(Berget 1995; De Conti et al. 2013). The first model is called intron definition and it postulates 
that the ends of the intron are recognized and paired making the intron the unit of recognition. In 
this case, the exons are defined by the introns that flank them. The second model is called exon 
definition and it postulates that the exon is recognized as a unit. Exons are subsequently paired 
up in a collinear manner and in this way the introns are defined. Both models could be affecting 






definition while short exons are recognized by exon definition (Fox-Walsh et al. 2005). In higher 
eukaryotes it has been noted that most exons are relatively short while the flanking introns are 
relatively long, making exon definition the predominant mechanism (Fox-Walsh et al. 2005). 
 
One of the main tools available to study splicing is in vitro splicing (Krainer et al. 1984). 
It entails mainly the placement of in vitro pre-synthesized RNA in an environment similar to the 
cell nucleus, in the form of nuclear extract obtained from cultured cells. Under appropriate 
conditions RNA splices and, while some of the characteristics observed in vivo are reproduced, 
others are not. For example, this type of assay forces a sequential relationship between 
transcription and splicing. However, removal of introns has been shown to occur co-
transcriptionally (Kessler et al. 1993; Wada et al. 2009). Indeed, in many cases it has been shown 
to occur shortly after the two spliced exons have been synthesized and to be independent on the 
length of the downstream intron (Wada et al. 2009). This simultaneity makes it possible for one 
process to affect the other. It has been shown for example that changes in the rate of transcription 
elongation can affect how often an exon is included (de la Mata et al. 2003). Another aspect that 
deserves mention is the time required for splicing to occur. In in vitro assays, the time required 
for splicing is at least an order of magnitude greater than in vivo (Hicks et al. 2005). 
Transcription/splicing assays have been developed but these shortcomings have not been 
addressed properly (Lazarev and Manley 2007). 
 
The decision to include a specific exon in the mRNA molecule occurs early as an 
irreversible step (Lim and Hertel 2004). This step precedes or coincides with formation of 






intron to be removed. The formation of an exon definition complex should precede these events 
and is usually associated with complex E formation. This complex depends on the presence of 
both splice sites defining the exon. It is these early steps the ones affected by specific sequences 
in many of the exons studied (Black 2003; House and Lynch 2006; Chen and Manley 2009). 
However, other steps of the splicing process might be affected. 
 
Early observations in Miller chromatin spreads of D. melanogaster embryos provided 
evidence for co-transcriptional removal of introns (Osheim et al. 1985; Osheim et al. 1988). This 
has been confirmed by studies of long genes (Singh and Padgett 2009; Wada et al. 2009). These 
and other studies indicate that splicing takes place mere minutes after transcription (Kessler et al. 
1993; Singh and Padgett 2009; Wada et al. 2009). For long genes this allows the removal of the 
introns to occur co-transcriptionally. For short genes on the other hand, the nominal time 
required for transcription might be too short for the removal to occur. Importantly though, 
several of the early steps in the splicing process should have had enough time to occur making 
the splicing process co-transcriptional. 
 
Here the development of a novel mathematical tool that allows testing of mechanisms for 
splicing is presented. For its development, a focus was put on exon definition since it is the 
predominant mechanism in humans (Fox-Walsh et al. 2005). The problem was simplified by 
studying designer exons (DEs), exons of our own making made of combinations of a small 
number of modules. This allowed the exploration of general mechanisms that would affect 
equally these simplified exons and the natural ones, while avoiding the complexities present in 






different ideas about exon recognition. The effect of size is modeled as mediated by tethered 
collisions of exon ends that when successful allow the formation of a complex enabling exon 
definition. ESEs are modeled as having an effect on the stability of this complex. The resulting 
model will be tested in Chapter 5. 
 
A Biophysical Model to Explain Splicing Decisions 
 
 We embarked on the design of our own exons so as to be able to examine individual 
parameters that govern splicing decisions. While this reductionist approach dispenses with the 
complexity of natural exons, it has the advantage of making fundamental principles discernible. 
Having varied parameters in over 150 DEs (see Chapter 3), we sought to develop a biophysical 
model that could explain these data. The goal of this model is to relate the observed psi to the 
parameters that have been varied in these DEs. 
 
 The biophysical model is centered on exon definition as a decisive step in the recognition 
of most splice sites and assumes that this step requires the formation of an RNA-protein complex 
on the exon of interest. The number of pre-mRNA molecules with a complex is determined by 
the balance between assembly and disassembly, which can be described by overall association 
and dissociation rate constants. Once assembled, complexed molecules can then proceed to a 







First time period 
 
 We start with a set of assumptions that are described in Box 4.1 and focus on a group of 
pre-mRNA molecules (conceptually “tagged”) that are all in the same state of synthesis. To 
consider the choice between inclusion and skipping, it seems necessary that the exon 
 
Figure 4.1. Complex kinetics can be described in simpler terms. The squares and circles represent 
different states of a pre-mRNA molecule: L, “naked” transcript; P, exon of interest in an exon 
definition complex (EDC) with the downstream exon either not present or present but not in an EDC; 
b, downstream exon in an EDC with the exon of interest not in an EDC; B, both exons in EDCs; I 
(inclusion) and S (skipping) represent molecules that have either committed to or achieved their 
respective splicing outcomes. The arrows represent transitions between states, and are labeled with 
rate constants: a and d, association and dissociation, respectively, of the complex on the exon of 
interest; a’ and d’, the same for the downstream exon; ρI and ρS, commitment to inclusion and 
skipping, respectively, of the exon of interest. A. Model for the splicing reactions before time τ. 
Importantly, the transition from P to I is independent of the presence of exon 3. B. Simplified model 
before time τ; pI amalgamates a, d and ρI. C. Model for the splicing reactions after time τ. D. Model 
after time τ simplified analogously to panel B. See Supplemental Material for details. E. Cartoon 
showing the states implied in panel C for a pre-mRNA molecule depicting EDCs (green). Steps 1 to 4 







downstream be synthesized; we define time τ as the time required to make this downstream exon 
available for splicing. For times prior to τ, there are 3 types of pre-mRNA molecules with respect 
Box 4.1: Model assumptions and definitions 
 
 
General equations were obtained based on the following conditions and assumptions: 
 
 
1. The cell or system studied is at steady state. 
2. We consider all the pre-mRNA molecules of interest that have started transcription 
within the same negligibly small time interval as “tagged”; it is this “pulse-tagged” 
cohort of molecules whose fate will be analyzed. 
3. For simplicity, we assume that the transcription rate is the same for all of these 
molecules. 
4. We define time zero as the time at which the exon of interest has been synthesized and 
made available for splicing. 
5. Each tagged molecule contains at least one internal exon, one of which is the exon of 
interest. We will assess inclusion and skipping of this exon in all the tagged molecules. 
6. There is a complex that forms on the exon of interest that is an obligatory intermediate 
for exon inclusion. We consider this complex to be an exon definition complex. At any 
given point in time we define P as the number of tagged molecules with this complex 
and I as the number that are committed to inclusion, taken to be splicing to the 
committed exon that lies immediately upstream. 
7. The exons flanking the exon of interest are constitutive. In particular, we assume that by 
the time the exon of interest is made available for splicing, the upstream exon is already 
committed. 
8. Exon definition can commit an internal exon to inclusion whether or not the downstream 
exon has been synthesized. 
9. We assume first order kinetics for all transitions between states. In particular, dI/dt = ρI * 
P, where ρI is the rate at which these molecules commit to the included pathway. 
10. All tagged molecules will follow one of two pathways: inclusion or skipping; we will 








to the exon of interest: naked, L; complexed, P; committed to inclusion, I (Fig. 4.1A). A set of 
differential equations relates the number of tagged P, I and L molecules starting at t = 0: 
4.1  dL/dt = d P – a L 
4.2  dP/dt = a L – (d+ρI) P 
4.3  dI/dt = ρI P 
It is a cohort of previously tagged molecules that is being followed, so rates of synthesis need not 
be considered. 
 
 In equations 4.1 through 4.3, defining F as the number of uncommitted molecules, 
F = L + P, and taking the Laplace transform, indicated as X = X (s) for any function X(t), for the 
equations 4.1 and 4.2, we get 
4.4  (s+a) F = (s+d+a) P + F0 – P0 
4.5   (s+a+d+ρI) P = a F + P0 
where F0 and P0 represent initial values for F(t) and P(t) respectively.  
 
 Solving for F, 
4.6  [s2 + (a+d+ρI) s + aρI] F = (s+a+d+ρI) F0 – ρI P0 
 
Using partial fractions, we obtain 
4.7  F = [(r2 F0 – ρI P0) / (s – r1) – (r1 F0 – ρI P0) / (s – r2)] / ( r2 – r1 )  
with r1 & r2 (r1 ≥ r2) the roots of the quadratic equation  






Notice that a+d+ρI is greater than a+ρI > 0 and that ρI a > 0, which implies that both roots are real 
and negative. 
 
 This implies that 
4.9  F(t) = [(r2 F0 – ρI P0) er1 t – (r1 F0 – ρI P0) er2 t] / ( r2 – r1 ) 
 
 Now, solving for P 
4.10  [s2 + (a+d+ρI) s+ ρI a] P = a F0 + s P0 
 
 Therefore, 
4.11  P = [-(r1 P0 + r F0) / (s – r1) + (r2 P0 + r F0) / (s – r2)] / ( r2 – r1 )  
 
 This yields 
4.12  P(t) = [-(r1 P0 + r F0) er1 t + (r2 P0 + r F0) er2 t] / ( r2 – r1 )  
 
 Evaluating these equations at time τ and noting that I(t) = L0 – F(t) where L0 is the initial 
value for L(t), we obtain 
4.13  Fτ = [(r2 F0 – ρI P0) er1 τ – (r1 F0 – ρI P0) er2 τ] / (r2 – r1)  
4.14  Pτ = [(a F0 + r2 P0) er2 τ – (a F0 + r1 P0) er1 τ] / (r2 – r1) 
4.15  Iτ = L0 - Fτ 







 If we assume that at the beginning of the observation period no complexes have formed, 
then P0 = 0 and F0 = L0. If we further assume that the assembly and/or the dissociation of the 
complex occurs much faster than commitment, so that d+a >> ρI, we obtain  
4.16  r2 ≈ -(d+a),  
4.17  r1 ≈ -ρI a / (d+a) and 
4.18  r2– r1 ≈ -(d+a).  
Defining pI as 
4.19  pI = ρI  / (1+d/a)  
we get  
4.20  Fτ ≈ L0 e-pI τ 
Therefore the system can now be approximated by the state diagram shown in Fig 4.1B. 
 
Second time period 
 
 For times starting at time τ the molecules can consider splicing the upstream exon to the 
downstream exon; i.e., skipping the exon of interest (Fig. 4.1C and E). To minimize the 
complexity of notation below, we define a new reference time t' that sets time τ to zero: t' = t – τ. 
From the state diagram shown in Fig. 4.1C, the following equations are obtained for t' > 0: 
4.21  dL/dt' =  d P + d' b – (a+a') L 
4.22  dP/dt' = a L + d' B – (d+a'+ρI) P 
4.23  db/dt' = a' L + d B – (d'+a+ρS) b 
4.24  dB/dt' = a' P + a b – (d+d'+ρI+ρS) P 






4.26  dS/dt' = ρS (b+B)  
 
 The Laplace transform of the first four equations, indicated as X = X(s) for any function 
X(t'), was taken yielding 
4.27  sL – Lτ = d P + d' b – (a+a') L 
4.28  sP – Pτ = a L + d' B – (d+a'+ρI) P 
4.29  sb – bτ = a' L + d B – (d'+a+ρS) b 
4.30  sB – Bτ = a' P + a b – (d+d'+ρI+ρS) B 
where the notation Xτ represents X(t’) at t’ = 0 (i.e., at t = τ). 
 
 Although we are most interested in the probability of exon inclusion, it is easier to 
calculate S, and its final expression actually provides more insight into the roles of the different 
parameters. I becomes simply all the tagged molecules not included in S. Therefore we will 
focus on an expression for S∞. Let's define Б = b+B. Notice that according to the previous 
assumptions, the value of S(t') = 0 for t' ≤ 0 and, according to the final value theorem and 
equation 4.26, as t' → ∞, S(t') approaches S∞ = ρS lims→0 Б(s) = ρS Б0, where the notation X0 
represents X(s) evaluated at s = 0. Substituting L = F – P and b = Б – B, and assuming no tagged 
molecules contain the second complex at t' = 0, bτ = Bτ = 0 which implies Бτ = 0, we obtain 
4.31  s (F – P) – Fτ + Pτ = d P + d' (Б – B) – (a+a') (F – P)  
4.32  sP – Pτ = a (F – P) + d' B – (d+a'+ρI) P 
4.33  s (Б – B) = a' (F – P) + d B – (d'+a+ρS) (Б – B)  







 Taking s = 0, the equations become 
4.35  (a+a') F0 = (d+a+a') P0 + d' Б0  – d' B0 + Fτ – Pτ 
4.36   (d+a+a'+ρI) P0 = a F0 + d' B0 + Pτ 
4.37  (d'+a+ρS) Б0 = a' F0 + (d+d'+a+ρS) B0 – a' P0 
4.38  (d+d'+a+ρI+ρS) B0 = a' P0 + a Б0 
 
 Substituting F0 from equation 4.36 into equations 4.35 and 4.37, we get 
4.39  [a' (d+a+a'+ρI) + a ρI] P0 = d' a Б0  + d' a' B0 + a Fτ + a' Pτ 
4.40   (d'+a+ρS) a Б0 = (d+a'+ρI) a' P0 + [(d+d'+a+ρS) a – d' a'] B0 – a' Pτ 
 
 Substituting P0 from equation 4.38 into these equations, they become  
4.41  {[a' (d+a+a'+ρI) + a ρI] (d+d'+a+ρI+ρS) – d' a'2}fc B0 = [a' (d+d'+a+a'+ρI) + a ρI] a Б0  + a 
a' Fτ + a'
2
 Pτ 
4.42   (d+d'+a+a'+ρI+ρS) a Б0 = [(d+d'+a+ρI+ρS) (d+a'+ρI) + (d+d'+a+ρS) a – d' a'] B0 – a' Pτ 
 
 Taking α = d+d'+a+a' and β = α (d+a) + (α+d) ρI + (d+a+a') ρS + (ρI+ρS) ρI, these 
equations simplify to 
4.43  {β a' + a [α ρI+(ρI + ρS) ρI]} B0 = [α a' + (a+a') ρI] a Б0  + a a' Fτ + a'2 Pτ 
4.44   (α+ρI+ρS) a Б0 + a' Pτ = β B0 
 
 Substituting B0 from equation 4.44 into equation 4.43, taking γ = α+ρI+ρS and 







4.45  {α [(d'+a') aρI + (d+a) a'ρS] + (a+a') (aρI2+γρIρS+a'ρS2) + (d'aρI+da'ρS) (ρI+ρS)} S∞ = a'ρS 
[βFτ – γρIPτ]  
 
 This, along with equations 4.13 and 4.14, provide the general solution for S∞. However a 
more useful expression can be obtained if we assume that assembly and/or dissociation of the 
complexes on both exons occur much faster than commitment for either pathway: i.e., d+a >> ρI, 
d+a >> ρS, d'+a' >> ρI and d'+a' >> ρS. This approximation yields: 
4.46  S∞ ≈ L0 e-pI τ (d+a) a'ρS / [(d'+a') aρI + (d+a) a'ρS]  
Using pI as defined previously and defining pS analogously as 
4.47  pS = ρS / (1 +d' / a')  
yields 
4.48  S∞ ≈ L0 e-pI τ pS/(pS+pI)  
This situation can be summarized with the state diagram shown in Fig. 4.1D for t > τ, with the 
initial condition Lτ = L0 e
-pI τ
. To model the system at all times requires only three constants, 
namely τ, pI and pS (see Fig. 4.1B and 4.1D). 
 
 If the rates of degradation of the included and skipped molecules are similar, equation 
4.48 provides approximations for the fraction of skipped and, by subtraction, of included 
untagged molecules at steady state. The form of equation 4.48 lends itself to intuitive 
interpretation, and the focus on S provided insight into the roles of the different parameters (see 
below). The exponential decay term describes the commitment to inclusion during the pre-τ 
interval: molecules no longer available for skipping. The remaining fraction reflects the 






either. At this point the model predicts splicing outcomes in terms of an unspecified exon 
definition complex and of the ratios of rate constants pI and pS. We now turn to relating these 
terms to biophysical processes and to use the resulting model to predict psi values. 
 
 Modeling the DEs 
 
Equation 4.48 should be applicable to the definition of any internal exon. In the case of 
natural exons there are many factors that could be in play and that are poorly understood. For 
instance, protein-protein interactions and pre-mRNA secondary or tertiary structure could well 
determine ρ, a, d and/or τ. We did not consider such factors in applying this model to DEs, which 
represent a simplified framework for testing the validity of the model and for building more 
refined versions. 
 
 In order to apply equation 4.48 to the DE data, we needed to model τ, pI and pS. We 
consider τ and pS to be constant for all DEs used, τ depending on the transcription time and pS 
depending on the downstream exon. Thus we are left with pI, which is ρI / (1+d/a). A physical 
model for ρI is challenging, as this term describes the conversion of an initial complex to a 
commitment complex. It is not yet understood what commitment entails or how it is achieved. 
We therefore decided to focus on the formation of the initial complex itself, asking whether the 
effect of exon size, ESEs and ESSs on its formation (a/d) can explain our data. That is, we 
assume that ρI, the rate constant for the conversion of an exon with an assembled complex to a 
committed exon, remains constant with respect to these 3 parameters. Equation 4.48 can be 






experiments we carried out and which serves as the proving ground for fitting the data to the 
model: 
4.49  pso ≈ 100 e-T/(1+D)/(1+C/(1+D)) 
where pso denotes percent spliced out (i.e., skipped), T=ρI τ, C=ρI/pS and D=d/a. We then 
focused on how all the different DE configurations affect D, the ratio of the disassociation and 
assembly rate constants of the initial complex, while T and C were taken to be constant.  
 
 We first sought an expression relating size and D, modeling the formation of an exon-
spanning complex. There is evidence for indirect interactions between the macromolecules at the 
two ends of an exon (Wu and Maniatis 1993), and the motifs present in the intermediate protein 
involved are present in subunits at the two ends, opening the possibility for an RNA-binding 
activated direct interaction. We reasoned that in the simplest case, the formation of this complex 
is proportional to the probability of the two tethered ends of the exon having undergone a 
productive collision, which occurs when both ends of the exon are suitably occupied and they 
approach each other in the correct orientation through thermal movements. The ends will then be 
at a fitting distance, yi from each other as shown in Fig. 4.2A for the direct interaction and 
analogously for the indirect one. Assuming the RNA behaves as a worm-like chain with contour 
length much greater than persistence length, the probability for a given end-to-end distance as a 
function of exon size can be obtained using a Gaussian approximation (Becker et al. 2010). 
Using this approximation, the ends of the molecule while inside the range of distances within 
which attractive and repulsive forces become important can be modeled. Taking this range to be 
small with respect to the fitting distance, yi, and applying the mean-value theorem for integrals, 






4.50  P(Yi,x) ≈ ki Yi2 x-3/2 e-3/2 Yi²/x 
Here x is contour length of the exon in nm and is determined by the exon size in nucleotides (see 
 
Figure 4.2. Modeling exon end-to-end contact in exon definition. RNA molecules are bound by 
U2AF proteins (blue circles) at the 3’ SS and U1 snRNPs (red rectangles with semicircular sockets) at 
the 5’ SS (gray rectangle). A. After a collision between the two ends of the exon, the exon definition 
complex forms. Communication between these two ends is mediated by protein-protein interaction. 
The arrow line indicates the fitting distance yi, which is the distance between the outermost points in 
the exon that are unconstrained by protein binding. Here, SS Set 2 is modeled (i=2). B. A change in 
the point or angle at which the pre-mRNA extends from a binding protein can increase yi and 
consequently the minimum exon size that allows proper protein-protein contact. Here, SS Set 3 is 
modeled. C. Same as A but with a shorter exon. D. Same as B but showing the impaired recognition of 






equation 4.55), the index i refers to the splice sites used (4 sets, Table 3.1 in Chapter 3: sets 2, 3, 
5 and 7), Yi is the distance yi divided by the square root of the Kuhn length for an RNA 
molecule, which is a measure of stiffness and assuming a cationic concentration equivalent to 
~300 mM should be approximately ~3.0 nm (Chen et al. 2012). The catch-all constant ki depends 
on the Kuhn length, the range of distances within which attractive and repulsive forces become 
important and the chance that a collision will result in an association and is independent of the 
length of the exon in question. Although the values of these parameters are unknown, we 
consider them as constant for any set of splice sites. D is inversely proportional to a, and so will 
be inversely proportional to P(Yi,x).  
 
 As shown in Fig. 4.2B, different SS sets are allowed to have different geometries in their 
interaction. Therefore, a different fitting distance can be used for each SS set. For example, in 
Fig. 4.2B the fitting distance for SS Set 3 is modeled as being greater than that for SS Set 2 due 
to differences in the geometry of the interaction between U1 snRNP and the 5’ SS of the exon of 
interest. Fig. 4.2C and D show the effects of these fitting distances on short exons. The fitting 
distance for SS Set 2 allows the interaction to occur in exons as short as 30 nt. However, the 
fitting distance and the geometry required for SS Set 3 make the interaction between the two 
ends impossible for these short exons. As will be seen in chapter 5, this difference in the fitting 
distance is enough to explain the shift observed in Fig. 3.2 between the curves relating psi and 
size for different SS sets. 
 
Due to the ability of ESE-binding activators to interact with proteins at either end of the 






they act by increasing the stability of the exon definition complex. In this case, the rate of 
dissociation should be proportional to the rate at which random collisions transfer kinetic energy 
greater than a threshold, Ethreshold, to the complex. The addition of a single ESE was taken to 
increase this energy threshold by a fixed constant amount ΔE. Any additional ESE will increase 
this energy threshold by an additional ΔE. 
 
For a simplified analysis, we considered the collision between the complex on the exon of 
interest, C, and a molecule, M. This collision transfers enough kinetic energy to cause 
dissociation of C if the collision is head-on and the relative kinetic energy of M is higher than a 
threshold. However, if the collision is not head-on, then the geometry of the collision should be 
taken into account. As an approximation, C and M were modeled as spheres; the angles between 
the collision trajectory and the tangent plane at the site of contact determine the energy that is 
transferred. An analogous situation is found when modeling reactive encounters (Atkins and de 
Paula 2002): following a traditional analysis of such situations, an equation for the rate of 
dissociation d was obtained 
4.51  d ≈ W e-Ethreshold/(kT)  
where W is a proportionality constant that takes into account all speeds and collision angles, k is 
the Boltzmann constant, T is the absolute temperature and  Ethreshold is the energy necessary to 
cause dissociation of C. If the complex is modified so that the energy required to cause its 
dissociation becomes E'threshold = Ethreshold + Eenh, then the new dissociation constant, dE, becomes 
4.52  dE ≈ W e-(Ethreshold+Eenh)/(kT) = W e-Ethreshold/(kT) e-Eenh/(kT) = d e-Eenh/(kT)  
The addition of a single enhancer, then, modified the dissociation rate by a factor of 
cE = e
-Eenh/(kT)






4.53  dE ≈ d cE 
Repeating the analysis to account for the addition of n identical enhancers yielded 
4.54  dn ≈ d cEn 
(These results could be generalized by making cE = γ e
-Eenh/(kT), which allows γ to account for 
other parameters such as occupancy.) 
 
Consequently, each ESE affects D by the factor cE and n of those sequences affect it by 
cE
n
. To be consistent with the results observed for the ESE under consideration, this effect was 
taken to be independent of position. In this simple scenario, multiple enhancers were modeled as 
independent, leading to an exponential dependence of D on the number of enhancers present. 
 
A similar approach was taken for modeling the ESSs, which are considered to be 
disruptive to the complex and therefore decrease its stability. Since the ESS used showed a 
position-dependent effect, we divided the ESSs into 3 categories based on their position: first, 
last and remaining intermediate positions. As in the case of the ESEs, multiple ESSs were 
modeled as independent of each other. 
 
 The effect of the reference sequences on stability also had to be considered, for it is 
unknown if they should be modeled as enhancers, silencers or something else. However, since 
the effect of replacing reference sequences with ESEs was shown to be position-independent, the 
effect of individual reference sequences should also be position-independent. Extending the 








 Taking all of this into account and modeling these effects as independent of each other 
gave the following approximation for D in equation 4.49: 
4.55  D ≈ Ki Yi-2 cEnE cRnR cFnF cLnL cInI Z3/2 e3Yi²/Z 
where Z is the size of the DE in nucleotides figuring 2 nt/nm (Chen et al. 2012), Yi is 
yi/√KuhnLength, nI is the number of non-terminal ESSs, nF and nL are 1 if the first or last 
position, respectively, is occupied by an ESS and 0 otherwise, nR is the total number of reference 
sequences present, and nE is the number of ESEs. The c constants represent destabilization 
coefficients for the ESSs (cF, cL, cI), reference sequences (cR) and ESEs (cE). Ki is a constant that 
combines all the constants generated by each of the individual terms; the index i refers to the set 




The derivation of the commitment progression equation, which assumed no mechanisms 
for formation or dissociation of the exon definition complex, was based on simple assumptions. 
The physical model is centered on exon definition as a decisive step in the recognition of most 
splice sites and assumes that this step requires the formation of an RNA-protein complex on the 
exon of interest. A general solution was found but its complexity precluded intuitive analyses 
and interpretations. For this reason, simplifying assumptions were made and a simpler and more 
intuitive equation was obtained. This equation had two components: one derived from the period 
in which skipping is not an option yet and the other when the two fates, inclusion and skipping, 






period could be safely ignored making Fτ in equation 4.23 or its approximation in equation 4.20 
an appropriate estimate for S∞. 
 
The formation of exon definition complex was modeled as dependent on an indirect 
physical interaction across the exon of its ends. The mathematical treatment of this scenario was 
fairly intuitive and included treating the RNA molecule as a polyelectrolyte. The dissociation of 
this complex was modeled based on collisions with random molecules. The effects of ESEs were 
incorporated as providing stability to the complex against these collisions. All aspects that went 
into these equations were combined by assuming independence of the different actions which 
might be an oversimplification but worked well here (Chapter 3). 
 
Importantly, an emphasis was placed on mechanisms that would affect both DEs and 
natural exons alike. The mechanisms proposed align well with published observations as 
described in Chapter 3. Both the general commitment progression equation as well as the 
mechanistic equations contributed to this. 
 
 Some published mechanisms were not considered and might be attempted later. One of 
them, the recruitment model for ESE action, was briefly addressed in Chapter 3 with only limited 
success in predicting splicing outcomes. Another one is the scanning hypothesis for exon/intron 
recognition (Kuhne et al. 1983; Lang and Spritz 1983; Borensztajn et al. 2006). In the exon 
definition variant of this hypothesis, putative machinery, upon finding one end of an exon, scans 
the RNA molecule searching for the other end. When it finds it according to some criteria, an 






hypothesis presented here is more intuitive, does not require cellular machinery for which no 
evidence exists, does not require as many exceptions when analyzing exons with multiple splice 
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Transcription generates pre-mRNA molecules that are then processed to produce mRNA. 
Modifications of the pre-mRNA molecule include capping, cleavage, polyadenylation, and 
splicing. The latter refers to the removal of usually long stretches of RNA designated introns 
yielding a concatenation of the flanking sequences designated exons in mRNA molecules. This 
process occurs with great fidelity and therefore requires precise definitions of the sequences to be 
removed and/or the sequences to be kept. Early on, the sequences at the boundaries between 
exons and introns were identified as having a fundamental role in this process (Mount 1982). 
However, these sequences proved insufficient to define the exons/introns of transcrpts (Sun and 
Chasin 2000).  
 
For studying the early recognition of splice sites, two alternative models have been put 
forth (De Conti et al. 2013). In the first model, intron definition, the introns are recognized and 
removed; the exons are joined as a byproduct. In the second model, exon definition, the exons 
are recognized and joined to one another. This requires a subsequent intron definition for the 
ends of each intron must be paired. In this study we focus on exon definition and in particular on 






about 250 nt flanked by long introns, longer than about 250 nt, a category that includes most 
exons present in humans (Fox-Walsh et al. 2005). 
 
As the pre-mRNA is being synthesized, some of the events involved in splicing can  be 
taking place. Indeed, there is evidence that in some cases the introns are removed before 
transcription finishes (Osheim et al. 1985; Osheim et al. 1988; Singh and Padgett 2009; Wada et 
al. 2009). More importantly, critical events such as exon recognition should then be taking place 
as the pre-mRNA is being synthesized. This possibility is substantiated by the finding that 
slowing down the RNA polymerase II affects splicing decisions (Roberts et al. 1998; de la Mata 
et al. 2003; Munoz et al. 2009). These observations have led to the kinetic model of splicing 
(Dujardin et al. 2013). For these reasons co-transcriptional splicing was incorporated in a model 
for splicing presented in Chapter 4.  
 
Exon recognition involves binding of U1 to the 5’ SS, which is the earliest event 
characterized in in vitro reactions (Hoskins et al. 2011). However, there are reports that on the 
upstream end of exons U2AF65 binds shortly after the 3’ SS is synthesized  (Ujvari and Luse 
2004), making it likely that this event precedes U1 snRNP binding in vivo. These two ends of the 
exon are therefore recognized early. They also provide near equal contributions toward efficient 
exon recognition(Shepard et al. 2011). One possibility for this symmetry is a direct or indirect 
interaction. Evidence for interactions of proteins at both ends of the exon and  SC25, an SR 
protein, was presented by Wu and Maniatis (Wu and Maniatis 1993). Therefore it was proposed 
in Chapter 4 that this interaction determines the effect of size on inclusion level and an 







Sequences in addition to the ones found at the ends of exons were identified early on as 
having an important role in exon recognition (Reed and Maniatis 1986; Mardon et al. 1987; 
Cooper and Ordahl 1989; Tsai et al. 1989). The sequences in the exons themselves were named 
exonic splicing enhancers (ESEs) when they had a positive effect on inclusion or exonic splicing 
silencers (ESSs) when the effect was negative. Shortly afterwards, proteins binding some of 
these sequences were found (Ge and Manley 1990; Krainer et al. 1990).  It has been 
hypothesized that these and similar proteins act by increasing the likelihood that U1 snRNP or 
U2AF would bind to their respective sequences (Fu 1995). Further experiments have shown 
inadequacies in the model by requiring that U1 snRNP be recruited with U2AF (Lam and Hertel 
2002). These results are easily reconciled with the ESEs having a stabilization effect on the exon 
definition complex. Networks of interactions including these proteins and components of the 
early splicing machinery have been shown (Hoffman and Grabowski 1992; Wu and Maniatis 
1993). Importantly, ESEs can have further effects in downstream reactions in the splicing 
process. However, this chapter focuses exclusively on exon recognition. An appropriate model 
incorporating these ideas was developed in Chapter 4. 
 
In this chapter the performance of the model developed in Chapter 4 is evaluated using 
the data obtained for single-perturbation experiments in Chapter 3 to gather the information 
necessary to use it. After finding appropriate constants for the different parameters in the model, 
the performance for the single-perturbation data is evaluated to assess the correctness of the 
procedure to obtain the paramenters. Finally, the model is used to predict the inclusion levels of 









 A biophysical model to explain splicing decisions 
 
 We embarked on the design of our own exons so as to be able to examine individual 
parameters that govern splicing decisions. While this reductionist approach dispenses with the 
complexity of natural exons, it has the advantage of making fundamental principles discernible. 
Having varied parameters in over 150 DEs, we next sought to develop a biophysical model that 
could explain these data. The goal of this model is to relate the observed psi to the parameters 
that have been varied in these DEs. 
 
 The physical model is centered on exon definition as a decisive step in the recognition of 
most splice sites and assumes that this step requires the formation of an RNA-protein complex 
on the exon of interest. The number of pre-mRNA molecules with a complex is determined by 
the balance between assembly and disassembly, which can be described by overall association 
and dissociation rate constants. Once assembled, complexed molecules can then proceed to a 
state of commitment to exon inclusion (Fig. 4.1A). 
 
 We start with a set of assumptions that are described in Chapter 4, specifically in Box 
4.1, and focus on a group of pre-mRNA molecules (conceptually “tagged”) that are all in the 
same state of synthesis. To consider the choice between inclusion and skipping, it seems 






make this downstream exon available for splicing. For times prior to τ, there are 3 types of pre-
mRNA molecules with respect to the exon of interest: naked, L; complexed, P; committed to 
inclusion, I (Fig. 4.1A). A set of differential equations relates the number of tagged P, I and L 
molecules starting at t = 0: 
3.2. dL/dt = d P – a L 
3.3. dP/dt = a L – (d+ρI) P 
3.4. dI/dt = ρI P 
It is a cohort of previously tagged molecules that is being followed, so rates of synthesis need not 
be considered. 
 
 For times starting at time τ the molecules can consider splicing the upstream exon to the 
downstream exon; i.e., skipping the exon of interest (Fig. 4.1C and E). A set of differential 
equations, analogous to the set for the pre-τ period, describes this situation (see Chapter 4). 
Although we are most interested in the probability of exon inclusion, it is easier to calculate the 
probability of exon skipping. The general solutions as well as some approximations and 
intermediate results are presented in Chapter 4. Equation 5.4 describes the fraction of tagged 
molecules that skip the exon: 
3.5. S∞ / L0 ≈ e-pI τ pS/(pS+pI) 
where L0 represents the total number of molecules that were initially tagged, S∞ is the final 
number of skipped molecules, pI = 1/(1+d/a) and pS = 1/(1+d’/a’), and a, d, a’, and d’ can be seen 







 If the rates of degradation of the included and skipped molecules are similar, equation 5.4 
provides approximations for the fraction of skipped and, by subtraction, of included untagged 
molecules at steady state. The form of equation 5.4 lends itself to intuitive interpretation, and the 
focus on S provided insight into the roles of the different parameters (see below). The 
exponential decay term describes the commitment to inclusion during the pre-τ interval: 
molecules no longer available for skipping. The remaining fraction reflects the competition after 
time τ between inclusion and skipping among those molecules capable of either. At this point the 
model predicts splicing outcomes in terms of an unspecified exon definition complex and of the 
ratios of rate constants pI and pS. We now turn to relating these terms to biophysical processes 
and to use the resulting model to predict psi values. 
 
 Modeling the DEs 
 
Equation 5.4 should be applicable to the definition of any internal exon. In the case of 
natural exons there are many factors that could be in play and that are poorly understood. For 
instance, protein-protein interactions and pre-mRNA secondary or tertiary structure could well 
determine ρ, a, d and/or τ. We did not consider such factors in applying this model to DEs, which 
represent a simplified framework for testing the validity of the model and for building more 
refined versions. 
 
 In order to apply equation 5.4 to the DE data, we needed to model τ, pI and pS. We 
consider τ and pS to be constant for all DEs used, τ depending on the transcription time and pS 






model for ρI is challenging, as this term describes the conversion of an initial complex to a 
commitment complex. It is not yet understood what commitment entails or how it is achieved. 
We therefore decided to focus on the formation of the initial complex itself, asking whether the 
effect of exon size, ESEs and ESSs on its formation (a/d) can explain our data. That is, we 
assume that ρI, the rate constant for the conversion of an exon with an assembled complex to a 
committed exon, remains constant with respect to these 3 parameters. Equation 5.4 can be 
rewritten as equation 5.5, which combines those terms that are not resolvable by the experiments 
we carried out and which serves as the proving ground for fitting the data to the model: 
3.6. pso ≈ 100 e-T/(1+D)/(1+C/(1+D)) 
where pso denotes percent spliced out (i.e., skipped), T=ρI τ, C=ρI/pS and D=d/a. We then 
focused on how all the different DE configurations affect D, the ratio of the disassociation and 
assembly rate constants of the initial complex, while T and C were taken to be constant.  
 
 We first sought an expression relating size and D, modeling the formation of an exon-
spanning complex. We reasoned that in the simplest case, the formation of this complex is 
proportional to the probability of the two tethered ends of the exon having undergone a 
productive collision, which occurs when both ends of the exon are suitably occupied and they 
approach each other in the correct orientation through thermal movements. The ends will then be 
at a fitting distance, yi from each other as shown in Fig. 4.2A. See Chapter 4 for the translation of 
these ideas and those below into equation 5.6. 
 
We modeled the effect of enhancers by assuming that they act by increasing the stability 






such as recruitment or catalysis. In this simple scenario, multiple enhancers are modeled as 
independent, leading to an exponential dependence of D on the number of enhancers present. A 
similar approach was taken for modeling the ESSs, which are considered to be disruptive to the 
complex and therefore decrease its stability. Since the ESS used showed a position-dependent 
effect, we divided the ESSs into 3 categories based on their position: first, last and remaining 
intermediate positions. As in the case of the ESEs, multiple ESSs were modeled as independent 
of each other. 
 
 The effect of the reference sequences on stability also had to be considered, for it is 
unknown if they should be modeled as enhancers, silencers or something else. However, since 
the effect of replacing reference sequences with ESEs was shown to be position-independent, the 
effect of individual reference sequences should also be position-independent. Extending the 
analogy with ESEs and ESSs, multiple reference sequences in a single exon were modeled as 
independent. 
 
 Taking all of this into account and modeling these effects as independent of each other 
gave the following approximation for D in equation 5.5: 
3.7. D ≈ Ki Yi-2 cEnE cRnR cFnF cLnL cInI Z3/2 e3Yi²/Z 
where Z is the size of the DE in nucleotides figuring 2 nt/nm (Chen et al. 2012), Yi is 
yi/√KuhnLength, nI is the number of non-terminal ESSs, nF and nL are 1 if the first or last 
position, respectively, is occupied by an ESS and 0 otherwise, nR is the total number of reference 
sequences present, and nE is the number of ESEs. The c constants represent destabilization 






combines all the constants generated by each of the individual terms; the index i refers to the set 
of splice sites present. 
 
 To optimize the values for Ki, yi, and the c constants in equation 5.6 we used the BFGS 
algorithm for minimizing the sum of the squared differences between predicted and observed pso 
values. Due to the lack of size perturbation data for some of the splice site sets, it was necessary 
to assume the parameters y5 and y7, which are related to the distance between the two ends of the 
exon in the complex, to be equal to a discoverable y; y3 was chosen and turned out to be 
appropriate (see below). The data used for optimization are described fully in Materials and 






Table 5.1. Best fit for parameters in equations 5.5 and 5.6 
Parameter Value Parameter Value 
T 5.24 cE 0.611 
C 22.5 x 10
-6
 cR 1.48 
K2 1.36 x 10
-5
 cF 1.57 
K3 1.70 x 10
-4
 cL 3.04 
K5 4.76 x 10
-4
 cI 2.26 
K7 3.36 x 10
-3
 y2 21.6 








Testing the model 
 
One test for this model is how well the equation fits the data that was used for its 
optimization. That is, can this model, built on biophysical principles, fit the data; and if so how 
good is the fit? Using the parameter set in Table 5.1 and equations 5.5 and 5.6, the 112 data 
points of single-parameter perturbation data (size, ESE number and position, ESS number and 
position) were predicted very accurately (R
2
 = 0.94, Table 5.2 and Fig. 5.1). Importantly, the 
slope of the fit was 1.04, very close to the expected 1.00; and the intercept for observed psi was -
0.96%, again very close to the expected zero. A visual way to assess the accuracy achieved is to 
 
Figure 5.1. The model accurately predicts the inclusion levels of DEs with single parameter 
perturbations. Psi were predicted using the sequences of the exons and equations 5.5 and 5.6. Values used 
were those derived for the single parameter experiments described here (Table 5.1). A) Psi for DEs described 
in Chapter 3. 
y = 1.0367x - 0.9635 























examine the correspondence between the points in Fig. 3.2 and 3.4 and the curves in Fig. 5.2A 
 
 
Figure 5.2. The model predicts the size and ESE dependences accurately. Curves drawn using the 
model described in the text were superimposed on the data points shown in Fig. 3.2 (A) and Fig 3.4 
(B). A. Size distributions for SS Set 2 (filled symbols and solid line) and SS Set 3 (open symbols and 






























and B, for size and ESEs respectively; these curves were drawn according to the predictions of 
the model and not by a heuristic fit to the points. The agreement between the points and the 
curves is excellent in both cases. We could not draw a comparable curve for ESSs due to position 
dependence. However, the accuracy of the observed vs. predicted values can be visualized in Fig. 
 
 
Figure 5.3. The model accurately predicts the inclusion levels of DEs for each parameter 
examined.  The values in Table 5.1 were used to predict the psi; these values were optimized using a 
condensed and abridged version of the data presented in Chapter 3. A. Exons of different sizes using 
SS Set 2. B. Exons of different sizes using SS Set 3. C. Exons with 0, 1, 2, 3 or 6 ESEs in all 
positional combinations. SS Set 7 was used. D. Exons with 0, 1, 2, 3 or 6 ESSs in all positional 






5.3 for all 3 parameters separately. We conclude that the values shown in Table 5.1 along with 
equations 5.5 and 5.6 provide a satisfactory model for the single-parameter perturbation data. 
 
A more demanding validation is to test the power of this model on a set of data that was 
not used for its generation. In the present experiments we purposely examined size, ESEs, and 
ESSs separately so as to be able to focus on the role of each individual parameter in these DEs. 
In a previous experiment we examined a much more complex set of 142 DEs that were 
comprised of  exons of varying size and randomly mixed ESE and ESS composition (Zhang et 
al. 2009).  These DEs ranged from 62 to 270 nt in length and included sequences such as SES,  
SSSE, EEESEE, etc. We asked whether our model could explain the behavior of these more 
complex DEs, despite the fact that it was optimized without using any exon in which an ESE and 
an ESS were present together. We refer to these previously studied DEs as “complex DEs.” 
 
 
Complex DEs differ in two additional ways from the present set of DEs: 1) In the present 
DEs, a different promoter and polyadenylation site were incorporated, as well as some additional 
mutations in the first and last exons (see Methods); and 2) semiquantitative endpoint RT-PCR 












 0.94 0.86 0.86 
Slope 1.04 0.95 0.95 








was used in the older experiments as opposed to RT-QPCR used here. These caveats 
notwithstanding, the model worked quite well in predicting this untouched data, generating an R
2
 
of 0.86, a slope of 0.95 and an intercept of 0.69% (Table 5.2 and Fig. 5.4). The high correlation 
indicated by the R
2
 is complemented by the high accuracy implied by the match to expected 
slope and intercept, providing substantial additional support to the model. Although the R
2
 value 
achieved was gratifying, some points were evidently not accurately predicted. There are two 
types of explanations for such discrepancies. The first is technical, due to the different contexts 
and methods used and to simple experimental error. The second may be due to limitations in the 
 
Figure 5.4. The model accurately predicts the inclusion levels of DEs. Psi were predicted using the 
sequences of the exons and equations 5.5 and 5.6. Values used were those derived for the single 
parameter experiments described here (Table 5.1). The graph shows psi for more complex DEs 
harboring combinations of ESEs and ESSs reported in Chapter 2. 
y = 0.9524x + 0.686 























current model, which does not take into account possible ESE/ESS interactions or a role for 
secondary structures. 
 
We addressed three anticipated sources of discrepancy between the old and new data. 
First, because we examined the size dependence using SS Sets 2 and 3 (Table 3.1) we were able 
to discover the fitting distance y2 and y3 (Table 5.1). Since we did not have a fitting distance (y7) 
for the splice site set used to generate the complex DEs, we tried setting it equal to y2 or to y3. 
Either value accurately predicted the results for ESE and ESS variation, as expected for 
fixed-size DEs. However, in predicting the observations of the complex DEs that differ in size, 
y3 was clearly superior (R
2 
of 0.86 vs. 0.64). To further explore this issue, we asked what the 
optimal value for y7 was for predicting the complex DEs. The BFGS routine was used to 
optimize y7 and K7, while keeping all other parameters constant. The optimized value for y7 was 
in fact close to that of y3 (11.2 vs. 12.0) and quite different from that of y2 (21.6). Moreover, as 
shown in Table 5.2, the BFGS-optimized y7 performed no better than y3. This suggests a 
similarity between SS Sets 3 and 7, while it also implies a difference between these and Set 2. As 
should be evident from Table 3.1, these relationships point to the 5’SS as being the determinant 
factor in the shift observed in Fig. 5.2A for this limited collection of three SS sets (see 
Discussion). Second, since the effects of ESEs and ESSs were studied separately here, we 
evaluated the assumption of independence used to predict the splicing seen in the complex DEs. 
We studied ESE and ESS action here exclusively in 110 nt exons; therefore, we only examined 
complex DEs of this length to eliminate any confounding effect of size. As shown in Fig. 5.5, 
prediction for the splicing of these complex DEs is excellent, with an R
2
 of 0.96, a slope of 1.02 






Third, extending this analysis to other sizes we found that even though predictions for the great 
majority of complex DEs in all size classes showed good correlations (data not shown), a 
systematic trend was revealed in their accuracy. Beyond ~140 nt the observed values 
progressively fell short of the predictions at a rate of about 1% per additional nt as shown in Fig. 
5.6. We interpret this distortion as being due to a drop-off in PCR efficiency for longer 
templates, an artifact that is expected in the older data but was avoided by the use of QPCR in 
the present study. Taking all these results together, the good fit seen suggests that the possible 
omission of some biological factors in the model is not having a substantial effect on any of 
these DEs. 
 
Figure 5.5. The combinations of ESEs and ESSs are accurately modeled in 110 nt exons. The 
predictions of complex DEs of 110 nt were assessed separately to evaluate the performance of the 









In chapter 3, we described the splicing phenotypes of exons of our own design, each 
principally comprised of just 1 or 2 prototype 8-base sequence modules that represent an ESE, an 
ESS or a reference sequence that resembles neither. This approach enabled us to focus on each of 
these parameters individually. We found an optimal size range for inclusion that depended on the 
splice site sequences used. A stronger 5’ splice site favored inclusion of longer exons while 
disfavoring the inclusion of shorter exons. In contrast, a stronger 3’ splice site favored inclusion 
 
 
Figure 5.6. The observed psi for complex DEs progressively falls short of prediction as sizes 
increase above 140 nt. A best fit was performed comparing observed vs. predicted psi for complex 
DEs of the indicated sizes. Although R
2
 values were high in all, accuracy, as reflected in the slope of 
the fit, decreased with size. This artifact is expected when we consider the decrease in the efficiency of 



















of shorter exons while disfavoring the inclusion of longer exons, the opposite effect. That is, 
surprisingly, changes that worked for improving the splicing of longer exons did not work for 
improving the splicing of shorter exons, and vice versa. An ESE enhanced splicing uniformly 
from any position along the exon; the expected position dependence was not seen. The ESS 
showed some position dependence: the most downstream position tested was the most effective 
while the most upstream position had little effect; intermediate positions showed uniform 
intermediate effects. Multiple enhancers or silencers showed additive enhancing or silencing 
effects respectively.  
 
Many systems used to study splicing, especially in vitro splicing, use 2-exon substrates or 
substrates with short (<200 nt) introns, favoring intron definition rather than exon definition 
(Talerico and Berget 1994; Fox-Walsh et al. 2005).  In contrast, we sought here to focus on exon 
definition, and so studied splicing of an internal exon and used longer introns (~300 and ~600 
nt). Importantly, weakening either splice site of the internal exon resulted only in increased 
skipping, as expected with exon-definition, with no signs of intron retention (data not shown). 
Prompted by these results indicating that DEs were recognized by exon definition, we devised a 
general equation for exon definition that incorporated several intermediate states along a splicing 
pathway (equation 5.4). It is noteworthy that this equation predicts that lengthening τ, the time 
available for commitment exclusively to the included fate (e.g., by slowing synthesis), should 
increase psi; this kinetic effect has been observed previously in exon-definition systems 
(Dujardin et al. 2013). Using the equations developed in Chapter 4, we also explored the 
potential of intuitive but novel mechanisms to explain our observations. While these 






to be equally applicable to the definition of natural exons since they are based on straightforward 
biophysical assumptions and are indeed supported by previous studies (see below). 
 
Modeling the effect of size 
 
It has been suggested that there is an interaction between U2AF and U1 snRNP not only 
across the intron (Michaud and Reed 1993) but also across the exon (Hoffman and Grabowski 
1992; Reed 1996). We modeled this interaction across the exon as an exon definition complex. 
Tethered collisions were used to model the formation of this complex (Fig. 4.2). Not all 
collisions will be productive; both ends of the exon must approach each other in the correct 
orientation in order to interact. The probability of a productive collision was modeled assuming 
the RNA behaves as a flexible worm-like chain. After the bound RNA sequences at the ends of 
this chain become associated the physical distance between these two ends becomes fixed (the 
fitting distance yi in Fig. 4.2). The emerging equations predict that splicing efficiency should 
decrease for short exons and for long exons: if an exon is very short no collisions may be 
possible while for long exons the chance of a collision between the ends is low. Effects of length 
have been observed previously (Black 1991; Dominski and Kole 1991; Peterson et al. 1994; 
Sterner et al. 1996; Hwang and Cohen 1997; Borensztajn et al. 2006) as well as in these 
systematic DE results. By optimizing the fitting distance independently for each set of SSs used, 
we found that a difference in this parameter could predict the surprising shift seen in Fig. 5.2A. 
The optimal size range shift is explained solely by the difference in these two distances. 
However, a low psi would be expected at this peak for SS Set 3 but a high K3 relative to K2 






complexes posited (Kastner and Luhrmann 1989; Pomeranz Krummel et al. 2009; Weber et al. 
2010). Importantly, in this limited collection of three SS sets, the 5’ SS is the determinant factor, 
since yi changes substantially only when the 5’ SS is changed. Three possibilities come to mind 
to explain this SS sequence dependence: 1) a large conformational change in one or more of the 
proteins bound to these sequences. Although a difference of 9.6 nm (Table 5.1) seems large, 
protuberances of this size have been seen in U1 snRNP (Kastner and Luhrmann 1989; Pomeranz 
Krummel et al. 2009; Weber et al. 2010). 2) A small conformational change that enables one or 
more proteins to recruit an additional “bulging” factor. 3) A sequence dependent change in the 
point or angle at which the pre-mRNA extends from U1 snRNP (Fig. 4.2B-D). A possible 
example of this last option can be seen by comparing the crystal structures of different nucleic 
acid sequences bound by U1 snRNP described by Pomeranz Krummel et al., (PDB ID 3CW1, 
2009) and by Weber et al., (PDB ID 3PGW , 2010): the two different nucleic acid molecules 
extend from the U1 snRNP in a different manner. Irrespective of the model used, the shift 
between these two curves implies that comparing the strengths of 5’SS sequences might be more 
complex than previously thought.  
 
Several similarities have been noted between the size restrictions for exons in exon 
definition and those for introns in intron definition. For example, introns longer than ~300 nt are 
disfavored in organisms relying mostly on intron definition (D. melanogaster) and exons longer 
than ~300 nt are disfavored in organisms relying mostly on exon definition (humans) (Sterner et 
al. 1996; Fox-Walsh et al. 2005; Xiao et al. 2007). Moreover, Garcia-Blanco and colleagues 
presented evidence supporting pairing of the ends of introns via three dimensional diffusion 






pairing. Interestingly, the size distributions of short introns in human and Drosophila are greatly 
disjoint (Fig. 3.6 in (Fox-Walsh et al. 2005)). The optimum size for splicing is greater in human 
(90 nt) than in Drosphila (75 nt) nuclear extracts (Guo et al. 1993). These observations suggest 
that a size dependence similar to that in Fig 5.2A could explain this species difference by 
assuming tethered end collisions across the intron with a different yi for each organism. This 
difference could be dictated by differences in the size and/or number of the proteins involved. 
 
 
Modeling the effect of ESEs 
 
Recruitment of the splicing machinery as a mode of action for ESEs (Kohtz et al. 1994; 
Staknis and Reed 1994) is supported by evidence of interactions between activator proteins that 
bind ESEs and some of the proteins involved in the early steps of splicing (Hoffman and 
Grabowski 1992; Kohtz et al. 1994; Staknis and Reed 1994). There is an expected position effect 
that this interaction should display: the closer the binding site for the activator to the splice site, 
the more efficient it should be in recruiting the splicing machinery to that site. The absence of 
this effect prompted us to model the action of the ESE as simply stabilizing an otherwise volatile 
interaction between U2AF and U1 snRNP. 
 
Previously observed increases in theyield of splicing complexes (Hoffman and 
Grabowski 1992) can be explained by stabilization as well as by recruitment. Changes in 
stability, expressed as the rate of dissociation (d within equation 5.4), should respond 






near linear relationship between psi and the number of ESEs over much of the range examined 
and accounts for the saturation effect when more than 4 ESEs are used (Fig. 5.2B). In contrast, 
recruitment depends on a change in binding probability of the splicing machinery, which is 
expected to be linear with respect to ESE number. This linearity could be incorporated in a (the 
association rate constant) within equation 5.4 (see Supplemental Material). The resulting 
recruitment model led to a fit for predicting the results on the single-parameter-perturbation data 
(an R
2
 of 0.92, a slope of 0.90, and an intercept of 5.62%) that was nearly as good as the stability 
model (Fig. 5.1). However, it produced a negative exponential shaped curve that did not fit the 
ESE data as well (See Supplemental Fig. S5.1) and unlike the stability model it performed poorly 
for the complex DEs (R
2
 of 0.37 compared to 0.86). In particular, for the constant size class of 
110 nt which isolates the effect of ESE/ESS combinations, even though an acceptable R
2
 of 0.84 
was obtained, a slope of 1.78 and an intercept of -63% revealed a flawed performance compared 
to the stability model (compare Supplemental Fig. S5.2 and Fig. 5.5). 
 
 Thus although recruitment may play a role, we conclude that stabilization is the 
dominant feature. It is interesting to note that the model used here could account for the 
dependence of in vitro splicing efficiency on the number of doublesex enhancers (compare 
Supplemental Fig. S5.3 to Fig. 2D in (Hertel and Maniatis 1998)). This agreement with long-
established data suggests that these results using a prototype ESE of our own design reflect 
general mechanisms involved in splicing and may not be limited to internal exons. Recruitment 
and stabilization are not at all mutually exclusive; one can imagine recruitment of a factor 
followed by stabilization of the binding of that factor and/or the subsequent stabilization of a full 







ESS number and position effect 
 
In Chapter 3 we showed that the effect of multiple ESSs could be predicted by their linear 
combination as long as the particular characteristics of positions 1 and 6 were taken into account 
(Fig. 3.6B). For modeling, we contented ourselves with considering the action of ESSs to be 
opposite that of ESEs; that is, as destabilizing elements. Although only the data for single-ESS 
DEs were used to optimize the model, the effect of multiple ESSs (which included the saturating 
case of 6 ESSs) was accurately predicted (Supplemental Fig. S5.4) these predictions were in fact 
more highly correlated (R
2
 = 0.82) than simply summing the effects of the individual ESSs 
(equation 3.1; R
2
 = 0.73 when the 6 ESS data point was included). The position effect seen for 
ESSs suggests that ESSs may act by destabilizing bound U1 snRNP or even blocking its binding 
rather than by affecting an exon definition complex. Further studies using different ESS/splice 
sites combinations and incorporating mechanisms such as competition for binding RNA into the 




These results indicate that modeling a proposed irreversible step in exon recognition 
(exon commitment) coupling statistical mechanics and a reductionist approach is enough to make 
accurate predictions for the psi of combinations of the sequences presented in Chapters 2 and 3. 
This result agrees with those of previous studies showing that the sequences studied, which 






complex A formation. It could be envisioned that once the initial hurdle of exon recognition is 
surpassed, effects on subsequent steps in the splicing reaction might delay the final outcome but 
not affect it significantly. Thus, “commitment” becomes an appropriate description for this early 
milestone and is reminiscent of cell differentiation  and promoter clearance in transcription. 
Indeed this commitment step might be related to the probability of the exon being captured by an 
exon hub, a function that could be fulfilled by the CTD (see below). 
 
The values of the optimized equation coefficients used in the model (Table 5.1) show 
expected characteristics as well as some surprises. The coefficients for dissociation for ESEs (cE) 
and ESSs (cF, cL and cI) were less and greater than unity, respectively, as expected. We expected 
the coefficient for the reference sequence (cR) to be close to unity if it were neutral, but obtained 
a value of 1.5, which leads to a substantial decrease in the predicted psi (data not shown). 
Therefore this reference sequence has a negative effect on the formation of the exon definition 
complex. 
 
Ki is a catch-all constant in equation 5.6 that notably includes the effect of SS “strength.” 
SS Set 3 differs from Set 5 by only a single base in the 3’SS (see Table 3.1) and results in a 2.8-
fold increase in Ki. Set 5 differs from Set 7 by two bases in the 3’ SS and results in a 7.1-fold 
increase in Ki. Differences in the 5’ SS were found to be substantially greater. Set 2 differs from 
Set 7 by only a single base in the 5’ SS yet results in a ~250-fold increase in Ki. The greater 
effect of the 5’ SS suggests a more critical role of its sequence, as has been suggested before 







Finally, T and C in equation 5.5 provide an indication of the contributions of the pre-τ 
and the post-τ phases. The value for T represents the commitment to inclusion that takes place 
even before the third exon is synthesized while the value for C models the period after the third 
exon becomes available. As shown in Table 5.1, C is several orders of magnitude smaller than T, 
implying that by the time competition becomes possible, essentially no additional molecules 
commit to inclusion (i.e., all remaining molecules will be committed to skipping). Indeed, setting 
C = 0 does not change the performance of the model (data not shown). This surprising result 
could be due to an unexplained relative weakness of the DEs used compared to the downstream 
exon; or, more intriguingly, to a mechanism that was not considered in the model: that there is a 
restricted window of commitment time that is shorter than τ. Consequently, molecules that have 
not committed to inclusion within this window of time can no longer do so; paradoxically, they 
are, by default, “committed” to skipping even before the downstream exon is synthesized. This 
shifts the critical time period from minutes (Kessler et al. 1993; Singh and Padgett 2009; Wada 
et al. 2009) to seconds, arguing that most of the time spent before the spliced product is formed 
is spent after the commitment step has been taken. As a matter of fact this window of 
commitment might be dictated by the time the exon containing the exon definition complex can 
be captured by a putative hub. In the case of the hub being the CTD of the RNA polymerase II, 
this might be related to the time at which transcription on the subsequent intron tethers the exon 
too far to ensure a collision of the exon definition complex and the CTD. Four regimens are then 
established: the time involved in exon definition complex formation, which should be in the 
order of milliseconds at most (Chen et al. 2012; Hyeon and Thirumalai 2012); the time required 






product, a few minutes (Kessler et al. 1993; Singh and Padgett 2009; Wada et al. 2009), and the 
time required to generate the final mRNA molecule, up to several hours. 
 
Materials and Methods 
 
Parameter optimization 
A BFGS algorithm adapted from Press et al (Press et al. 2007) implementing walls to force all 
parameters to be non-negative and using explicit gradient was written in Perl for minimizing the 
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To model recruitment, we made use of the linearity predicted previously (Hertel and 
Maniatis 1998) and assumed that the rate of association would be affected by the number of 
enhancers in a linear manner. The same was assumed for the silencers and reference sequences, 
generating the approximation 
S1. D ≈ Ki Yi-2 cRnR Z3/2 e3Yi²/Z / (1+cE*nE+ cF*nF +cL*nL +cI*nI) 
Preliminary attempts using this equation gave values for T, C, K2, K3 and K5 of the order of 
thousands and for K7 of the order of millions, suggesting that the rate of dissociation was much 
greater than the rate of association and convergence was difficult to achieve. To solve this issue, 
a was assumed to be neglible compared to d in equation 5.5 to generate 
S2. pso ≈ 100 e-T/D/(1+C/D) 
 
The data available cannot be used to separate the contributions of T, C and Ki in equation 
S5.2. However, assuming a value for T allows C and Ki to be optimized. We decided to retain 
the value for T obtained with the stability model: 5.24 (see Table 5.1). After a first round of 
optimization, a second round was performed using as input only DEs for which a positive 
prediction was obtained in the first round. Additionally, in order to mimic the effects of 
saturation, any predicted value above 100% was taken to be 100% and any negative value was 
taken to be 0%. The optimized values for the model are shown in Supplemental Table S5.1. 
Using this model a good fit was obtained for the single-parameter-perturbation data (R
2






slope = 0.90 and intercept = 5.62%). However, the predictions of the complex DEs were poor 
(R
2
 = 0.37, slope = 1.18, intercept = -35.7%). In particular for 110 nt DEs, even though the R
2
 
was acceptable (0.84), the poor predictions as indicated by a slope of 1.78 and an intercept of -
63%, suggest that the combination of ESEs and ESSs in a single exon is not modeled 
appropriately. We considered the possibility that these regulatory sequences affect both splice 
sites by squaring each contribution; this modification did not improve R
2
 for either the input data 
or the more complex DEs (data not shown). 
 
Materials and methods 
 
Model optimization 
A Broyden-Fletcher-Goldfarb-Shanno algorithm (BFGS) adapted from Press et al. (Press et al. 
2007) implementing walls to force all optimized values to be non-negative and using explicit 
gradient was written in Perl for minimizing the sum of the squared differences between observed 
and predicted pso (equation 5.5). All values for the model were seeded as 1 except for T, C and 
Yi. T was allowed to vary between 0 and 10 in steps of 1, C between 10
-8
 and 100 with a factor 
of 10 between steps and Y3 between 1 and 25 in steps of 1. Y2 and Y3 were started with the same 
seed but subsequently allowed to vary independently; any other Yi was assumed to be equal to 
either Y3 or Y2 as indicated in the Results. To improve convergence, the routine was modified to 
reset the direction for line minimization to that of steepest descent if the vector of values for the 
model did not change when a full step in the updated BFGS direction was taken. This 
modification reduces the number of seed sets for which the program crawls to a stop without 






solutions by allowing otherwise stalled runs to converge. So as not to include the results of 
stalled runs, a set of values was taken as a solution if and only if, for a set of input data, 
considering the full set of seeds, it provided the minimum sum of the squared differences. This 
same minimum sum had to be obtained several times with all optimized values identical to at 
least 5 significant figures (using different seeds). The magnitude of the gradient had to be smaller 
than 10
-7
 in at least 2 cases. If no such solution was found the program was said to have failed to 
find a convergent solution. These criteria were met for all optimized values except for C, which 
was so low as to be negligible. In this case the value yielding the minimum sum with the 
minimum gradient was used. In fact, setting C equal to zero did not affect the results. 
 
Using all the data points available (Supplemental Table S3.1), the program failed to converge on 
a set of values for the model. We reasoned that the multidimensional surface was too complex 
and relatively flat causing the program to crawl to a stop when exploring it. To address this issue, 
we simplified the data by using our observations that ESEs are position independent and that, 
using single-ESS DEs, the effects of multiple-ESS DEs can be predicted. We thus condensed all 
ESE results corresponding to a given number of ESEs by their average and removed the 36 data 
points corresponding to multiple-ESS DEs. (The data points for ESEs exclusively with SS Set 7 
were used.) We also found it necessary to remove a single outlying point (SS Set 3, length = 206 
in Fig. 3.2) from the 19 size perturbation points in order to achieve reproducible convergence. 
This point also did not agree with the data from permanent transfections (Supplemental Fig. 
S3.2). While this reduced and condensed set was used for optimizing the values for the model, 









Supplemental Table S5.1. Values for the recruitment model. 






































Figure S5.1. Increasing the number of ESEs yields distinctive curves for the stability and the 
recruitment models for ESE action. Adding ESEs generates a sigmoidal curve according to the 
stability model and a negative exponential curve according to the recruitment model. The stability 









Figure S5.2. The recruitment model fails to accurately predict the effect of combining ESEs and 
ESSs in 110 nt exons. The predictions of complex DEs of 110 nt were assessed separately to evaluate 
the performance of the model for combining ESEs and ESSs while removing the effect of size. 
Although a high R
2
 was achieved the slope and intercept deviate markedly from the expected values of 









Figure S5.3. Comparison of time course experiments using constructs with multiple ESEs in 
(Hertel and Maniatis 1998) with time course predictions by the model described in the text. The 
observed data (points) were extracted from Fig. 2D of (Hertel and Maniatis 1998) and plotted 
assuming a splicing delay of 1 hr and a total time (τ) of 7.6 hrs. The values in Table 3.2 were used for 
the model (curves). The points and the curve corresponding to 1 ESE are shown in red, 2 ESEs in 











Figure S5.4. The psi of DEs with multiple ESSs as predicted by the model. The values in Table 3.2 
were used to predict the psi for all constructs with multiple ESSs. These values were obtained using 
only single-ESS DEs. The predictions show a good level of correlation: R
2
 = 0.82. Although the R
2
 is 
high, the slope and intercept deviate somewhat from what is expected (1 and 0%, respectively) 











In the late 1970s, it was discovered that genes of higher organisms are interrupted by 
non-coding intervening sequences (Berget et al. 1977; Chow et al. 1977). After the genetic 
information is copied into a pre-mRNA molecule, these sequences are removed to generate the 
mature mRNA. This surprising result has led to studies aiming at elucidating the mechanism that 
allows the recognition of the regions that are removed, introns, and the ones that are kept and 
spliced together, exons. The first functional sequences to be defined were at the exon/intron 
boundaries (Lerner et al. 1980; Mount and Steitz 1981; Mount 1982). However, by the late 1980s 
there was evidence that sequences inside of the exons themselves played a role (Reed and 
Maniatis 1986; Mardon et al. 1987; Cooper and Ordahl 1989; Tsai et al. 1989). 
 
At the time of these studies, a new tool was being developed: in vitro splicing. In 1983 
Dignam and colleagues developed a protein extraction procedure from the nucleus that allowed 
in vitro transcription to be performed efficiently (Dignam et al. 1983). Shortly thereafter, these 
nuclear extracts were used for splicing pre-mRNA molecules in vitro (Krainer et al. 1984). These 
developments allowed the discovery of the first splicing factor in higher eukaryotes (Ge and 
Manley 1990; Krainer et al. 1990). This factor, known as SRSF1, has two RNA binding domains 
known as RRM domains and a region rich in arginine and serine dipeptides known as RS domain 






became hallmarks of a set of proteins that was shown to affect splicing decisions by preventing 
exon skipping (Ibrahim et al. 2005). Further work characterized the RNA sequences recognized 
by many of them (Tacke and Manley 1995; Lynch and Maniatis 1996; Tacke et al. 1997; Liu et 
al. 1998a; Lou et al. 1998; Long and Caceres 2009) and currently high-throughput approaches 
are providing tools to refine our understanding of their sequence recognition specificity (Ray et 
al. 2009; Anko et al. 2012). 
 
Another family of proteins was discovered for its binding to pre-mRNA; these proteins 
formed heterogeneous nuclear ribonucleoprotein complexes (Pinol-Roma et al. 1988). These so 
called hnRNPs have a diverse set of functions with respect to RNA metabolism (Han et al. 
2010). However, many of these proteins have been characterized as sharing the function of 
splicing repressors (Martinez-Contreras et al. 2007). The binding sequences for many of these 
proteins have been elucidated (Han et al. 2010). Even though these proteins have been grouped 
as a family, their heterogeneity and the diversity of their functions warrant prudence when 
making generalizations. 
 
 In our study of splicing, we have taken a reductionist approach to understand the 
mechanism by which the proper splice sites are selected. These studies used designer exons 
made up of a few prototype modules of our own design (including an exonic splicing enhancer, 
ESE, and silencer, ESS) in a three exon minigene. In this chapter I focus on the identification of 
the proteins that bind these modules and that provide the functionality observed in vivo. Recent 
advances in mass spectrometry allowed us to efficiently make a fairly comprehensive list of 











Four sequences were chosen for proteomics studies. Three of them were introduced in 
Chapters 2 and 3 and comprised the building blocks for the construction of Designer Exons 
(DEs): a reference sequence, CCAAACAA; an ESE, UCCUCGAA; and an ESS, CACAUGGU. 
Another ESS was added for future extensions and was included in this study for it also served as 
an additional reference for some of the experiments that follow: ESS2, CACAUACA. The first 
three sequences were presented previously and their effects were described at length (Chapters 2 
and 3). 
 
The additional silencing sequence ESS2 was chosen in a similar manner to ESS, so as to 
not create any other predicted splicing regulatory sequence when placed in the DE. Preliminary 
tests substituting ESS2 for ESS, indicated that ESS2 had stronger silencer effects than ESS (data 
not shown) and that a strong set of splice sites was required to fully observe the effects of adding 
it to the DE. For this purpose, we strengthened the 3’SS of the DEs used (SS Set 5 in Table 3.1) 
and tested the effect of the ESS2 at all six positions defined previously along the exon. For 
reference purposes, a DE with a sole ESS at position 4 was included as well as a DE with only 
reference sequences. For ESS2, the psi decreased substantially from 92% to 42% or less for all 






other hand, the effect of the original ESS was statistically significant (t-test, p<0.01) but modest: 




Figure 6.1. ESS2 has stronger silencer activity than ESS and works at all positions 
tested. ESS2 was placed in all six positions in a 110 nt DE. For all positions, the effect was 
substantial, reducing the psi from ~92% to ~42% or less. For reference purposes, an ESS was 
tested at position 4. The decrease was statistically significant (p<0.01) but modest: from 
~92% to ~89%. n=3. Exons are indicated using a six letter code indicating the sequence 







The variation in the effect of the ESS2 with position was small: from a decrease of 50% 
at either end to a fairly uniform decrease of ~64% in the middle of the DE. However, a 
statistically significant difference was found between the first position and each of the four 
intermediate positions (t-test, p<0.05). No other statistically significant difference was found 
between the positions tested. 
 
Interestingly, in the presence of a weaker 3’SS and a reference psi of ~50%, a reduction 
of ~10% was observed using the analogous construct for ESS (see Chapter 3). This indicates that 
the observed effect of ESS depended on the quality of the splice sites. A similar observation was 
made regarding the effect of ESEs in Chapter 3 and might be a general phenomenon. Indeed, this 
observation is consistent with saturation of the psi near 0% and 100%. Hence, the presence of 
strong splice sites generated a high psi value for the DE composed of reference sequences which 
in turn led to a saturation effect that resulted in a smaller reduction in psi upon the addition of an 
ESS. Alternatively, considering the ESS-containing DE, the high psi signals saturation. Hence, 
removal of the ESS causes an increase that is constricted due to its proximity to 100%. 
 
Proteins bound to the ESE, ESS, ESS2 and reference sequences 
 
We performed protein binding experiments using 32 nt biotinylated RNA molecules. 
Four different molecules were evaluated. The first three RNA molecules evaluated the ESE, ESS 
and ESS2 sequences separately using two copies of the corresponding sequence. These copies 
were placed in a sequence environment that duplicates that found in DEs by including a 






RNA molecule and the 5’ half at the 3’ end (see Materials and Methods). An analogous fourth 
RNA molecule consisting exclusively of reference sequences was evaluated to identify proteins 
bound to the reference sequences themselves. These RNA molecules were bound to streptavidin 
beads and exposed to nuclear extract. After several washes, the proteins bound were released by 
digesting the RNA molecules with RNase A. (See Materials and Methods for further details.) 
 
An initial assessment of the differential binding of proteins to the RNA molecules was 
performed using a sensitive zinc-imidazole reverse staining assay (Fernandez-Patron et al. 1992). 
However, it should be taken into account that due to the use of relatively high amounts of RNase 
A and BSA (see Materials and Methods), the presence of proteins at around 15, 35 and 70 kDa 
was obscured by their bands: the first two bands were observed when purified RNase A was run 
by itself with the second band probably due to dimerization (Crestfield and Fruchter 1967; Liu et 
al. 1998b); the third band was observed when purified BSA was run by itself (data not shown). 
Additionally, proteins of around 30kDa or less are not detected well with this reverse staining 
assay. Only low stringency washes were performed after exposing the RNA molecules to nuclear 
extract to ensure good coverage yielding a fairly “crowded” gel. In spite of this, some differences 
were observed (Fig. 6.2). Among the differences observed, a ~57 kDa band was present only in 
the ESE lane, ~80 and ~50 kDa bands were only present in the ESS lane and the ratio between 
the band at ~42 kDa and the band at ~41 kDa was higher for ESS2 indicating at least an 
enrichment or a depletion for proteins in one of these two bands. Further experiments without 
BSA, using pre-passed nuclear extract and running higher stringency washes yielded a bright 






tandem mass spectrometry. In spite of these promising results, the presence of a high number of 




Figure 6.2. Proteins pulled down by RNA baits for the reference sequence, ESE, ESS 
and ESS2. RNA binding experiments were performed and the proteins released upon 
treatment with RNase A were electrophoresed in a 10% polyacrylamide gel and stained with 
zinc-imidazole; the bands are white on a dark background. The lanes shown correspond to 







To identify the proteins with differential binding as well as to make a more exhaustive 
comparison, the proteins bound to the RNA sequences were trypsinized on the beads themselves 
without the use of RNase A and the mixture of the resulting fragments was analyzed by liquid 
chromatography linked to mass spectrometry for the intact fragments alternating with mass 
spectrometry for their dissociation products (LC-MS/MS). Comparison of the resulting 
fingerprints with those expected for known proteins in human allowed identification of the 
proteins as well as label-free quantification of their abundance (Zhu et al. 2010). We then 
performed comparisons of the levels of the different proteins and identified those enriched for 
each one of the different RNA bait molecules (Materials and Methods). 
 
A total of 26 proteins with differential enrichments were found (Table 6.1). A subset of 
the proteins identified showing their quantification value is shown in Fig. 6.3. Some of these 
proteins represent different isoforms from the same gene. The case of hnRNP D0 is particularly 
interesting: isoform 1/a/Dx9 was enriched for ESS2 while isoform 2/b/Dx4 was enriched for 
ESE (Fig. 6.3G and 6.3I). Furthermore, isoform 3/c/Dx7 was present in the results and barely 
missed the cut for statistical significance (data not shown): its enrichment profile was similar to 
that of isoform 1/a/Dx9. Isoforms 1 and 3 share an alternative exon 2, which is missing from 
isoform 2. Not all cases were as complex. For hnRNP A1, all three isoforms were identified as 
being enriched for the ESS2 RNA molecule. For some of the proteins in Table 6.1, only the 
isoform reported showed noticeable differences between the RNA baits: e.g., SRSF7 isoform 2 
showed no enrichment between RNA molecules (data not shown). However, for some of them, 






higher than the threshold used, 7.3x10
-5
: PTB/hnRNP I isoform 2 showed enrichment for ESE 
but the p-values were above-the-threshold: around 0.0002 for the three comparisons involved. 
 
This set represents candidate proteins for providing the functional characteristics 
associated with each sequence. For the reference sequence, only two proteins showed 
enrichment: HqkI and hnRNP Q. For ESS, only one protein showed enrichment: CSTF1/CstF-
50. Interestingly, eight proteins showed depletion: SRSF3, hnRNP K, hnRNP A0, hnRNP 
A2/B1, hnRNP A3, RNP L, MAP4 and p100 co-activator. For ESS2, many proteins showed 
enrichment: hnRNP proteins A0, A1, A2/B1, A3, D0 (isoform 1/a/Dx9), L and U, DEAH box 
protein 36, DAZ-associated protein 1, and p100 co-activator. Only one protein showed depletion: 
ZC3H4. For ESE, many proteins showed enrichment: hnRNP proteins E2, I/PTB, K and D0 
(isoform 2/b/Dx4), Matrin-3, SRSF7/9G8, and DAZ-associated protein 1. Two proteins showed 
depletion: hnRNP L and PPIase PIN4. 
 
These results explain some of the previous observations but not all. For ESS, the band at 
around 50 kDa could be due to CSTF1/CstF-50, but the band at ~80 kDa remains a mystery. For 
ESS2, the previously identified hnRNP L was detected anew. The higher intensity of the band at 
~42 kDa could be due to DAZ-associated protein 1, which has a predicted molecular mass of 43 
kDa. For ESE, the band at around 57 kDa can be explained by PTB/hnRNP I: isoform 1 has 
predicted molecular mass of ~57 kDa; a doublet would be expected if isoform 2 was considered 
as mentioned before for it has a predicted mass of 59 kDa. However, due to variation in protein 
migration due to post-translational modifications, more analyses would be required to assign the 



















ESS ESS2 ESE 
CSTF1/CstF-50 - Q05048  Enrichment   
DAZ-associated protein 1 1 Q96EP5   Enrichment Enrichment 
DEAH box protein 36 2 Q9H2U1   Enrichment  
hnRNP A0 - Q13151  Depletion Enrichment  
hnRNP A1 A1-B P09651   Enrichment  
hnRNP A1 A1-A P09651   Enrichment  
hnRNP A1 2 P09651   Enrichment  
hnRNP A2/B1 B1 P22626  Depletion Enrichment  
hnRNP A3 1 P51991  Depletion Enrichment  
hnRNP D0 1/a/Dx9 Q14103   Enrichment  
HnRNP D0 2/b/Dx4 Q14103    Enrichment 
hnRNP E2/Alpha-CP2 1 Q15366    Enrichment 
hnRNP K 2 P61978  Depletion  Enrichment 
hnRNP L 1 P14866   Enrichment Depletion 
hnRNP Q 1 O60506 Enrichment    
hnRNP U/SAF-A Long Q00839   Enrichment  
HqkI 6 Q96PU8 Enrichment    
MAP-4 6 P27816  Depletion   
Matrin-3 1 P43243    Enrichment 
p100 co-activator/SND1 - Q7KZF4  Depletion Enrichment  
PPIase Pin4 2 Q9Y237    Depletion 
PTB/hnRNP I 1 P26599    Enrichment 
RNPL - P98179  Depletion   
SRSF3/SRp20 - P84103  Depletion   
SRSF7/9G8 1 Q16629    Enrichment 
ZC3H4 - Q9UPT8   Depletion  
1
The information for the isoform was obtained from the mass spectrometry report. When no 
isoform was indicated it was assumed that the canonical isoform was used: isoform 1 in most 
cases. For most proteins, the other isoforms were present in the output file confirming this fact 
and showed differences that were not statistically significant. However, for hnRNP E2, hnRNP L 
and Matrin-3 no other isoforms were found in the report; isoform 1 was assumed. For proteins 




For hnRNP Q and HqkI, the other three RNA molecules showed depletion. This was interpreted 








Figure 6.3. Proteins are enriched differentially for the four bait sequences. A. HqkI 
shows enrichment for the reference sequence and a non-statistically-significant depletion for 
the ESS bait. B. CSTF1/Cstf-50 shows enrichment for ESS. C. SRSF3 shows depletion for 
ESS. D. DAZ-associated protein 1 shows enrichment for ESS2 and ESE. E. hnRNP L shows 
significant enrichment for ESS2 and depletion for ESE. F. hnRNP A2/B1 shows enrichment 
for ESS2 and depletion for ESS. G. hnRNP D0 isoform 1 shows enrichment for ESS2. H. 
SRSF7 shows dramatic enrichment for ESE. I. hnRNP D0 isoform 2 shows enrichment for 







In order to validate the results of these experiments, two proteins were selected for spot 
checking through western blots. The presence of PTB/hnRNP I and hnRNP L was assessed in the 
supernatants after treating the beads with RNase A. As shown in Fig. 6.4, the results of the 
western blot closely follow the results obtained through mass spectrometry. For PTB/hnRNP I 
the resolution of the scanner used to document the western blots was unable to capture the 
presence of an observed doublet for PTB/hnRNP I. This doublet was expected based on the mass 
spectrometry results. For ESS, the band for hnRNP L came out weaker than expected. 
 
 
From the results obtained, it is interesting that many of the proteins identified were 
missed when analyzing the gel. For instance, many of the proteins had molecular masses below 
30 kDa: PPIase Pin4 and SRSF3 for example. Other proteins would require modifications to the 
zinc-imidazole assay for identification for they were hidden “behind” highly abundant proteins 
 
Figure 6.4. Western blots confirm the mass spectrometry results. A. A western blot for 
PTB/hnRNP I detects PTB only for the ESE bait as expected. B. A western blot for hnRNP L 







with similar migration rates: hnRNPL and many of the proteins at around 35 kDa are good 
examples. 
 
To assess a link between the functional characteristics of the sequences used and the 
proteins found, in vivo experiments were planned. Preliminary siRNA experiments were 
performed for hnRNP K. As shown in Fig. 6.5A, a significant reduction in the level of hnRNP K 
mRNA was maintained after 5 and 6 days. Since this protein was enriched for the ESE bait, it 
was expected that knocking it down would reduce the psi of DEs that include an ESE. A 
decrease of ~10% was observed (Fig. 6.5B) and it was statistically significant after 6 days in 
comparisons with the three controls (t-test, p<0.05). This is seemingly consistent with hnRNP K 
having a positive effect on the ESE-containing DEs. However, a more dramatic reduction of 
~20% was observed for DEs that did not contain the ESE. This difference was statistically 
significant after 5 and 6 days (t-test, p<0.05). These results indicate that hnRNP K has a positive 
effect on the inclusion of the DE both in the presence and in the absence of ESEs in the DE. The 
observations for the NNNNNN DE might be effected through hnRNP K actions not involving 
the DE per se. For the NNENNN DE, on the other hand, a comparison between knockdown cells 
indicates an ESE-linked increase of ~40%. This is higher than the increase of ~30% observed in 









Figure 6.5. Knock down results make hnRNP K an unlikely candidate to explain the 
effect of ESE. A. Two cell lines were simultaneously tested with hnRNP K knock downs. 
These cell lines have a modified DHFR minigene in the same chromosomal location but 
contain different DEs. NNNNNN represents a DE containing no ESEs whereas NNENNN 
contains a single ESE on the third position (see Chapter 3). All DEs use SS Set 5 (see Chapter 
3). Quantification of hnRNP K mRNA was performed at two different time points: 5 and 6 
days after the initial transfection. hnRNP K was effectively knocked down. Three controls 
were used: NC, negative control using an innocuous siRNA molecule; PC, positive control for 
siRNA using cyclophilin B (no effect expected on hnRNP K); UT, untransfected cells. The 
expression data was normalized to the average of the three controls. B. PSI for the DHFR 
minigenes was measured for the cells with hnRNP K knock downs and for the controls. After 









We have introduced a new sequence, ESS2, and added it to the set of sequences we used 
in DEs. ESS2 showed a stronger silencer effect than ESS and this effect was present in all 
positions tested. Only minor decreases in its intensity were found in the terminal positions. 
 
Identification of the proteins involved in splicing that are recruited by the different 
sequences studied here allows the whole set of results previously obtained to be connected to 
other studies in the literature. These connections might inform new approaches for the study of 
DEs or for the study of the protein themselves, which is not limited to our research group. Due to 
the ease and comprehensive nature of shotgun proteomics, such approach was used and several 
candidates were obtained for every sequence. All these candidates have to be evaluated carefully 
in order to assign functionality but priorities can be assigned to direct those efforts based on what 
is known about each candidate. A short list of the candidates is presented in Table 6.2. 
 
Table 6.2. Short list of candidate proteins for providing the observed functionality of each 
sequence. 
Reference Sequence ESS ESS2 ESE 
HqkI CSTF1/CstF-50 hnRNP L SRSF7/9G8 
 CSPF5  hnRNP L 
 CSPF7   










For the ESE, many of the candidates obtained have shown effects that are opposite the 
ones required for the function studied here. Of these, four enriched candidates belong to the 
family of hnRNP proteins, which has many members with silencer effects (Han et al. 2010): 
hnRNP D0, hnRNP E2, PTB/hnRNP I and hnRNP K. In the case of hnRNP K, results consistent 
with such a silencer effect mediated by the ESE were obtained through siRNA experiments. A 
further candidate belonging to this family, hnRNP L, shows depletion, which is consistent with a 
positive effect on psi due to the presence of an ESE. The isoform for Pin4 reported as a depleted 
candidate includes a mitochondrial localization signal. Even though similarities exist between 
PIN4 and PIN1 (Sekerina et al. 2000), which is known to affect the conformation of the CTD in 
RNA polymerase II (Xu and Manley 2007) and potentially affect splicing, PIN4 is not predicted 
to serve a similar role but to function instead in ribosome biogenesis (Fujiyama-Nakamura et al. 
2009) or in the mitochondria (Kessler et al. 2007). There is little information in the literature 
about the candidate DAZ-associated protein 1 at this time but it might be associated with intronic 
splicing enhancers (Pastor and Pagani 2011) and probably has silencing effects when placed in 
the exon (Goina et al. 2008) making it an unlikely candidate for ESE. Matrin-3 and PTB/hnRNP 
I have been isolated by their association with an U/C rich RNA sequence (Sharma 2008) and in 
the case of PTB/hnRNP I a sequence containing UCCU, which is found in ESE, was found to 
interact strongly with PTB/hnRNP I (Ray et al. 2009). The proteins hnRNP K, hnRNP E2 and 
SRSF7 were found to interact with Matrin-3 by yeast two-hybrid assays (Zeitz et al. 2009), 
suggesting an indirect interaction with the RNA bait. However, hnRNP K has also been shown to 
interact with Matrin-3 by co-immunoprecipitation in a RNA dependent fashion (Salton et al. 
2011), making RNA mediated interactions a possible explanation for the yeast two-hybrid 






et al. 2002). All of these results are consistent with Matrin-3, hnRNP K, hnRNP E2 and 
PTB/hnRNP I interacting with U/C rich sequences similar to the ones in ESE. Binding of SRSF7 
requires more consideration for the characterized binding sites are fairly different from the 
sequences present in ESE (Lynch and Maniatis 1996; Cavaloc et al. 1999; Schaal and Maniatis 
1999). This might indicate that one of the other proteins is recruiting it or that the ESE bait 
contains a new type of binding sequence for SRSF7. In any case, SR proteins are associated with 
enhanced splicing and its recruitment/binding might provide the functionality observed for ESE. 
From this analysis, SRSF7 and hnRNP L emerge as the leading candidates to explain the 
enhancing effect of ESE. 
 
For ESS the situation is more complicated. Only CSTF1 showed enrichment with the 
threshold used. Binding of this cleavage stimulation factor to the DE might interfere with the 
proper recruitment of the splicing machinery. Interestingly, relaxing the threshold to 0.001 
uncovers only two other enriched proteins, CPSF5 and CPSF7, which show p-values of 0.0003 
or lower and are functionally related to CSTF1. A possible participation of factors involved in 
pre-mRNA 3' processing is reminiscent of the role of CPSF1 in the inclusion exon 6 in IL7R, 
where CPSF1 seems to interfere with spliceosome binding without causing cleavage (Evsyukova 
et al. 2013) and the active role of “silenced” polyadenylation signals in transcripts (Almada et al. 
2013). Additional candidates include the proteins that were depleted. However, hnRNP A0, 
hnRNP B1, hnRNP A3 and hnRNP K belong to the hnRNP family and due to their predicted 
silencing effect (Revil et al. 2009; Han et al. 2010), depletion would not explain the observed 
effects of ESS. Similarly, the depleted candidate RBM3 has been linked to splicing changes for 






depleted candidate. SND1, on the other hand, has been shown to facilitate the assembly of the 
spliceosome (Yang et al. 2007) making it a likely candidate. For MAP4 more information on its 
roles in splicing would be needed. The other depleted candidate, SRSF3, has been shown to 
facilitate splicing when placed in exons (Long and Caceres 2009). Therefore, substituting a 
sequence that has low affinity for SRSF3 instead of one that has high affinity would decrease psi 
and would look as if a “silencer” had been added and would coincide with the treatment of ESS 
in the model in Chapters 4 and 5. A final candidate that might satisfy the requirements is hnRNP 
R which is enriched for the ESS sequence (maximum p-value of 0.0025) but did not reach the 
conservative threshold used. This protein has the fourth lowest p-value for a  protein showing 
enrichment for ESS over the other sequences and migrates at around 80 kDa (Pinol-Roma et al. 
1988), which might explain the band observed in the zinc-imidazole gel (Fig. 6.2). However, 
there is little information about its function in the literature. These considerations make CSTF1, 
CPSF5, CPSF7, SRSF3 and SND1 favored candidates to explain the effect of ESS. 
 
The manner in which these proteins contribute to the silencing effect of ESS might be 
more complex than suggested in the previous paragraph. CTSF1 is part of a complex that 
participates in pre-mRNA 3’ end processing (Mandel et al. 2008). Binding of this complex to 
ESS might interfere with proteins binding to nearby regions explaining the depletion of many 
proteins observed in the mass spectrometry results for ESS (Table 6.1). In particular, it might 
interfere with binding of proteins in the flanking reference sequences. Since a binding sequence 
for SRSF3, UCAAC (Anko et al. 2012), is similar to ACAAC in the reference sequence, the 
substitution of ESS for a reference sequence in a DE would contribute to a decrease of bound 






per se and the interference with SRSF3 binding to other flanking reference sequences. 
Furthermore, this interference might be related to transcription along the RNA molecule and 
could potentially explain the position effect observed for ESS in Chapter 3: proteins binding to 
parts of the molecule that are synthesized first might interfere with binding of proteins to parts of 
the molecule that are synthesized later. Therefore, U2AF65 having early access to the 
synthesized RNA (Ujvari and Luse 2004) might prevent a big complex from forming near the 5’ 
end of the exon allowing SRSF3 binding to the abutting reference sequences. At the other end, 
the presence of ESS near the 3’ end of the exon might interfere with U1 snRNP binding, the 
delay in synthesis effectively providing enough time for the complex to form and negatively 
affecting inclusion of the exon. Taking all this into consideration, the expected effect would then 
resemble Fig. 3.5: no significant effect for ESS when placed near the 5’ end of the exon, a 
uniform intermediate effect in the middle of the exon and a stronger effect near the 3’ end of the 
exon. 
 
For ESS2, hnRNP L binds preferentially to CA and TA repetitions such as those present 
in ESS2. Indeed ESS2 is listed as a high scoring binding site for hnRNP L (Hung et al. 2008). 
The other hnRNP proteins reported would probably be recruited by bound hnRNP L molecules 
(Chiou et al. 2013). Additionally, DAZ-associated protein 1 has been shown to interact through 
its RRM domains with hnRNP U and hnRNP A1 (Yang et al. 2009), which is consistent with 
hnRNP L being the only protein directly bound to the ESS2 while the rest are recruited directly 
or indirectly by it. Information about a role for ZC3H4 in splicing was lacking. Therefore, its 






it facilitates the assembly of spliceosomes. Taking all this into account, a very likely candidate 
for explaining the effects of ESS2 is hnRNP L. 
 
Regarding the reference sequence, it was found that two proteins were enriched when it 
was used as bait: HqkI and hnRNP Q. The function of HqkI depends on where it binds on the 
RNA molecule: stabilization, localization and translation of mRNA when bound to the 3’-UTR 
(Saccomanno et al. 1999; Li et al. 2000; Lakiza et al. 2005; Zhao et al. 2010; Zearfoss et al. 
2011) and facilitator of exon inclusion when bound to intronic splicing enhancers (Hall et al. 
2013). Taking into account that several factors that have a silencing role when their binding sites 
are placed in exons have an enhancing role when placed in introns (Martinez-Contreras et al. 
2006), we can hypothesize that HqkI might display a silencing effect when its binding sequence 
is placed in exons. This is consistent with the likely silencer effect predicted by the model for the 
reference sequences (Chapter 3). The other candidate, hnRNP Q, was characterized as a 
component of the spliceosome (Mourelatos et al. 2001) which also bound exon 7 in SMN2 and 
promoted its inclusion (Chen et al. 2008). However, the sequence involved included many 
uracils which are absent in the reference sequence, making its role in DEs uncertain. These 






Materials and Methods 
RNA molecules 
The biotinylated RNA molecules were obtained from Dharmacon. The sequences were as 
follows:  
reference sequence  5'–Bi–ACAACCAAACAACCAAACAACCAAACAACCAA–3',  
ESS    5'–Bi–ACAACACAUGGUCCAAACAACACAUGGUCCAA–3',  
ESS2    5'–Bi–ACAACACAUACACCAAACAACACAUACACCAA–3' and  
ESE    5’–Bi–ACAAUCCUCGAACCAAACAAUCCUCGAACCAA–3’. 
 
Protein binding experiment 
The following buffers were prepared: Buffer B (20 mM HEPES-Na pH 7.9, 20% Glycerol, 42 
mM (NH4)2SO4, 0.5 mM DTT and 0.2 mM EDTA), Buffer FW (2 mM MgCl2, 20 mM KCl, 100 
µM EDTA, 1mM DTT, 0.25 units/µl RNAseOUT—Invitrogen—, 0.4X Buffer B, 0.1% NP-40 
and 0.1% w/v BSA—NEB), Buffer PW (2 mM MgCl2, 20 mM KCl, 100 µM EDTA, 1mM DTT, 
0.25 units/µl RNAseOUT, 0.4X Buffer B and 0.1% NP-40) and Buffer SMNNE (2 mM MgCl2, 
20 mM KCl, 100 µM EDTA, 1 mM DTT and 0.4X Buffer B). 
 
For experiments other than shotgun mass spectrometry experiments, MyOne T1 beads 
(Invitrogen), 25 ul per sample, were prepared and washed according to the manufacturer’s 
protocol. Biotinylated RNA, 5 nmol per sample, was mixed with the beads and incubated for 15 
min at room temperature using gentle rotation.  Nuclear extract from HEK 293 cells 






and used to prepare splicing mix (20 mM creatine phosphate, 500 µM ATP, 2 mM MgCl2, 20 
mM KCl, 0.25 units/ul RNAseOUT, 100 uM EDTA, 1 mM DTT and diluted nuclear extract), 
50ul per sample. After two washes in Buffer FW, the beads were placed in 50 ul of splicing mix 
at 30°C for 30 min using gentle rotation. After two washes with Buffer PW and three washes 
with Buffer SMNNE, the RNA was digested with 500 ng/µl of RNase A (Invitrogen) in Buffer 
SMNNE at 30°C for 20 min. The supernatant was retrieved and run in 10% polyacrylamide gels. 
 
For shotgun mass spectrometry experiments, MyOne C1 beads (Invitrogen), 20 ul per sample, 
were prepared and washed according to the manufacturer’s protocol. Biotinylated RNA, 4 nmol 
per sample, was mixed with the beads and incubated for 15 min at room temperature using gentle 
rotation.  Nuclear extract from HEK 293 cells (ProteinOne), 12 ul per sample, was diluted 3:4 in 
Buffer B, incubated for 5 to 10 min at 30°C and used to prepare splicing mix (20 mM creatine 
phosphate, 500 µM ATP, 2 mM MgCl2, 20 mM KCl, 0.25 units/ul RNAseOUT, 100 uM EDTA, 
1 mM DTT and diluted nuclear extract), 40ul per sample. After two washes in Buffer PW, the 
beads were placed in 40 ul of splicing mix at 30°C for 30 min using gentle rotation. After two 
washes with Buffer PW and two washes with Buffer SMNNE, the beads were washed three 
times in 500 mM ammonium bicarbonate, resuspended in 30 µl of 500 mM ammonium 
bicarbonate and sent for mass spectrometry at the local facility. 
 
Shotgun mass spectrometry and data processing 
For shotgun mass spectrometry, three samples were prepared for each of the four RNA 






the local facility and the proteins were identified yielding a total of 36 individual lists that 
included a quantification index. The samples were segregated into two groups based on principal 
component analysis of the quantification results (data not shown). These two groups showed 
different quantification characteristics which might interfere with direct comparisons (data not 
shown; see below). All three measurements for two samples for the reference sequence and the 
three measurements for one sample for the ESE constituted the first group. The second group 
contained the 27 remaining measurements corresponding to the remaining 9 samples, which 
included a sample for the reference sequence (see below). To reduce false discovery, proteins for 
which a sole fragment was identified were removed. 
 
Each of the 36 lists was normalized to the total sum of its quantification index to allow 
comparison between samples in the same group. Subsequently, for each one of the two groups, 
the measurements for each protein were further normalized to the average of the measurements 
for the reference sequence for that protein. This normalization was performed to allow 
comparisons between different groups by at least partially compensating for their differing 
quantification characteristics. After these normalization steps all the resulting normalized 
measurements were combined. Proteins for which any measurement was missing were discarded. 
A list of 686 proteins was obtained. In order to identify proteins with sample specific 
enrichment, a two tailed t-test was performed using all available measurements for each possible 
pairing of RNA molecules. Proteins were chosen that had, for all comparisons, a p-value smaller 
than 7.3x10
-5







Zinc-imidazole reverse staining and gel documentation 
The protocol from Fernandez-Patron et al. (Fernandez-Patron et al. 1992) was used. Briefly, after 
electrophoresis, the gel was equilibrated in 0.2 M imidazole with 0.1% w/v SDS for 15 min and 
then exposed to 0.3 M Zn sulfate for ~30 s until the bands became easily visible but were not too 
sharp. The gel was quickly transferred to a container with double-distilled water and rinsed 5 
times for approximately 1 min each time. The gel was then placed in 0.5% w/v sodium carbonate 
and moved to a tight plastic bag; excess buffer was removed. This gel-containing bag was 
scanned in a Bio-5000 Microtek gel scanner using the “Transparent” option at high resolution. 
 
Western blots 
Western blots were performed using monoclonal mouse antibodies from Santa Cruz 
Biotechnology against PTB/hnRNP I (SH54) and hnRNP L (4D11). Detection was performed 
using secondary antibodies linked to alkaline phosphatase and CDP-Star (Roche). 
 
siRNA 
Preliminary experiments showed that even though the hnRNP K mRNA levels decreased by 48 
hrs, the protein levels had only slightly decreased by 3 days (data not shown). The half life for 
many of the proteins in Table 6.1 is suspected to be long and the absurd results observed in some 
of the articles indicate difficulties in their measurements (Boisvert et al. 2012). Therefore, 5 and 
6 day siRNA experiments were carried out with two sequential siRNA transfections (Bartlett and 






NNENNN DE using SS Set 5 (see Chapter 3) were seeded on 12-well dishes using 1 ml 
antibiotic-free MEM alpha modification (Hyclone) with 10% FBS serum (Atlanta Biologicals): 1 
large dish (100 mm) 80% confluent was enough to seed 70 wells. After 24 hours, 60 pmol of 
siRNA (siGenome Smart Pool, Dharmacon) was transfected using DharmaFECT 1 according to 
the manufacuter’s protocol. After 24 hours, the medium was changed and the cells were split: 
60% for 5-day 12-well plate and 40% to 6-day 12-well plate. After 40 hours, the cells were 
transfected again. After 48 to 58 hours, RNA was extracted from the 5-day plate and the medium 




The methodology presented in Chapter 3 was used for quantification of psi. Gamma actin was 
also quantified as explained in Chapter 3. Changes in hnRNP K were quantified using the delta-
delta-ct methodology (Livak and Schmittgen 2001). The primer for reverse transcription was 
5’-GCATTCTGTCAAAACCACCTCTT-3’. The primers for QPCR of hnRNP K mRNA were 
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Designer exons were developed to unravel the complex aspects of natural phenomena. 
These exons diminish the risks inherent in modifying sequences by controlling and reducing the 
number of changes made while studying the effect of different parameters on splicing. DEs 
constructed by random combinations of ESE and ESS modules explored a broad range of sizes 
and ESE and ESS content, and were shown to generate a gamut of inclusion levels. These exons 
did not provide a systematic approach to understand splicing but explore their potential in this 
regard. 
 
A systematic effort was then undertaken to understand the effect of three parameters 
separately: size, ESE composition and ESS composition. The relationships obtained between 
these parameters and splicing ratified previous knowledge but contained several surprising 
results. The effect of varying size on inclusion level showed the existence of an optimum size 
confirming previous observations. However, these studies also uncovered that the optimum size 
range shifted according to the splice site sequences used. For a certain size a specific 
combination of splice sites yielded a higher inclusion level than another. However, for a different 
size the opposite was true. This variation suggests that previous studies on the inherent 
“strength” of specific splice sites in a fixed context need to be reconsidered since repeating the 







Regarding the prototypical sequences used, it was found that inclusion level is positively 
affected by the presence of ESE and that multiple ESEs showed increased effects. This 
relationship can be linearly approximated. However, contrary to common assumptions, it was 
found that positional dependence is not essential and that a linear approximation is not the best 
option for modeling this phenomenon. Importantly, it was found that functional sequences need 
not be close to the splice sites in order to affect splicing. Indeed it was found that all the 
sequences used are effective in the middle of the exons and that their effectiveness is sometimes 
greater when away from the splice sites: ESS2 for example. No support was found for the 
function of specific sequences varying drastically depending on its position along the exon. One 
possible explanation for position effects reported in the past is the introduction of different 
unintended changes depending on the sequences surrounding each target position in previous 
studies. Some of these changes might have a positive effect and some a negative one that masked 
the actual effect of the studied sequence. 
 
The use of DEs was complemented by a mathematical treatment that allows the 
exploration of the predictive power of different mechanisms on splicing outcomes. A framework 
equation was obtained based on the existence of an exon definition complex by following a 
cohort of molecules that start synthesis in a negligibly small window of time. No details were 
assumed about the formation or dissociation of the exon definition complex. The obtained 
general solution for the model proved fairly complex for intuitive analysis. However, a much 
more manageable equation was found after certain assumptions were made. This equation had 
two components. The first describes the depletion of the uncommitted pool of pre-mRNA 






the time required to transcribe enough of the pre-mRNA molecule to make skipping an option 
defines this component. The second describes the competition between inclusion and skipping 
when they are available at the same time. Both the equations obtained as well as the approach 
used represent useful tools for the analysis of splicing outcomes, even if incipient efforts to 
characterize it. 
 
Two mechanisms were tested using the framework equation. The first attempted to 
explain the splicing outcomes observed when size was varied. For this purpose, interactions 
across the exon involving its ends were used as the basis of the exon definition complex. For 
these interactions to occur, the ends were assumed to establish an indirect physical contact. This 
was modeled treating the RNA molecule as a polyelectrolyte and using statistical mechanics. For 
ESEs, their facility to form interactions with other proteins involved in the splicing process was 
used as a basis for proposing a role in the stability of the exon definition complex. This was 
modeled as changes in the probability of random collisions disrupting the exon definition 
complex. An analogous model was used for ESSs and reference sequences. All of the above 
considerations were combined by assuming the contributions were independent of each other. 
Good performance was obtained for the model both in terms of its ability to reproduce the single-
parameter results as well as in terms of its ability to predict the inclusion level of more complex 
designer exons. A surprising result was that the competition component of the framework 








These results are interesting in several ways. First, the biophysical models used are 
intentionally of sufficient generality to apply to both DEs and natural exons alike. Moreover, 
these models aligned well with previously reported observations as explained in Chapters 4 and 5 
and compare favorably with some other proposed ideas in the literature. Second, the combination 
of the different contributions was potentially treacherous because interactions between different 
functional elements require time and effort to sort out. However, good results were obtained by 
simply assuming independent contributions. Third, some of the results are suggestive of a new 
understanding for how splicing occurs. As mentioned in Chapter 5, the sufficiency of the time 
component in explaining the behavior of DEs suggests that no competition between fates is 
taking place. This is consistent with an intriguing scenario in which exons can commit to 
inclusion for only a brief window of time. Fourth, even though some exons with similar contents 
of ESE and ESS modules showed different outcomes, it was found that sufficiently accurate 
predictions were obtained using general mechanisms. This is reassuring for the focus of these 
studies is the understanding of natural exons; DEs are only a tool to accomplish that goal. 
Therefore, the mechanisms used to predict DE splicing give insight into splicing of natural exons 
avoiding the risks of overanalyzing a simplified system. In a similar vein, while the conclusions 
reached are constrained by the limited number of sequences used, they still provide a platform to 
explore the predictive power of new mechanisms in a more controlled system. These 
mechanisms can then be evaluated in the context of the results available in the literature. 
 
The studies presented here are not aimed at understanding splicing in its entirety. 
However, they focus on what has been considered a crucial aspect of this process: exon 






shown here that modeling this step is enough to predict accurately the behavior of DEs. It was 
further shown that other observations in the literature are consistent with this idea. This is 
surprising given the differences between what is modeled in the equations and what is present in 
many of the insightful studies performed in vitro. How can the in vitro assay, which ignores the 
length of natural introns, the order of availability of the different parts of the pre-mRNA 
molecule and the time dimension of splicing perform so well? A partial explanation could be 
provided by the expectation that some of the functional elements in pre-mRNA sequences have 
analogous roles in both intron definition as well as exon definition, explaining the convergence 
of the results between in vitro and in vivo results. However, this convergence does not 
necessarily mean that the observations in vitro are accurate representations of the situation in 
vivo. 
 
 The proteins identified as candidates are for the most part proteins that have been shown 
to affect splicing. Further analysis would identify the contribution of each one of these proteins 
to the effect of the different sequences studied on splicing. This would allow a connection to be 
established between these results and those of other research groups. However, the effort 
required and the promising leads in other aspects of this project precluded more research in this 
area at this time. 
 
 Currently new directions are being explored for future research. Many of the ideas 
highlighted here would require more experiments to become established. Priorities need to be set 
based to a great degree on currently available technology. For example, the time frame for the 






study in vivo. The distances involved in the proposed exon-end interactions are expected to be 
around ~15 nm, which happens to be too long for FRET and too short for microscopy, even 
using super resolution techniques: a de facto blind spot. These problems are not unsolvable but 
their solution might require considerable effort, guesswork and creative solutions. Some of these 
results though suggest the existence of unexpected mechanisms that open a plethora of more 
accessible opportunities, even if they are riskier. For example, it can be surmised that a hub 
might exist and be anchored to the polymerase, maybe its CTD. Properly defined exons attach to 
this hub shortly after they are synthesized. In this way the small window of commitment time 
would be caused by the decrease in the probability of collision between the properly defined 
exons and the hub as the RNA tether between them is elongated by transcription. In this way 
exons that form an exon definition complex quickly have an advantage over those that take 
longer. Similarly, exons for which the exon definition complex is more stable have better odds of 
being captured when bumping into the hub, while those with unstable complexes might miss the 
few opportunities available to them. Safer options that are feasible with current technology 
include the study of how optimal range of exon size for splicing is affected by different splice 
site sequences. Another possibility involves studies to understand the effects of combining SR 
protein binding sites with hnRNP binding sites in the same DE. 
 
 To assess the length of the window of time for commitment, a modified version of the 
minigene used in Chapter 3 can be used. The downstream intron would be modified to have a 
long stretch of reference sequences ~500 nt. The middle exon would be a designer exon of ~20nt 
with SS Set 3 yielding an inclusion level of ~50%. In parallel, a stronger 5’ SS, AAGgtaagt for 






relationship for exon sizes from ~20 nt to ~400 nt. From the results in Chapter 3, this SS set 
should provide high psi for most of the range. This will be followed by competition experiments 
in which the stronger 5’ SS will be added downstream of the weaker 5’ SS. Since the weaker 5’ 
SS is not able to commit the middle exon to inclusion in the full window of opportunity we can 
assume that there are exons being committed all along this time period. Depending on the 
distance between the competing sites, there will be a bigger or smaller overlap in the windows of 
opportunity of the two 5’ SS. Due to the high efficiency of the downstream 5’ SS, uncommitted 
molecules would be “stolen” from the upstream 5’ SS reducing its ~50% share. When there is no 
overlap due to the time delay introduced by the elongation time required to synthesize the 
sequence separating the two 5’ SSs, the ~50% share would remain invariant as the strong 5’ SS 
is placed further downstream. This is the critical parameter to be found and can be expressed in 
nucleotides or, by simple conversion using the nominal elongation rate of the RNA polymerase 
II, in seconds. 
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